id	sid	tid	token	lemma	pos
dpc-3486	1	1	dermatology	dermatology	NOUN
dpc-3486	1	2	:	:	PUNCT
dpc-3486	1	3	practical	practical	ADJ
dpc-3486	1	4	and	and	CCONJ
dpc-3486	1	5	conceptual	conceptual	ADJ
dpc-3486	1	6	original	original	ADJ
dpc-3486	1	7	article	article	NOUN
dpc-3486	1	8	|	|	ADV
dpc-3486	1	9	dermatol	dermatol	ADJ
dpc-3486	1	10	pract	pract	NOUN
dpc-3486	1	11	concept	concept	NOUN
dpc-3486	1	12	.	.	PUNCT
dpc-3486	2	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	2	2	1	1	NUM
dpc-3486	2	3	oral	oral	ADJ
dpc-3486	2	4	mucosal	mucosal	NOUN
dpc-3486	2	5	manifestations	manifestation	NOUN
dpc-3486	2	6	associated	associate	VERB
dpc-3486	2	7	with	with	ADP
dpc-3486	2	8	pcr	pcr	ADJ
dpc-3486	2	9	positivity	positivity	NOUN
dpc-3486	2	10	in	in	ADP
dpc-3486	2	11	patients	patient	NOUN
dpc-3486	2	12	with	with	ADP
dpc-3486	2	13	covid-19	covid-19	PROPN
dpc-3486	2	14	nurcan	nurcan	ADJ
dpc-3486	2	15	metin1	metin1	NOUN
dpc-3486	2	16	,	,	PUNCT
dpc-3486	2	17	türkan	türkan	VERB
dpc-3486	2	18	tuğba	tuğba	PROPN
dpc-3486	2	19	yıldız1	yıldız1	PROPN
dpc-3486	2	20	,	,	PUNCT
dpc-3486	2	21	çağrı	çağrı	ADJ
dpc-3486	2	22	turan2	turan2	NOUN
dpc-3486	2	23	1	1	NUM
dpc-3486	2	24	department	department	NOUN
dpc-3486	2	25	of	of	ADP
dpc-3486	2	26	dermatology	dermatology	NOUN
dpc-3486	2	27	and	and	CCONJ
dpc-3486	2	28	venereology	venereology	NOUN
dpc-3486	2	29	,	,	PUNCT
dpc-3486	2	30	the	the	DET
dpc-3486	2	31	republic	republic	NOUN
dpc-3486	2	32	of	of	ADP
dpc-3486	2	33	turkey	turkey	PROPN
dpc-3486	2	34	,	,	PUNCT
dpc-3486	2	35	health	health	PROPN
dpc-3486	2	36	sciences	sciences	PROPN
dpc-3486	2	37	university	university	PROPN
dpc-3486	2	38	erzurum	erzurum	PROPN
dpc-3486	2	39	regional	regional	PROPN
dpc-3486	2	40	training	training	NOUN
dpc-3486	2	41	and	and	CCONJ
dpc-3486	2	42	research	research	NOUN
dpc-3486	2	43	hospital	hospital	NOUN
dpc-3486	2	44	,	,	PUNCT
dpc-3486	2	45	erzurum	erzurum	PROPN
dpc-3486	2	46	,	,	PUNCT
dpc-3486	2	47	turkey	turkey	PROPN
dpc-3486	2	48	2	2	NUM
dpc-3486	2	49	department	department	NOUN
dpc-3486	2	50	of	of	ADP
dpc-3486	2	51	dermatology	dermatology	NOUN
dpc-3486	2	52	and	and	CCONJ
dpc-3486	2	53	venereology	venereology	NOUN
dpc-3486	2	54	,	,	PUNCT
dpc-3486	2	55	the	the	DET
dpc-3486	2	56	republic	republic	NOUN
dpc-3486	2	57	of	of	ADP
dpc-3486	2	58	turkey	turkey	PROPN
dpc-3486	2	59	,	,	PUNCT
dpc-3486	2	60	afyonkarahisar	afyonkarahisar	PROPN
dpc-3486	2	61	health	health	PROPN
dpc-3486	2	62	sciences	sciences	PROPN
dpc-3486	2	63	university	university	PROPN
dpc-3486	2	64	,	,	PUNCT
dpc-3486	2	65	afyonkarahisar	afyonkarahisar	PROPN
dpc-3486	2	66	,	,	PUNCT
dpc-3486	2	67	turkey	turkey	NOUN
dpc-3486	2	68	key	key	ADJ
dpc-3486	2	69	words	word	NOUN
dpc-3486	2	70	:	:	PUNCT
dpc-3486	2	71	covid-19	covid-19	PROPN
dpc-3486	2	72	,	,	PUNCT
dpc-3486	2	73	pcr	pcr	ADJ
dpc-3486	2	74	test	test	NOUN
dpc-3486	2	75	,	,	PUNCT
dpc-3486	2	76	oral	oral	ADJ
dpc-3486	2	77	mucosa	mucosa	NOUN
dpc-3486	2	78	,	,	PUNCT
dpc-3486	2	79	manifestations	manifestation	NOUN
dpc-3486	2	80	,	,	PUNCT
dpc-3486	2	81	microvesicles	microvesicle	NOUN
dpc-3486	2	82	,	,	PUNCT
dpc-3486	2	83	petechiae	petechiae	NOUN
dpc-3486	2	84	citation	citation	NOUN
dpc-3486	2	85	:	:	PUNCT
dpc-3486	2	86	metin	metin	PROPN
dpc-3486	2	87	n	n	PROPN
dpc-3486	2	88	,	,	PUNCT
dpc-3486	2	89	yıldız	yıldız	PROPN
dpc-3486	2	90	tt	tt	PROPN
dpc-3486	2	91	,	,	PUNCT
dpc-3486	2	92	turan	turan	PROPN
dpc-3486	2	93	c.	c.	PROPN
dpc-3486	2	94	oral	oral	ADJ
dpc-3486	2	95	mucosal	mucosal	NOUN
dpc-3486	2	96	manifestations	manifestation	NOUN
dpc-3486	2	97	associated	associate	VERB
dpc-3486	2	98	with	with	ADP
dpc-3486	2	99	pcr	pcr	ADJ
dpc-3486	2	100	positivity	positivity	NOUN
dpc-3486	2	101	in	in	ADP
dpc-3486	2	102	patients	patient	NOUN
dpc-3486	2	103	with	with	ADP
dpc-3486	2	104	covid-19	covid-19	PROPN
dpc-3486	2	105	.	.	PROPN
dpc-3486	3	1	dermatol	dermatol	PROPN
dpc-3486	3	2	pract	pract	PROPN
dpc-3486	3	3	concept	concept	NOUN
dpc-3486	3	4	.	.	PUNCT
dpc-3486	4	1	2024;14(1):e2024045	2024;14(1):e2024045	X
dpc-3486	4	2	.	.	PUNCT
dpc-3486	5	1	doi	doi	NOUN
dpc-3486	5	2	:	:	PUNCT
dpc-3486	5	3	https://doi.org/10.5826/dpc.1401a45	https://doi.org/10.5826/dpc.1401a45	PROPN
dpc-3486	5	4	accepted	accept	VERB
dpc-3486	5	5	:	:	PUNCT
dpc-3486	5	6	august	august	PROPN
dpc-3486	5	7	26	26	NUM
dpc-3486	5	8	,	,	PUNCT
dpc-3486	5	9	2023	2023	NUM
dpc-3486	5	10	;	;	PUNCT
dpc-3486	5	11	published	publish	VERB
dpc-3486	5	12	:	:	PUNCT
dpc-3486	5	13	january	january	PROPN
dpc-3486	5	14	2024	2024	NUM
dpc-3486	6	1	copyright	copyright	NOUN
dpc-3486	6	2	:	:	PUNCT
dpc-3486	6	3	©	©	PROPN
dpc-3486	6	4	2024	2024	NUM
dpc-3486	6	5	metin	metin	PROPN
dpc-3486	6	6	et	et	PROPN
dpc-3486	6	7	al	al	PROPN
dpc-3486	6	8	.	.	PUNCT
dpc-3486	7	1	this	this	PRON
dpc-3486	7	2	is	be	AUX
dpc-3486	7	3	an	an	DET
dpc-3486	7	4	open	open	ADJ
dpc-3486	7	5	-	-	PUNCT
dpc-3486	7	6	access	access	NOUN
dpc-3486	7	7	article	article	NOUN
dpc-3486	7	8	distributed	distribute	VERB
dpc-3486	7	9	under	under	ADP
dpc-3486	7	10	the	the	DET
dpc-3486	7	11	terms	term	NOUN
dpc-3486	7	12	of	of	ADP
dpc-3486	7	13	the	the	DET
dpc-3486	7	14	creative	creative	ADJ
dpc-3486	7	15	commons	common	NOUN
dpc-3486	7	16	attribution	attribution	NOUN
dpc-3486	7	17	-	-	PUNCT
dpc-3486	7	18	noncommercial	noncommercial	ADJ
dpc-3486	7	19	license	license	NOUN
dpc-3486	7	20	(	(	PUNCT
dpc-3486	7	21	by	by	ADP
dpc-3486	7	22	-	-	PUNCT
dpc-3486	7	23	nc-4.0	nc-4.0	NOUN
dpc-3486	7	24	)	)	PUNCT
dpc-3486	7	25	,	,	PUNCT
dpc-3486	7	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3486	7	27	,	,	PUNCT
dpc-3486	7	28	which	which	PRON
dpc-3486	7	29	permits	permit	VERB
dpc-3486	7	30	unrestricted	unrestricted	ADJ
dpc-3486	7	31	noncommercial	noncommercial	ADJ
dpc-3486	7	32	use	use	NOUN
dpc-3486	7	33	,	,	PUNCT
dpc-3486	7	34	distribution	distribution	NOUN
dpc-3486	7	35	,	,	PUNCT
dpc-3486	7	36	and	and	CCONJ
dpc-3486	7	37	reproduction	reproduction	NOUN
dpc-3486	7	38	in	in	ADP
dpc-3486	7	39	any	any	DET
dpc-3486	7	40	medium	medium	NOUN
dpc-3486	7	41	,	,	PUNCT
dpc-3486	7	42	provided	provide	VERB
dpc-3486	7	43	the	the	DET
dpc-3486	7	44	original	original	ADJ
dpc-3486	7	45	authors	author	NOUN
dpc-3486	7	46	and	and	CCONJ
dpc-3486	7	47	source	source	NOUN
dpc-3486	7	48	are	be	AUX
dpc-3486	7	49	credited	credit	VERB
dpc-3486	7	50	.	.	PUNCT
dpc-3486	8	1	funding	funding	NOUN
dpc-3486	8	2	:	:	PUNCT
dpc-3486	8	3	none	none	NOUN
dpc-3486	8	4	.	.	PUNCT
dpc-3486	9	1	competing	compete	VERB
dpc-3486	9	2	interests	interest	NOUN
dpc-3486	9	3	:	:	PUNCT
dpc-3486	9	4	none	none	NOUN
dpc-3486	9	5	.	.	PUNCT
dpc-3486	10	1	authorship	authorship	NOUN
dpc-3486	10	2	:	:	PUNCT
dpc-3486	10	3	all	all	DET
dpc-3486	10	4	authors	author	NOUN
dpc-3486	10	5	have	have	AUX
dpc-3486	10	6	contributed	contribute	VERB
dpc-3486	10	7	significantly	significantly	ADV
dpc-3486	10	8	to	to	ADP
dpc-3486	10	9	this	this	DET
dpc-3486	10	10	publication	publication	NOUN
dpc-3486	10	11	.	.	PUNCT
dpc-3486	11	1	corresponding	correspond	VERB
dpc-3486	11	2	author	author	NOUN
dpc-3486	11	3	:	:	PUNCT
dpc-3486	11	4	nurcan	nurcan	PROPN
dpc-3486	11	5	metin	metin	PROPN
dpc-3486	11	6	,	,	PUNCT
dpc-3486	11	7	department	department	NOUN
dpc-3486	11	8	of	of	ADP
dpc-3486	11	9	dermatology	dermatology	NOUN
dpc-3486	11	10	and	and	CCONJ
dpc-3486	11	11	venereology	venereology	NOUN
dpc-3486	11	12	,	,	PUNCT
dpc-3486	11	13	the	the	DET
dpc-3486	11	14	republic	republic	NOUN
dpc-3486	11	15	of	of	ADP
dpc-3486	11	16	turkey	turkey	PROPN
dpc-3486	11	17	,	,	PUNCT
dpc-3486	11	18	health	health	PROPN
dpc-3486	11	19	sciences	sciences	PROPN
dpc-3486	11	20	university	university	PROPN
dpc-3486	11	21	erzurum	erzurum	PROPN
dpc-3486	11	22	regional	regional	PROPN
dpc-3486	11	23	training	training	NOUN
dpc-3486	11	24	and	and	CCONJ
dpc-3486	11	25	research	research	NOUN
dpc-3486	11	26	hospital	hospital	NOUN
dpc-3486	11	27	,	,	PUNCT
dpc-3486	11	28	erzurum	erzurum	PROPN
dpc-3486	11	29	,	,	PUNCT
dpc-3486	11	30	turkey	turkey	PROPN
dpc-3486	11	31	;	;	PUNCT
dpc-3486	11	32	üniversitemahallesi	üniversitemahallesi	NOUN
dpc-3486	11	33	,	,	PUNCT
dpc-3486	11	34	çatyolu	çatyolu	PROPN
dpc-3486	11	35	cd	cd	PROPN
dpc-3486	11	36	.	.	PROPN
dpc-3486	11	37	,	,	PUNCT
dpc-3486	11	38	yakutiye	yakutiye	PROPN
dpc-3486	11	39	/	/	SYM
dpc-3486	11	40	erzurum	erzurum	PROPN
dpc-3486	11	41	,	,	PUNCT
dpc-3486	11	42	post	post	PROPN
dpc-3486	11	43	code	code	NOUN
dpc-3486	11	44	:	:	PUNCT
dpc-3486	11	45	25240	25240	NUM
dpc-3486	11	46	telephone	telephone	NOUN
dpc-3486	11	47	number	number	NOUN
dpc-3486	11	48	:	:	PUNCT
dpc-3486	11	49	+905075806255	+905075806255	NUM
dpc-3486	11	50	e	e	X
dpc-3486	11	51	-	-	NOUN
dpc-3486	11	52	mail	mail	NOUN
dpc-3486	11	53	:	:	PUNCT
dpc-3486	11	54	drnurcanmetin@hotmail.com	drnurcanmetin@hotmail.com	X
dpc-3486	12	1	introduction	introduction	NOUN
dpc-3486	12	2	:	:	PUNCT
dpc-3486	12	3	to	to	PART
dpc-3486	12	4	date	date	VERB
dpc-3486	12	5	various	various	ADJ
dpc-3486	12	6	oral	oral	ADJ
dpc-3486	12	7	manifestations	manifestation	NOUN
dpc-3486	12	8	in	in	ADP
dpc-3486	12	9	patients	patient	NOUN
dpc-3486	12	10	with	with	ADP
dpc-3486	12	11	coronavirus	coronavirus	NOUN
dpc-3486	12	12	disease	disease	NOUN
dpc-3486	12	13	2019	2019	NUM
dpc-3486	12	14	(	(	PUNCT
dpc-3486	12	15	covid-19	covid-19	PROPN
dpc-3486	12	16	)	)	PUNCT
dpc-3486	12	17	have	have	AUX
dpc-3486	12	18	been	be	AUX
dpc-3486	12	19	reported	report	VERB
dpc-3486	12	20	.	.	PUNCT
dpc-3486	13	1	objectives	objective	NOUN
dpc-3486	13	2	:	:	PUNCT
dpc-3486	13	3	in	in	ADP
dpc-3486	13	4	the	the	DET
dpc-3486	13	5	present	present	ADJ
dpc-3486	13	6	study	study	NOUN
dpc-3486	13	7	,	,	PUNCT
dpc-3486	13	8	we	we	PRON
dpc-3486	13	9	investigated	investigate	VERB
dpc-3486	13	10	the	the	DET
dpc-3486	13	11	relationship	relationship	NOUN
dpc-3486	13	12	between	between	ADP
dpc-3486	13	13	polymerase	polymerase	NOUN
dpc-3486	13	14	chain	chain	NOUN
dpc-3486	13	15	reaction	reaction	NOUN
dpc-3486	13	16	(	(	PUNCT
dpc-3486	13	17	pcr	pcr	NOUN
dpc-3486	13	18	)	)	PUNCT
dpc-3486	13	19	positivity	positivity	NOUN
dpc-3486	13	20	and	and	CCONJ
dpc-3486	13	21	oral	oral	ADJ
dpc-3486	13	22	signs	sign	NOUN
dpc-3486	13	23	in	in	ADP
dpc-3486	13	24	patients	patient	NOUN
dpc-3486	13	25	with	with	ADP
dpc-3486	13	26	suspected	suspect	VERB
dpc-3486	13	27	covid-19	covid-19	PROPN
dpc-3486	13	28	.	.	PUNCT
dpc-3486	13	29	methods	method	NOUN
dpc-3486	13	30	:	:	PUNCT
dpc-3486	13	31	a	a	DET
dpc-3486	13	32	total	total	NOUN
dpc-3486	13	33	of	of	ADP
dpc-3486	13	34	383	383	NUM
dpc-3486	13	35	patients	patient	NOUN
dpc-3486	13	36	who	who	PRON
dpc-3486	13	37	presented	present	VERB
dpc-3486	13	38	to	to	ADP
dpc-3486	13	39	the	the	DET
dpc-3486	13	40	emergency	emergency	NOUN
dpc-3486	13	41	department	department	NOUN
dpc-3486	13	42	for	for	ADP
dpc-3486	13	43	the	the	DET
dpc-3486	13	44	first	first	ADJ
dpc-3486	13	45	time	time	NOUN
dpc-3486	13	46	with	with	ADP
dpc-3486	13	47	any	any	DET
dpc-3486	13	48	symptoms	symptom	NOUN
dpc-3486	13	49	associated	associate	VERB
dpc-3486	13	50	with	with	ADP
dpc-3486	13	51	covid-19	covid-19	PROPN
dpc-3486	13	52	were	be	AUX
dpc-3486	13	53	included	include	VERB
dpc-3486	13	54	in	in	ADP
dpc-3486	13	55	the	the	DET
dpc-3486	13	56	study	study	NOUN
dpc-3486	13	57	.	.	PUNCT
dpc-3486	14	1	oral	oral	ADJ
dpc-3486	14	2	examinations	examination	NOUN
dpc-3486	14	3	were	be	AUX
dpc-3486	14	4	performed	perform	VERB
dpc-3486	14	5	and	and	CCONJ
dpc-3486	14	6	the	the	DET
dpc-3486	14	7	findings	finding	NOUN
dpc-3486	14	8	,	,	PUNCT
dpc-3486	14	9	pcr	pcr	ADJ
dpc-3486	14	10	status	status	NOUN
dpc-3486	14	11	,	,	PUNCT
dpc-3486	14	12	and	and	CCONJ
dpc-3486	14	13	thorax	thorax	NOUN
dpc-3486	14	14	computerized	computerized	ADJ
dpc-3486	14	15	tomography	tomography	NOUN
dpc-3486	14	16	(	(	PUNCT
dpc-3486	14	17	ct	ct	NOUN
dpc-3486	14	18	)	)	PUNCT
dpc-3486	14	19	reports	report	NOUN
dpc-3486	14	20	were	be	AUX
dpc-3486	14	21	recorded	record	VERB
dpc-3486	14	22	.	.	PUNCT
dpc-3486	15	1	results	result	NOUN
dpc-3486	15	2	:	:	PUNCT
dpc-3486	15	3	oral	oral	ADJ
dpc-3486	15	4	mucosa	mucosa	NOUN
dpc-3486	15	5	was	be	AUX
dpc-3486	15	6	involved	involve	VERB
dpc-3486	15	7	in	in	ADP
dpc-3486	15	8	246	246	NUM
dpc-3486	15	9	(	(	PUNCT
dpc-3486	15	10	64.2	64.2	NUM
dpc-3486	15	11	%	%	NOUN
dpc-3486	15	12	)	)	PUNCT
dpc-3486	15	13	patients	patient	NOUN
dpc-3486	15	14	.	.	PUNCT
dpc-3486	16	1	175	175	NUM
dpc-3486	16	2	(	(	PUNCT
dpc-3486	16	3	78,4	78,4	NUM
dpc-3486	16	4	%	%	NOUN
dpc-3486	16	5	)	)	PUNCT
dpc-3486	16	6	of	of	ADP
dpc-3486	16	7	patients	patient	NOUN
dpc-3486	16	8	with	with	ADP
dpc-3486	16	9	covid-19	covid-19	PROPN
dpc-3486	16	10	confirmed	confirm	VERB
dpc-3486	16	11	the	the	DET
dpc-3486	16	12	diagnosis	diagnosis	NOUN
dpc-3486	16	13	with	with	ADP
dpc-3486	16	14	pcr	pcr	ADJ
dpc-3486	16	15	test	test	NOUN
dpc-3486	16	16	or	or	CCONJ
dpc-3486	16	17	ct	ct	NUM
dpc-3486	16	18	results	result	NOUN
dpc-3486	16	19	had	have	VERB
dpc-3486	16	20	oral	oral	ADJ
dpc-3486	16	21	manifestation	manifestation	NOUN
dpc-3486	16	22	.	.	PUNCT
dpc-3486	17	1	dry	dry	ADJ
dpc-3486	17	2	mouth	mouth	NOUN
dpc-3486	17	3	,	,	PUNCT
dpc-3486	17	4	microvesicles	microvesicle	NOUN
dpc-3486	17	5	on	on	ADP
dpc-3486	17	6	the	the	DET
dpc-3486	17	7	tonsils	tonsil	NOUN
dpc-3486	17	8	or	or	CCONJ
dpc-3486	17	9	pharynx	pharynx	NOUN
dpc-3486	17	10	,	,	PUNCT
dpc-3486	17	11	and	and	CCONJ
dpc-3486	17	12	petechiae	petechiae	NOUN
dpc-3486	17	13	in	in	ADP
dpc-3486	17	14	the	the	DET
dpc-3486	17	15	oropharynx	oropharynx	NOUN
dpc-3486	17	16	were	be	AUX
dpc-3486	17	17	significantly	significantly	ADV
dpc-3486	17	18	higher	high	ADJ
dpc-3486	17	19	in	in	ADP
dpc-3486	17	20	patients	patient	NOUN
dpc-3486	17	21	with	with	ADP
dpc-3486	17	22	positive	positive	ADJ
dpc-3486	17	23	pcr	pcr	ADJ
dpc-3486	17	24	tests	test	NOUN
dpc-3486	17	25	(	(	PUNCT
dpc-3486	17	26	p	p	NOUN
dpc-3486	17	27	=	=	NOUN
dpc-3486	17	28	0.001	0.001	NUM
dpc-3486	17	29	,	,	PUNCT
dpc-3486	17	30	p	p	X
dpc-3486	17	31	<	<	X
dpc-3486	17	32	0.001	0.001	NUM
dpc-3486	17	33	,	,	PUNCT
dpc-3486	17	34	p	p	X
dpc-3486	17	35	<	<	X
dpc-3486	17	36	0.001	0.001	NUM
dpc-3486	17	37	,	,	PUNCT
dpc-3486	17	38	respectively	respectively	ADV
dpc-3486	17	39	)	)	PUNCT
dpc-3486	17	40	.	.	PUNCT
dpc-3486	18	1	the	the	DET
dpc-3486	18	2	ratio	ratio	NOUN
dpc-3486	18	3	of	of	ADP
dpc-3486	18	4	intact	intact	ADJ
dpc-3486	18	5	oral	oral	ADJ
dpc-3486	18	6	mucosa	mucosa	NOUN
dpc-3486	18	7	was	be	AUX
dpc-3486	18	8	statistically	statistically	ADV
dpc-3486	18	9	significantly	significantly	ADV
dpc-3486	18	10	higher	high	ADJ
dpc-3486	18	11	in	in	ADP
dpc-3486	18	12	patients	patient	NOUN
dpc-3486	18	13	with	with	ADP
dpc-3486	18	14	negative	negative	ADJ
dpc-3486	18	15	pcr	pcr	ADJ
dpc-3486	18	16	tests	test	NOUN
dpc-3486	18	17	compared	compare	VERB
dpc-3486	18	18	to	to	ADP
dpc-3486	18	19	those	those	PRON
dpc-3486	18	20	with	with	ADP
dpc-3486	18	21	positive	positive	ADJ
dpc-3486	18	22	pcr	pcr	ADJ
dpc-3486	18	23	tests	test	NOUN
dpc-3486	18	24	(	(	PUNCT
dpc-3486	18	25	p	p	X
dpc-3486	18	26	<	<	X
dpc-3486	18	27	0.001	0.001	NUM
dpc-3486	18	28	)	)	PUNCT
dpc-3486	18	29	.	.	PUNCT
dpc-3486	19	1	microvesicles	microvesicle	NOUN
dpc-3486	19	2	on	on	ADP
dpc-3486	19	3	the	the	DET
dpc-3486	19	4	tonsils	tonsil	NOUN
dpc-3486	19	5	or	or	CCONJ
dpc-3486	19	6	pharynx	pharynx	NOUN
dpc-3486	19	7	were	be	AUX
dpc-3486	19	8	most	most	ADV
dpc-3486	19	9	associated	associate	VERB
dpc-3486	19	10	with	with	ADP
dpc-3486	19	11	pcr	pcr	ADJ
dpc-3486	19	12	positivity	positivity	NOUN
dpc-3486	19	13	in	in	ADP
dpc-3486	19	14	patients	patient	NOUN
dpc-3486	19	15	without	without	ADP
dpc-3486	19	16	lung	lung	NOUN
dpc-3486	19	17	involvement	involvement	NOUN
dpc-3486	19	18	(	(	PUNCT
dpc-3486	19	19	p	p	X
dpc-3486	19	20	<	<	X
dpc-3486	19	21	0.001	0.001	NUM
dpc-3486	19	22	)	)	PUNCT
dpc-3486	19	23	.	.	PUNCT
dpc-3486	20	1	dry	dry	ADJ
dpc-3486	20	2	mouth	mouth	NOUN
dpc-3486	20	3	,	,	PUNCT
dpc-3486	20	4	erythema	erythema	ADV
dpc-3486	20	5	of	of	ADP
dpc-3486	20	6	the	the	DET
dpc-3486	20	7	tonsils	tonsil	NOUN
dpc-3486	20	8	and	and	CCONJ
dpc-3486	20	9	pharynx	pharynx	NOUN
dpc-3486	20	10	,	,	PUNCT
dpc-3486	20	11	petechiae	petechiae	NOUN
dpc-3486	20	12	in	in	ADP
dpc-3486	20	13	the	the	DET
dpc-3486	20	14	oropharynx	oropharynx	NOUN
dpc-3486	20	15	,	,	PUNCT
dpc-3486	20	16	and	and	CCONJ
dpc-3486	20	17	primary	primary	ADJ
dpc-3486	20	18	/	/	SYM
dpc-3486	20	19	secondary	secondary	ADJ
dpc-3486	20	20	herpes	herpe	NOUN
dpc-3486	20	21	infection	infection	NOUN
dpc-3486	20	22	are	be	AUX
dpc-3486	20	23	more	more	ADV
dpc-3486	20	24	related	related	ADJ
dpc-3486	20	25	to	to	ADP
dpc-3486	20	26	pcr	pcr	ADJ
dpc-3486	20	27	positivity	positivity	NOUN
dpc-3486	20	28	in	in	ADP
dpc-3486	20	29	patients	patient	NOUN
dpc-3486	20	30	without	without	ADP
dpc-3486	20	31	lung	lung	NOUN
dpc-3486	20	32	involvement	involvement	NOUN
dpc-3486	20	33	(	(	PUNCT
dpc-3486	20	34	p	p	X
dpc-3486	20	35	<	<	X
dpc-3486	20	36	0.05	0.05	NUM
dpc-3486	20	37	)	)	PUNCT
dpc-3486	20	38	.	.	PUNCT
dpc-3486	21	1	lung	lung	NOUN
dpc-3486	21	2	involvement	involvement	NOUN
dpc-3486	21	3	in	in	ADP
dpc-3486	21	4	patients	patient	NOUN
dpc-3486	21	5	with	with	ADP
dpc-3486	21	6	pcr	pcr	ADJ
dpc-3486	21	7	positivity	positivity	NOUN
dpc-3486	21	8	is	be	AUX
dpc-3486	21	9	related	relate	VERB
dpc-3486	21	10	to	to	ADP
dpc-3486	21	11	only	only	ADJ
dpc-3486	21	12	cheilitis	cheilitis	NOUN
dpc-3486	21	13	(	(	PUNCT
dpc-3486	21	14	p	p	NOUN
dpc-3486	21	15	=	=	NOUN
dpc-3486	21	16	0.034	0.034	NUM
dpc-3486	21	17	)	)	PUNCT
dpc-3486	21	18	.	.	PUNCT
dpc-3486	22	1	conclusions	conclusion	NOUN
dpc-3486	22	2	:	:	PUNCT
dpc-3486	22	3	our	our	PRON
dpc-3486	22	4	study	study	NOUN
dpc-3486	22	5	revealed	reveal	VERB
dpc-3486	22	6	that	that	SCONJ
dpc-3486	22	7	especially	especially	ADV
dpc-3486	22	8	microvesicles	microvesicle	NOUN
dpc-3486	22	9	,	,	PUNCT
dpc-3486	22	10	petechiae	petechiae	NOUN
dpc-3486	22	11	,	,	PUNCT
dpc-3486	22	12	erythema	erythema	ADV
dpc-3486	22	13	on	on	ADP
dpc-3486	22	14	the	the	DET
dpc-3486	22	15	tonsils	tonsil	NOUN
dpc-3486	22	16	or	or	CCONJ
dpc-3486	22	17	pharynx	pharynx	NOUN
dpc-3486	22	18	,	,	PUNCT
dpc-3486	22	19	and	and	CCONJ
dpc-3486	22	20	some	some	DET
dpc-3486	22	21	other	other	ADJ
dpc-3486	22	22	oral	oral	ADJ
dpc-3486	22	23	lesions	lesion	NOUN
dpc-3486	22	24	such	such	ADJ
dpc-3486	22	25	as	as	ADP
dpc-3486	22	26	dry	dry	ADJ
dpc-3486	22	27	mouth	mouth	NOUN
dpc-3486	22	28	,	,	PUNCT
dpc-3486	22	29	oral	oral	ADJ
dpc-3486	22	30	aphthae	aphthae	NOUN
dpc-3486	22	31	,	,	PUNCT
dpc-3486	22	32	and	and	CCONJ
dpc-3486	22	33	primary	primary	ADJ
dpc-3486	22	34	/	/	SYM
dpc-3486	22	35	secondary	secondary	ADJ
dpc-3486	22	36	herpes	herpe	NOUN
dpc-3486	22	37	infection	infection	NOUN
dpc-3486	22	38	are	be	AUX
dpc-3486	22	39	associated	associate	VERB
dpc-3486	22	40	with	with	ADP
dpc-3486	22	41	pcr	pcr	NOUN
dpc-3486	22	42	positivity	positivity	NOUN
dpc-3486	22	43	.	.	PUNCT
dpc-3486	23	1	abstract	abstract	ADJ
dpc-3486	23	2	2	2	NUM
dpc-3486	23	3	original	original	ADJ
dpc-3486	23	4	article	article	NOUN
dpc-3486	23	5	|	|	ADV
dpc-3486	23	6	dermatol	dermatol	ADJ
dpc-3486	23	7	pract	pract	NOUN
dpc-3486	23	8	concept	concept	NOUN
dpc-3486	23	9	.	.	PUNCT
dpc-3486	24	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	24	2	introduction	introduction	NOUN
dpc-3486	24	3	severe	severe	ADJ
dpc-3486	24	4	acute	acute	ADJ
dpc-3486	24	5	respiratory	respiratory	ADJ
dpc-3486	24	6	syndrome	syndrome	NOUN
dpc-3486	24	7	coronavirus	coronavirus	NOUN
dpc-3486	24	8	2	2	NUM
dpc-3486	24	9	(	(	PUNCT
dpc-3486	24	10	sars	sar	NOUN
dpc-3486	24	11	-	-	PUNCT
dpc-3486	24	12	cov2	cov2	PROPN
dpc-3486	24	13	)	)	PUNCT
dpc-3486	24	14	is	be	AUX
dpc-3486	24	15	a	a	DET
dpc-3486	24	16	novel	novel	ADJ
dpc-3486	24	17	virus	virus	NOUN
dpc-3486	24	18	that	that	PRON
dpc-3486	24	19	generating	generate	VERB
dpc-3486	24	20	coronavirus	coronavirus	NOUN
dpc-3486	24	21	disease	disease	NOUN
dpc-3486	24	22	2019	2019	NUM
dpc-3486	24	23	(	(	PUNCT
dpc-3486	24	24	covid-19	covid-19	PROPN
dpc-3486	24	25	)	)	PUNCT
dpc-3486	24	26	.	.	PUNCT
dpc-3486	25	1	the	the	DET
dpc-3486	25	2	disease	disease	NOUN
dpc-3486	25	3	first	first	ADV
dpc-3486	25	4	started	start	VERB
dpc-3486	25	5	in	in	ADP
dpc-3486	25	6	china	china	PROPN
dpc-3486	25	7	and	and	CCONJ
dpc-3486	25	8	spread	spread	VERB
dpc-3486	25	9	rapidly	rapidly	ADV
dpc-3486	25	10	all	all	ADV
dpc-3486	25	11	over	over	ADP
dpc-3486	25	12	the	the	DET
dpc-3486	25	13	world	world	NOUN
dpc-3486	25	14	in	in	ADP
dpc-3486	25	15	a	a	DET
dpc-3486	25	16	short	short	ADJ
dpc-3486	25	17	time	time	NOUN
dpc-3486	25	18	.	.	PUNCT
dpc-3486	26	1	transmission	transmission	NOUN
dpc-3486	26	2	mainly	mainly	ADV
dpc-3486	26	3	happens	happen	VERB
dpc-3486	26	4	through	through	ADP
dpc-3486	26	5	large	large	ADJ
dpc-3486	26	6	droplets	droplet	NOUN
dpc-3486	26	7	that	that	PRON
dpc-3486	26	8	occur	occur	VERB
dpc-3486	26	9	during	during	ADP
dpc-3486	26	10	coughing	cough	VERB
dpc-3486	26	11	and	and	CCONJ
dpc-3486	26	12	sneezing	sneeze	VERB
dpc-3486	26	13	by	by	ADP
dpc-3486	26	14	symptomatic	symptomatic	ADJ
dpc-3486	26	15	patients	patient	NOUN
dpc-3486	26	16	.	.	PUNCT
dpc-3486	27	1	also	also	ADV
dpc-3486	27	2	contact	contact	VERB
dpc-3486	27	3	with	with	ADP
dpc-3486	27	4	contaminated	contaminate	VERB
dpc-3486	27	5	surfaces	surface	NOUN
dpc-3486	27	6	may	may	AUX
dpc-3486	27	7	be	be	AUX
dpc-3486	27	8	a	a	DET
dpc-3486	27	9	risk	risk	NOUN
dpc-3486	27	10	for	for	ADP
dpc-3486	27	11	transmission	transmission	NOUN
dpc-3486	27	12	[	[	X
dpc-3486	27	13	1	1	NUM
dpc-3486	27	14	]	]	PUNCT
dpc-3486	27	15	.	.	PUNCT
dpc-3486	28	1	the	the	DET
dpc-3486	28	2	respiratory	respiratory	ADJ
dpc-3486	28	3	tract	tract	NOUN
dpc-3486	28	4	is	be	AUX
dpc-3486	28	5	the	the	DET
dpc-3486	28	6	primary	primary	ADJ
dpc-3486	28	7	site	site	NOUN
dpc-3486	28	8	of	of	ADP
dpc-3486	28	9	infection	infection	NOUN
dpc-3486	28	10	,	,	PUNCT
dpc-3486	28	11	with	with	ADP
dpc-3486	28	12	no	no	DET
dpc-3486	28	13	symptoms	symptom	NOUN
dpc-3486	28	14	or	or	CCONJ
dpc-3486	28	15	symptoms	symptom	NOUN
dpc-3486	28	16	ranging	range	VERB
dpc-3486	28	17	from	from	ADP
dpc-3486	28	18	mild	mild	ADJ
dpc-3486	28	19	flu	flu	NOUN
dpc-3486	28	20	-	-	PUNCT
dpc-3486	28	21	like	like	ADJ
dpc-3486	28	22	symptoms	symptom	NOUN
dpc-3486	28	23	to	to	ADP
dpc-3486	28	24	fulminant	fulminant	ADJ
dpc-3486	28	25	pneumonia	pneumonia	NOUN
dpc-3486	28	26	and	and	CCONJ
dpc-3486	28	27	potentially	potentially	ADV
dpc-3486	28	28	mortal	mortal	ADJ
dpc-3486	28	29	respiratory	respiratory	ADJ
dpc-3486	28	30	distress	distress	NOUN
dpc-3486	28	31	[	[	X
dpc-3486	28	32	2	2	NUM
dpc-3486	28	33	]	]	PUNCT
dpc-3486	28	34	.	.	PUNCT
dpc-3486	29	1	the	the	DET
dpc-3486	29	2	most	most	ADV
dpc-3486	29	3	common	common	ADJ
dpc-3486	29	4	reported	report	VERB
dpc-3486	29	5	symptoms	symptom	NOUN
dpc-3486	29	6	among	among	ADP
dpc-3486	29	7	patients	patient	NOUN
dpc-3486	29	8	with	with	ADP
dpc-3486	29	9	symptomatic	symptomatic	ADJ
dpc-3486	29	10	covid-19	covid-19	PROPN
dpc-3486	29	11	are	be	AUX
dpc-3486	29	12	dry	dry	ADJ
dpc-3486	29	13	cough	cough	NOUN
dpc-3486	29	14	,	,	PUNCT
dpc-3486	29	15	myalgias	myalgia	NOUN
dpc-3486	29	16	,	,	PUNCT
dpc-3486	29	17	fever	fever	NOUN
dpc-3486	29	18	and	and	CCONJ
dpc-3486	29	19	headache	headache	NOUN
dpc-3486	29	20	.	.	PUNCT
dpc-3486	30	1	high	high	ADJ
dpc-3486	30	2	fever	fever	NOUN
dpc-3486	30	3	(	(	PUNCT
dpc-3486	30	4	>	>	X
dpc-3486	30	5	38	38	NUM
dpc-3486	30	6	°	°	NOUN
dpc-3486	30	7	c	c	NOUN
dpc-3486	30	8	)	)	PUNCT
dpc-3486	30	9	was	be	AUX
dpc-3486	30	10	found	find	VERB
dpc-3486	30	11	associated	associate	VERB
dpc-3486	30	12	with	with	ADP
dpc-3486	30	13	covid-19	covid-19	PROPN
dpc-3486	30	14	pcr	pcr	ADJ
dpc-3486	30	15	positivity	positivity	NOUN
dpc-3486	30	16	[	[	X
dpc-3486	30	17	3	3	NUM
dpc-3486	30	18	]	]	PUNCT
dpc-3486	30	19	.	.	PUNCT
dpc-3486	31	1	research	research	NOUN
dpc-3486	31	2	shows	show	VERB
dpc-3486	31	3	that	that	SCONJ
dpc-3486	31	4	sars	sar	NOUN
dpc-3486	31	5	-	-	PUNCT
dpc-3486	31	6	cov-2	cov-2	PART
dpc-3486	31	7	enters	enter	VERB
dpc-3486	31	8	human	human	ADJ
dpc-3486	31	9	cells	cell	NOUN
dpc-3486	31	10	by	by	ADP
dpc-3486	31	11	binding	bind	VERB
dpc-3486	31	12	to	to	ADP
dpc-3486	31	13	the	the	DET
dpc-3486	31	14	angiotensin	angiotensin	NOUN
dpc-3486	31	15	-	-	PUNCT
dpc-3486	31	16	converting	convert	VERB
dpc-3486	31	17	enzyme	enzyme	NOUN
dpc-3486	31	18	2	2	NUM
dpc-3486	31	19	(	(	PUNCT
dpc-3486	31	20	ace2	ace2	NOUN
dpc-3486	31	21	)	)	PUNCT
dpc-3486	31	22	receptor	receptor	NOUN
dpc-3486	31	23	.	.	PUNCT
dpc-3486	32	1	the	the	DET
dpc-3486	32	2	ace2	ace2	PROPN
dpc-3486	32	3	receptor	receptor	NOUN
dpc-3486	32	4	is	be	AUX
dpc-3486	32	5	detected	detect	VERB
dpc-3486	32	6	in	in	ADP
dpc-3486	32	7	the	the	DET
dpc-3486	32	8	cell	cell	NOUN
dpc-3486	32	9	membrane	membrane	NOUN
dpc-3486	32	10	of	of	ADP
dpc-3486	32	11	many	many	ADJ
dpc-3486	32	12	human	human	ADJ
dpc-3486	32	13	organs	organ	NOUN
dpc-3486	32	14	and	and	CCONJ
dpc-3486	32	15	tissues	tissue	NOUN
dpc-3486	32	16	,	,	PUNCT
dpc-3486	32	17	including	include	VERB
dpc-3486	32	18	the	the	DET
dpc-3486	32	19	upper	upper	ADJ
dpc-3486	32	20	respiratory	respiratory	ADJ
dpc-3486	32	21	tract	tract	NOUN
dpc-3486	32	22	,	,	PUNCT
dpc-3486	32	23	epithelial	epithelial	ADJ
dpc-3486	32	24	cells	cell	NOUN
dpc-3486	32	25	of	of	ADP
dpc-3486	32	26	the	the	DET
dpc-3486	32	27	tongue	tongue	NOUN
dpc-3486	32	28	and	and	CCONJ
dpc-3486	32	29	salivary	salivary	ADJ
dpc-3486	32	30	glands	gland	NOUN
dpc-3486	32	31	,	,	PUNCT
dpc-3486	32	32	and	and	CCONJ
dpc-3486	32	33	lungs	lung	NOUN
dpc-3486	32	34	.	.	PUNCT
dpc-3486	33	1	thus	thus	ADV
dpc-3486	33	2	,	,	PUNCT
dpc-3486	33	3	cells	cell	NOUN
dpc-3486	33	4	with	with	ADP
dpc-3486	33	5	ace2	ace2	NOUN
dpc-3486	33	6	receptor	receptor	NOUN
dpc-3486	33	7	distribution	distribution	NOUN
dpc-3486	33	8	may	may	AUX
dpc-3486	33	9	become	become	VERB
dpc-3486	33	10	host	host	NOUN
dpc-3486	33	11	cells	cell	NOUN
dpc-3486	33	12	for	for	ADP
dpc-3486	33	13	the	the	DET
dpc-3486	33	14	virus	virus	NOUN
dpc-3486	33	15	and	and	CCONJ
dpc-3486	33	16	cause	cause	VERB
dpc-3486	33	17	an	an	DET
dpc-3486	33	18	inflammatory	inflammatory	ADJ
dpc-3486	33	19	response	response	NOUN
dpc-3486	33	20	[	[	X
dpc-3486	33	21	4	4	NUM
dpc-3486	33	22	]	]	PUNCT
dpc-3486	33	23	.	.	PUNCT
dpc-3486	34	1	the	the	DET
dpc-3486	34	2	oral	oral	ADJ
dpc-3486	34	3	cavity	cavity	NOUN
dpc-3486	34	4	is	be	AUX
dpc-3486	34	5	one	one	NUM
dpc-3486	34	6	of	of	ADP
dpc-3486	34	7	the	the	DET
dpc-3486	34	8	main	main	ADJ
dpc-3486	34	9	entryways	entryway	NOUN
dpc-3486	34	10	for	for	ADP
dpc-3486	34	11	sars	sar	NOUN
dpc-3486	34	12	-	-	PUNCT
dpc-3486	34	13	cov-2	cov-2	NOUN
dpc-3486	34	14	.	.	PUNCT
dpc-3486	35	1	various	various	ADJ
dpc-3486	35	2	oral	oral	ADJ
dpc-3486	35	3	mucosal	mucosal	NOUN
dpc-3486	35	4	symptoms	symptom	NOUN
dpc-3486	35	5	and	and	CCONJ
dpc-3486	35	6	signs	sign	NOUN
dpc-3486	35	7	such	such	ADJ
dpc-3486	35	8	as	as	ADP
dpc-3486	35	9	vesiculobullous	vesiculobullous	ADJ
dpc-3486	35	10	lesions	lesion	NOUN
dpc-3486	35	11	,	,	PUNCT
dpc-3486	35	12	taste	taste	NOUN
dpc-3486	35	13	disorder	disorder	NOUN
dpc-3486	35	14	,	,	PUNCT
dpc-3486	35	15	nonspecific	nonspecific	ADJ
dpc-3486	35	16	oral	oral	ADJ
dpc-3486	35	17	ulcerations	ulceration	NOUN
dpc-3486	35	18	,	,	PUNCT
dpc-3486	35	19	cheilitis	cheilitis	NOUN
dpc-3486	35	20	,	,	PUNCT
dpc-3486	35	21	desquamative	desquamative	ADJ
dpc-3486	35	22	gingivitis	gingivitis	NOUN
dpc-3486	35	23	,	,	PUNCT
dpc-3486	35	24	petechiae	petechiae	NOUN
dpc-3486	35	25	,	,	PUNCT
dpc-3486	35	26	herpes	herpe	NOUN
dpc-3486	35	27	virus	virus	NOUN
dpc-3486	35	28	infections	infection	NOUN
dpc-3486	35	29	,	,	PUNCT
dpc-3486	35	30	candidiasis	candidiasis	NOUN
dpc-3486	35	31	and	and	CCONJ
dpc-3486	35	32	lingua	lingua	PROPN
dpc-3486	35	33	villosa	villosa	PROPN
dpc-3486	35	34	nigra	nigra	PROPN
dpc-3486	35	35	due	due	ADP
dpc-3486	35	36	to	to	ADP
dpc-3486	35	37	covid-19	covid-19	PROPN
dpc-3486	35	38	have	have	AUX
dpc-3486	35	39	been	be	AUX
dpc-3486	35	40	reported	report	VERB
dpc-3486	35	41	in	in	ADP
dpc-3486	35	42	the	the	DET
dpc-3486	35	43	literature	literature	NOUN
dpc-3486	35	44	5	5	NUM
dpc-3486	35	45	-	-	SYM
dpc-3486	35	46	8	8	NUM
dpc-3486	35	47	.	.	PUNCT
dpc-3486	36	1	however	however	ADV
dpc-3486	36	2	,	,	PUNCT
dpc-3486	36	3	it	it	PRON
dpc-3486	36	4	is	be	AUX
dpc-3486	36	5	still	still	ADV
dpc-3486	36	6	unknown	unknown	ADJ
dpc-3486	36	7	whether	whether	SCONJ
dpc-3486	36	8	these	these	DET
dpc-3486	36	9	manifestations	manifestation	NOUN
dpc-3486	36	10	in	in	ADP
dpc-3486	36	11	the	the	DET
dpc-3486	36	12	oral	oral	ADJ
dpc-3486	36	13	cavity	cavity	NOUN
dpc-3486	36	14	develop	develop	VERB
dpc-3486	36	15	directly	directly	ADV
dpc-3486	36	16	or	or	CCONJ
dpc-3486	36	17	indirectly	indirectly	ADV
dpc-3486	37	1	[	[	X
dpc-3486	37	2	9	9	NUM
dpc-3486	37	3	]	]	PUNCT
dpc-3486	37	4	.	.	PUNCT
dpc-3486	38	1	objectives	objective	VERB
dpc-3486	38	2	the	the	DET
dpc-3486	38	3	gold	gold	ADJ
dpc-3486	38	4	standard	standard	NOUN
dpc-3486	38	5	for	for	ADP
dpc-3486	38	6	diagnosis	diagnosis	NOUN
dpc-3486	38	7	of	of	ADP
dpc-3486	38	8	the	the	DET
dpc-3486	38	9	disease	disease	NOUN
dpc-3486	38	10	is	be	AUX
dpc-3486	38	11	the	the	DET
dpc-3486	38	12	finding	finding	NOUN
dpc-3486	38	13	of	of	ADP
dpc-3486	38	14	viral	viral	ADJ
dpc-3486	38	15	genome	genome	NOUN
dpc-3486	38	16	by	by	ADP
dpc-3486	38	17	real	real	ADJ
dpc-3486	38	18	-	-	PUNCT
dpc-3486	38	19	time	time	NOUN
dpc-3486	38	20	polymerase	polymerase	NOUN
dpc-3486	38	21	chain	chain	NOUN
dpc-3486	38	22	reaction	reaction	NOUN
dpc-3486	38	23	(	(	PUNCT
dpc-3486	38	24	rt	rt	NOUN
dpc-3486	38	25	-	-	PUNCT
dpc-3486	38	26	pcr	pcr	NOUN
dpc-3486	38	27	)	)	PUNCT
dpc-3486	38	28	in	in	ADP
dpc-3486	38	29	respiratory	respiratory	ADJ
dpc-3486	38	30	tract	tract	NOUN
dpc-3486	38	31	secretions	secretion	NOUN
dpc-3486	38	32	[	[	X
dpc-3486	38	33	10	10	NUM
dpc-3486	38	34	]	]	PUNCT
dpc-3486	38	35	.	.	PUNCT
dpc-3486	39	1	although	although	SCONJ
dpc-3486	39	2	many	many	ADJ
dpc-3486	39	3	oral	oral	ADJ
dpc-3486	39	4	mucosal	mucosal	NOUN
dpc-3486	39	5	involvements	involvement	NOUN
dpc-3486	39	6	associated	associate	VERB
dpc-3486	39	7	with	with	ADP
dpc-3486	39	8	covid-19	covid-19	PROPN
dpc-3486	39	9	have	have	AUX
dpc-3486	39	10	been	be	AUX
dpc-3486	39	11	reported	report	VERB
dpc-3486	39	12	in	in	ADP
dpc-3486	39	13	the	the	DET
dpc-3486	39	14	literature	literature	NOUN
dpc-3486	39	15	,	,	PUNCT
dpc-3486	39	16	there	there	PRON
dpc-3486	39	17	is	be	VERB
dpc-3486	39	18	no	no	DET
dpc-3486	39	19	data	datum	NOUN
dpc-3486	39	20	on	on	ADP
dpc-3486	39	21	oral	oral	ADJ
dpc-3486	39	22	manifestations	manifestation	NOUN
dpc-3486	39	23	that	that	PRON
dpc-3486	39	24	may	may	AUX
dpc-3486	39	25	be	be	AUX
dpc-3486	39	26	associated	associate	VERB
dpc-3486	39	27	with	with	ADP
dpc-3486	39	28	pcr	pcr	NOUN
dpc-3486	39	29	positivity	positivity	NOUN
dpc-3486	39	30	.	.	PUNCT
dpc-3486	40	1	in	in	ADP
dpc-3486	40	2	this	this	DET
dpc-3486	40	3	study	study	NOUN
dpc-3486	40	4	,	,	PUNCT
dpc-3486	40	5	we	we	PRON
dpc-3486	40	6	aimed	aim	VERB
dpc-3486	40	7	to	to	PART
dpc-3486	40	8	investigate	investigate	VERB
dpc-3486	40	9	oral	oral	ADJ
dpc-3486	40	10	mucosal	mucosal	NOUN
dpc-3486	40	11	signs	sign	NOUN
dpc-3486	40	12	and	and	CCONJ
dpc-3486	40	13	symptoms	symptom	NOUN
dpc-3486	40	14	related	relate	VERB
dpc-3486	40	15	to	to	ADP
dpc-3486	40	16	pcr	pcr	ADJ
dpc-3486	40	17	positivity	positivity	NOUN
dpc-3486	40	18	in	in	ADP
dpc-3486	40	19	patients	patient	NOUN
dpc-3486	40	20	with	with	ADP
dpc-3486	40	21	suspected	suspect	VERB
dpc-3486	40	22	covid-19	covid-19	PROPN
dpc-3486	40	23	.	.	PUNCT
dpc-3486	41	1	methods	method	NOUN
dpc-3486	41	2	all	all	DET
dpc-3486	41	3	patients	patient	NOUN
dpc-3486	41	4	were	be	AUX
dpc-3486	41	5	recruited	recruit	VERB
dpc-3486	41	6	from	from	ADP
dpc-3486	41	7	the	the	DET
dpc-3486	41	8	covid-19	covid-19	PROPN
dpc-3486	41	9	emergency	emergency	NOUN
dpc-3486	41	10	service	service	NOUN
dpc-3486	41	11	in	in	ADP
dpc-3486	41	12	the	the	DET
dpc-3486	41	13	erzurum	erzurum	PROPN
dpc-3486	41	14	city	city	PROPN
dpc-3486	41	15	hospital	hospital	PROPN
dpc-3486	41	16	,	,	PUNCT
dpc-3486	41	17	the	the	DET
dpc-3486	41	18	only	only	ADJ
dpc-3486	41	19	pandemic	pandemic	ADJ
dpc-3486	41	20	hospital	hospital	NOUN
dpc-3486	41	21	in	in	ADP
dpc-3486	41	22	the	the	DET
dpc-3486	41	23	province	province	NOUN
dpc-3486	41	24	,	,	PUNCT
dpc-3486	41	25	between	between	ADP
dpc-3486	41	26	01	01	NUM
dpc-3486	41	27	januar-30	januar-30	PROPN
dpc-3486	41	28	june	june	PROPN
dpc-3486	41	29	2020	2020	NUM
dpc-3486	41	30	.	.	PUNCT
dpc-3486	42	1	adult	adult	NOUN
dpc-3486	42	2	patients	patient	NOUN
dpc-3486	42	3	who	who	PRON
dpc-3486	42	4	presented	present	VERB
dpc-3486	42	5	to	to	ADP
dpc-3486	42	6	the	the	DET
dpc-3486	42	7	emergency	emergency	NOUN
dpc-3486	42	8	department	department	NOUN
dpc-3486	42	9	for	for	ADP
dpc-3486	42	10	the	the	DET
dpc-3486	42	11	first	first	ADJ
dpc-3486	42	12	time	time	NOUN
dpc-3486	42	13	with	with	ADP
dpc-3486	42	14	any	any	DET
dpc-3486	42	15	symptoms	symptom	NOUN
dpc-3486	42	16	in	in	ADP
dpc-3486	42	17	terms	term	NOUN
dpc-3486	42	18	of	of	ADP
dpc-3486	42	19	covid-19	covid-19	PROPN
dpc-3486	42	20	were	be	AUX
dpc-3486	42	21	included	include	VERB
dpc-3486	42	22	in	in	ADP
dpc-3486	42	23	the	the	DET
dpc-3486	42	24	study	study	NOUN
dpc-3486	42	25	.	.	PUNCT
dpc-3486	43	1	patients	patient	NOUN
dpc-3486	43	2	with	with	ADP
dpc-3486	43	3	complaints	complaint	NOUN
dpc-3486	43	4	for	for	ADP
dpc-3486	43	5	a	a	DET
dpc-3486	43	6	maximum	maximum	NOUN
dpc-3486	43	7	of	of	ADP
dpc-3486	43	8	14	14	NUM
dpc-3486	43	9	days	day	NOUN
dpc-3486	43	10	were	be	AUX
dpc-3486	43	11	enrolled	enrol	VERB
dpc-3486	43	12	,	,	PUNCT
dpc-3486	43	13	as	as	SCONJ
dpc-3486	43	14	pcr	pcr	ADJ
dpc-3486	43	15	test	test	NOUN
dpc-3486	43	16	may	may	AUX
dpc-3486	43	17	become	become	VERB
dpc-3486	43	18	negative	negative	ADJ
dpc-3486	43	19	.	.	PUNCT
dpc-3486	44	1	the	the	DET
dpc-3486	44	2	patients	patient	NOUN
dpc-3486	44	3	were	be	AUX
dpc-3486	44	4	questioned	question	VERB
dpc-3486	44	5	in	in	ADP
dpc-3486	44	6	terms	term	NOUN
dpc-3486	44	7	of	of	ADP
dpc-3486	44	8	sore	sore	ADJ
dpc-3486	44	9	throat	throat	NOUN
dpc-3486	44	10	,	,	PUNCT
dpc-3486	44	11	loss	loss	NOUN
dpc-3486	44	12	of	of	ADP
dpc-3486	44	13	taste	taste	NOUN
dpc-3486	44	14	and	and	CCONJ
dpc-3486	44	15	smell	smell	NOUN
dpc-3486	44	16	,	,	PUNCT
dpc-3486	44	17	presence	presence	NOUN
dpc-3486	44	18	of	of	ADP
dpc-3486	44	19	back	back	NOUN
dpc-3486	44	20	and	and	CCONJ
dpc-3486	44	21	chest	chest	NOUN
dpc-3486	44	22	pain	pain	NOUN
dpc-3486	44	23	,	,	PUNCT
dpc-3486	44	24	headache	headache	NOUN
dpc-3486	44	25	,	,	PUNCT
dpc-3486	44	26	and	and	CCONJ
dpc-3486	44	27	dry	dry	ADJ
dpc-3486	44	28	mouth	mouth	NOUN
dpc-3486	44	29	sensation	sensation	NOUN
dpc-3486	44	30	(	(	PUNCT
dpc-3486	44	31	xerostomia	xerostomia	NOUN
dpc-3486	44	32	)	)	PUNCT
dpc-3486	44	33	.	.	PUNCT
dpc-3486	45	1	the	the	DET
dpc-3486	45	2	oral	oral	ADJ
dpc-3486	45	3	mucosa	mucosa	NOUN
dpc-3486	45	4	of	of	ADP
dpc-3486	45	5	patients	patient	NOUN
dpc-3486	45	6	was	be	AUX
dpc-3486	45	7	examined	examine	VERB
dpc-3486	45	8	by	by	ADP
dpc-3486	45	9	a	a	DET
dpc-3486	45	10	dermatologist	dermatologist	NOUN
dpc-3486	45	11	and	and	CCONJ
dpc-3486	45	12	the	the	DET
dpc-3486	45	13	findings	finding	NOUN
dpc-3486	45	14	(	(	PUNCT
dpc-3486	45	15	erythema	erythema	ADJ
dpc-3486	45	16	,	,	PUNCT
dpc-3486	45	17	xerosis	xerosis	NOUN
dpc-3486	45	18	,	,	PUNCT
dpc-3486	45	19	vesicle	vesicle	NOUN
dpc-3486	45	20	,	,	PUNCT
dpc-3486	45	21	crypt	crypt	NOUN
dpc-3486	45	22	,	,	PUNCT
dpc-3486	45	23	candida	candida	NOUN
dpc-3486	45	24	,	,	PUNCT
dpc-3486	45	25	tonsillar	tonsillar	ADJ
dpc-3486	45	26	hypertrophy	hypertrophy	NOUN
dpc-3486	45	27	,	,	PUNCT
dpc-3486	45	28	leukoplakia	leukoplakia	NOUN
dpc-3486	45	29	,	,	PUNCT
dpc-3486	45	30	geographic	geographic	ADJ
dpc-3486	45	31	tongue	tongue	NOUN
dpc-3486	45	32	,	,	PUNCT
dpc-3486	45	33	scrotal	scrotal	ADJ
dpc-3486	45	34	tongue	tongue	NOUN
dpc-3486	45	35	,	,	PUNCT
dpc-3486	45	36	herpes	herpe	NOUN
dpc-3486	45	37	simplex	simplex	NOUN
dpc-3486	45	38	infections	infection	NOUN
dpc-3486	45	39	,	,	PUNCT
dpc-3486	45	40	aphthae	aphthae	NOUN
dpc-3486	45	41	/	/	SYM
dpc-3486	45	42	ulcer	ulcer	NOUN
dpc-3486	45	43	,	,	PUNCT
dpc-3486	45	44	other	other	ADJ
dpc-3486	45	45	)	)	PUNCT
dpc-3486	45	46	were	be	AUX
dpc-3486	45	47	recorded	record	VERB
dpc-3486	45	48	.	.	PUNCT
dpc-3486	46	1	these	these	DET
dpc-3486	46	2	disorders	disorder	NOUN
dpc-3486	46	3	were	be	AUX
dpc-3486	46	4	diagnosed	diagnose	VERB
dpc-3486	46	5	clinically	clinically	ADV
dpc-3486	46	6	.	.	PUNCT
dpc-3486	47	1	all	all	DET
dpc-3486	47	2	necessary	necessary	ADJ
dpc-3486	47	3	data	datum	NOUN
dpc-3486	47	4	such	such	ADJ
dpc-3486	47	5	as	as	ADP
dpc-3486	47	6	age	age	NOUN
dpc-3486	47	7	,	,	PUNCT
dpc-3486	47	8	gender	gender	NOUN
dpc-3486	47	9	of	of	ADP
dpc-3486	47	10	the	the	DET
dpc-3486	47	11	patients	patient	NOUN
dpc-3486	47	12	,	,	PUNCT
dpc-3486	47	13	complaints	complaint	NOUN
dpc-3486	47	14	,	,	PUNCT
dpc-3486	47	15	oral	oral	ADJ
dpc-3486	47	16	mucosal	mucosal	NOUN
dpc-3486	47	17	findings	finding	NOUN
dpc-3486	47	18	,	,	PUNCT
dpc-3486	47	19	pcr	pcr	ADJ
dpc-3486	47	20	status	status	NOUN
dpc-3486	47	21	,	,	PUNCT
dpc-3486	47	22	and	and	CCONJ
dpc-3486	47	23	thorax	thorax	NOUN
dpc-3486	47	24	computerized	computerized	ADJ
dpc-3486	47	25	tomography	tomography	NOUN
dpc-3486	47	26	(	(	PUNCT
dpc-3486	47	27	ct	ct	NOUN
dpc-3486	47	28	)	)	PUNCT
dpc-3486	47	29	reports	report	NOUN
dpc-3486	47	30	were	be	AUX
dpc-3486	47	31	anonymized	anonymize	VERB
dpc-3486	47	32	and	and	CCONJ
dpc-3486	47	33	obtained	obtain	VERB
dpc-3486	47	34	from	from	ADP
dpc-3486	47	35	the	the	DET
dpc-3486	47	36	electronic	electronic	ADJ
dpc-3486	47	37	database	database	NOUN
dpc-3486	47	38	and	and	CCONJ
dpc-3486	47	39	patient	patient	ADJ
dpc-3486	47	40	follow	follow	NOUN
dpc-3486	47	41	-up	-up	ADP
dpc-3486	47	42	forms	form	NOUN
dpc-3486	47	43	.	.	PUNCT
dpc-3486	48	1	behçet	behçet	PROPN
dpc-3486	48	2	disease	disease	PROPN
dpc-3486	48	3	,	,	PUNCT
dpc-3486	48	4	recurrent	recurrent	ADJ
dpc-3486	48	5	aphthous	aphthous	ADJ
dpc-3486	48	6	stomatitis	stomatitis	NOUN
dpc-3486	48	7	,	,	PUNCT
dpc-3486	48	8	inflammatory	inflammatory	ADJ
dpc-3486	48	9	bowel	bowel	NOUN
dpc-3486	48	10	diseases	disease	NOUN
dpc-3486	48	11	,	,	PUNCT
dpc-3486	48	12	and	and	CCONJ
dpc-3486	48	13	collagen	collagen	NOUN
dpc-3486	48	14	tissue	tissue	NOUN
dpc-3486	48	15	disease	disease	NOUN
dpc-3486	48	16	such	such	ADJ
dpc-3486	48	17	as	as	ADP
dpc-3486	48	18	systemic	systemic	ADJ
dpc-3486	48	19	lupus	lupus	NOUN
dpc-3486	48	20	erythematosus	erythematosus	NOUN
dpc-3486	48	21	which	which	PRON
dpc-3486	48	22	may	may	AUX
dpc-3486	48	23	cause	cause	VERB
dpc-3486	48	24	oral	oral	ADJ
dpc-3486	48	25	aphthae	aphthae	NOUN
dpc-3486	48	26	.	.	PUNCT
dpc-3486	49	1	in	in	ADP
dpc-3486	49	2	diabetes	diabetes	NOUN
dpc-3486	49	3	mellitus	mellitus	NOUN
dpc-3486	49	4	,	,	PUNCT
dpc-3486	49	5	anticholinergic	anticholinergic	ADJ
dpc-3486	49	6	drugs	drug	NOUN
dpc-3486	49	7	lead	lead	VERB
dpc-3486	49	8	to	to	PART
dpc-3486	49	9	dryness	dryness	VERB
dpc-3486	49	10	in	in	ADP
dpc-3486	49	11	the	the	DET
dpc-3486	49	12	oral	oral	ADJ
dpc-3486	49	13	mucosa	mucosa	NOUN
dpc-3486	49	14	.	.	PUNCT
dpc-3486	50	1	various	various	ADJ
dpc-3486	50	2	infection	infection	NOUN
dpc-3486	50	3	diseases	disease	NOUN
dpc-3486	50	4	such	such	ADJ
dpc-3486	50	5	as	as	ADP
dpc-3486	50	6	hand	hand	NOUN
dpc-3486	50	7	,	,	PUNCT
dpc-3486	50	8	foot	foot	NOUN
dpc-3486	50	9	,	,	PUNCT
dpc-3486	50	10	and	and	CCONJ
dpc-3486	50	11	mouth	mouth	NOUN
dpc-3486	50	12	disease	disease	NOUN
dpc-3486	50	13	,	,	PUNCT
dpc-3486	50	14	herpangina	herpangina	PROPN
dpc-3486	50	15	,	,	PUNCT
dpc-3486	50	16	and	and	CCONJ
dpc-3486	50	17	tularemia	tularemia	NOUN
dpc-3486	50	18	can	can	AUX
dpc-3486	50	19	cause	cause	VERB
dpc-3486	50	20	oral	oral	ADJ
dpc-3486	50	21	mucosal	mucosal	NOUN
dpc-3486	50	22	ulceration	ulceration	NOUN
dpc-3486	50	23	.	.	PUNCT
dpc-3486	51	1	some	some	DET
dpc-3486	51	2	drugs	drug	NOUN
dpc-3486	51	3	such	such	ADJ
dpc-3486	51	4	as	as	ADP
dpc-3486	51	5	isotretinoin	isotretinoin	PROPN
dpc-3486	51	6	may	may	AUX
dpc-3486	51	7	be	be	AUX
dpc-3486	51	8	a	a	DET
dpc-3486	51	9	reason	reason	NOUN
dpc-3486	51	10	for	for	ADP
dpc-3486	51	11	cheilitis	cheilitis	NOUN
dpc-3486	51	12	.	.	PUNCT
dpc-3486	52	1	oral	oral	ADJ
dpc-3486	52	2	lichen	lichen	NOUN
dpc-3486	52	3	planus	planus	PROPN
dpc-3486	52	4	clinically	clinically	ADV
dpc-3486	52	5	 	 	SPACE
dpc-3486	52	6	presents	present	VERB
dpc-3486	52	7	as	as	ADP
dpc-3486	52	8	reticular	reticular	ADJ
dpc-3486	52	9	,	,	PUNCT
dpc-3486	52	10	 	 	SPACE
dpc-3486	52	11	erosive	erosive	VERB
dpc-3486	52	12	or	or	CCONJ
dpc-3486	52	13	ulcerative	ulcerative	ADJ
dpc-3486	52	14	lesion	lesion	NOUN
dpc-3486	52	15	with	with	ADP
dpc-3486	52	16	whitish	whitish	ADJ
dpc-3486	52	17	streak	streak	NOUN
dpc-3486	52	18	or	or	CCONJ
dpc-3486	52	19	white	white	ADJ
dpc-3486	52	20	,	,	PUNCT
dpc-3486	52	21	lacy	lacy	NOUN
dpc-3486	52	22	patches	patch	NOUN
dpc-3486	52	23	.	.	PUNCT
dpc-3486	53	1	the	the	DET
dpc-3486	53	2	patients	patient	NOUN
dpc-3486	53	3	who	who	PRON
dpc-3486	53	4	have	have	VERB
dpc-3486	53	5	the	the	DET
dpc-3486	53	6	above	above	ADV
dpc-3486	53	7	-	-	PUNCT
dpc-3486	53	8	mentioned	mention	VERB
dpc-3486	53	9	diseases	disease	NOUN
dpc-3486	53	10	and	and	CCONJ
dpc-3486	53	11	use	use	VERB
dpc-3486	53	12	drugs	drug	NOUN
dpc-3486	53	13	that	that	PRON
dpc-3486	53	14	may	may	AUX
dpc-3486	53	15	cause	cause	VERB
dpc-3486	53	16	disorders	disorder	NOUN
dpc-3486	53	17	of	of	ADP
dpc-3486	53	18	oral	oral	ADJ
dpc-3486	53	19	mucosa	mucosa	NOUN
dpc-3486	53	20	and	and	CCONJ
dpc-3486	53	21	also	also	ADV
dpc-3486	53	22	those	those	PRON
dpc-3486	53	23	with	with	ADP
dpc-3486	53	24	dermatological	dermatological	ADJ
dpc-3486	53	25	diseases	disease	NOUN
dpc-3486	53	26	such	such	ADJ
dpc-3486	53	27	as	as	ADP
dpc-3486	53	28	oral	oral	ADJ
dpc-3486	53	29	lichen	lichen	NOUN
dpc-3486	53	30	planus	planus	NOUN
dpc-3486	53	31	and	and	CCONJ
dpc-3486	53	32	bullous	bullous	ADJ
dpc-3486	53	33	diseases	disease	NOUN
dpc-3486	53	34	with	with	ADP
dpc-3486	53	35	oral	oral	ADJ
dpc-3486	53	36	mucosal	mucosal	NOUN
dpc-3486	53	37	involvement	involvement	NOUN
dpc-3486	53	38	were	be	AUX
dpc-3486	53	39	excluded	exclude	VERB
dpc-3486	53	40	from	from	ADP
dpc-3486	53	41	the	the	DET
dpc-3486	53	42	study	study	NOUN
dpc-3486	53	43	.	.	PUNCT
dpc-3486	54	1	moreover	moreover	ADV
dpc-3486	54	2	,	,	PUNCT
dpc-3486	54	3	patients	patient	NOUN
dpc-3486	54	4	without	without	ADP
dpc-3486	54	5	ct	ct	PROPN
dpc-3486	54	6	were	be	AUX
dpc-3486	54	7	not	not	PART
dpc-3486	54	8	included	include	VERB
dpc-3486	54	9	.	.	PUNCT
dpc-3486	55	1	the	the	DET
dpc-3486	55	2	study	study	NOUN
dpc-3486	55	3	protocol	protocol	NOUN
dpc-3486	55	4	was	be	AUX
dpc-3486	55	5	approved	approve	VERB
dpc-3486	55	6	by	by	ADP
dpc-3486	55	7	the	the	DET
dpc-3486	55	8	ethics	ethic	NOUN
dpc-3486	55	9	committee	committee	PROPN
dpc-3486	55	10	of	of	ADP
dpc-3486	55	11	the	the	DET
dpc-3486	55	12	erzurum	erzurum	PROPN
dpc-3486	55	13	regional	regional	PROPN
dpc-3486	55	14	training	training	NOUN
dpc-3486	55	15	and	and	CCONJ
dpc-3486	55	16	research	research	NOUN
dpc-3486	55	17	hospital	hospital	NOUN
dpc-3486	55	18	(	(	PUNCT
dpc-3486	55	19	reference	reference	NOUN
dpc-3486	55	20	no	no	INTJ
dpc-3486	55	21	.	.	PUNCT
dpc-3486	56	1	2021/12	2021/12	NUM
dpc-3486	56	2	-	-	PUNCT
dpc-3486	56	3	187	187	NUM
dpc-3486	56	4	)	)	PUNCT
dpc-3486	56	5	.	.	PUNCT
dpc-3486	57	1	an	an	DET
dpc-3486	57	2	informed	informed	ADJ
dpc-3486	57	3	consent	consent	NOUN
dpc-3486	57	4	form	form	NOUN
dpc-3486	57	5	was	be	AUX
dpc-3486	57	6	obtained	obtain	VERB
dpc-3486	57	7	from	from	ADP
dpc-3486	57	8	all	all	DET
dpc-3486	57	9	participants	participant	NOUN
dpc-3486	57	10	.	.	PUNCT
dpc-3486	58	1	the	the	DET
dpc-3486	58	2	study	study	NOUN
dpc-3486	58	3	was	be	AUX
dpc-3486	58	4	performed	perform	VERB
dpc-3486	58	5	as	as	ADP
dpc-3486	58	6	per	per	ADP
dpc-3486	58	7	the	the	DET
dpc-3486	58	8	latest	late	ADJ
dpc-3486	58	9	version	version	NOUN
dpc-3486	58	10	of	of	ADP
dpc-3486	58	11	the	the	DET
dpc-3486	58	12	helsinki	helsinki	PROPN
dpc-3486	58	13	declaration	declaration	PROPN
dpc-3486	58	14	and	and	CCONJ
dpc-3486	58	15	the	the	DET
dpc-3486	58	16	guidelines	guideline	NOUN
dpc-3486	58	17	for	for	ADP
dpc-3486	58	18	good	good	ADJ
dpc-3486	58	19	clinical	clinical	ADJ
dpc-3486	58	20	practice	practice	NOUN
dpc-3486	58	21	.	.	PUNCT
dpc-3486	59	1	statistical	statistical	ADJ
dpc-3486	59	2	analysis	analysis	NOUN
dpc-3486	59	3	all	all	DET
dpc-3486	59	4	procedures	procedure	NOUN
dpc-3486	59	5	were	be	AUX
dpc-3486	59	6	performed	perform	VERB
dpc-3486	59	7	using	use	VERB
dpc-3486	59	8	statistical	statistical	ADJ
dpc-3486	59	9	package	package	NOUN
dpc-3486	59	10	for	for	ADP
dpc-3486	59	11	social	social	ADJ
dpc-3486	59	12	sciences	science	NOUN
dpc-3486	59	13	(	(	PUNCT
dpc-3486	59	14	spss	spss	PROPN
dpc-3486	59	15	inc	inc	PROPN
dpc-3486	59	16	.	.	PROPN
dpc-3486	59	17	v21.0	v21.0	PROPN
dpc-3486	59	18	)	)	PUNCT
dpc-3486	59	19	software	software	NOUN
dpc-3486	59	20	.	.	PUNCT
dpc-3486	60	1	after	after	ADP
dpc-3486	60	2	checking	check	VERB
dpc-3486	60	3	the	the	DET
dpc-3486	60	4	normality	normality	NOUN
dpc-3486	60	5	distribution	distribution	NOUN
dpc-3486	60	6	of	of	ADP
dpc-3486	60	7	scale	scale	NOUN
dpc-3486	60	8	variables	variable	NOUN
dpc-3486	60	9	by	by	ADP
dpc-3486	60	10	kolmogorov	kolmogorov	ADJ
dpc-3486	60	11	smirnov	smirnov	PROPN
dpc-3486	60	12	test	test	NOUN
dpc-3486	60	13	,	,	PUNCT
dpc-3486	60	14	the	the	DET
dpc-3486	60	15	pearson	pearson	PROPN
dpc-3486	60	16	chi	chi	PROPN
dpc-3486	60	17	-	-	PUNCT
dpc-3486	60	18	square	square	PROPN
dpc-3486	60	19	,	,	PUNCT
dpc-3486	60	20	and	and	CCONJ
dpc-3486	60	21	the	the	DET
dpc-3486	60	22	fisher	fisher	PROPN
dpc-3486	60	23	exact	exact	ADJ
dpc-3486	60	24	tests	test	NOUN
dpc-3486	60	25	were	be	AUX
dpc-3486	60	26	used	use	VERB
dpc-3486	60	27	for	for	ADP
dpc-3486	60	28	the	the	DET
dpc-3486	60	29	categorical	categorical	ADJ
dpc-3486	60	30	variables	variable	NOUN
dpc-3486	60	31	where	where	SCONJ
dpc-3486	60	32	appropriate	appropriate	ADJ
dpc-3486	60	33	.	.	PUNCT
dpc-3486	61	1	examination	examination	NOUN
dpc-3486	61	2	findings	finding	NOUN
dpc-3486	61	3	related	relate	VERB
dpc-3486	61	4	to	to	ADP
dpc-3486	61	5	pcr	pcr	ADJ
dpc-3486	61	6	results	result	NOUN
dpc-3486	61	7	were	be	AUX
dpc-3486	61	8	evaluated	evaluate	VERB
dpc-3486	61	9	with	with	ADP
dpc-3486	61	10	univariate	univariate	ADJ
dpc-3486	61	11	and	and	CCONJ
dpc-3486	61	12	multivariate	multivariate	VERB
dpc-3486	61	13	logistic	logistic	ADJ
dpc-3486	61	14	regression	regression	NOUN
dpc-3486	61	15	analysis	analysis	NOUN
dpc-3486	61	16	.	.	PUNCT
dpc-3486	62	1	multivariate	multivariate	NOUN
dpc-3486	62	2	analysis	analysis	NOUN
dpc-3486	62	3	was	be	AUX
dpc-3486	62	4	performed	perform	VERB
dpc-3486	62	5	using	use	VERB
dpc-3486	62	6	the	the	DET
dpc-3486	62	7	“	"	PUNCT
dpc-3486	62	8	backward	backward	ADJ
dpc-3486	62	9	:	:	PUNCT
dpc-3486	62	10	wald	wald	ADJ
dpc-3486	62	11	”	"	PUNCT
dpc-3486	62	12	method	method	NOUN
dpc-3486	62	13	.	.	PUNCT
dpc-3486	63	1	a	a	DET
dpc-3486	63	2	two	two	NUM
dpc-3486	63	3	-sided	-sided	ADJ
dpc-3486	63	4	p	p	NOUN
dpc-3486	63	5	value	value	NOUN
dpc-3486	63	6	less	less	ADJ
dpc-3486	63	7	than	than	ADP
dpc-3486	63	8	0.05	0.05	NUM
dpc-3486	63	9	was	be	AUX
dpc-3486	63	10	considered	consider	VERB
dpc-3486	63	11	statistically	statistically	ADV
dpc-3486	63	12	significant	significant	ADJ
dpc-3486	63	13	.	.	PUNCT
dpc-3486	64	1	results	result	VERB
dpc-3486	64	2	a	a	DET
dpc-3486	64	3	total	total	NOUN
dpc-3486	64	4	of	of	ADP
dpc-3486	64	5	383	383	NUM
dpc-3486	64	6	patients	patient	NOUN
dpc-3486	64	7	with	with	ADP
dpc-3486	64	8	any	any	DET
dpc-3486	64	9	symptoms	symptom	NOUN
dpc-3486	64	10	associated	associate	VERB
dpc-3486	64	11	with	with	ADP
dpc-3486	64	12	covid-19	covid-19	PROPN
dpc-3486	64	13	were	be	AUX
dpc-3486	64	14	included	include	VERB
dpc-3486	64	15	in	in	ADP
dpc-3486	64	16	the	the	DET
dpc-3486	64	17	study	study	NOUN
dpc-3486	64	18	.	.	PUNCT
dpc-3486	65	1	oral	oral	ADJ
dpc-3486	65	2	mucosal	mucosal	NOUN
dpc-3486	65	3	involvement	involvement	NOUN
dpc-3486	65	4	was	be	AUX
dpc-3486	65	5	present	present	ADJ
dpc-3486	65	6	in	in	ADP
dpc-3486	65	7	246	246	NUM
dpc-3486	65	8	(	(	PUNCT
dpc-3486	65	9	64.2	64.2	NUM
dpc-3486	65	10	%	%	NOUN
dpc-3486	65	11	)	)	PUNCT
dpc-3486	65	12	of	of	ADP
dpc-3486	65	13	all	all	DET
dpc-3486	65	14	patients	patient	NOUN
dpc-3486	65	15	.	.	PUNCT
dpc-3486	66	1	the	the	DET
dpc-3486	66	2	pcr	pcr	ADJ
dpc-3486	66	3	original	original	ADJ
dpc-3486	66	4	article	article	NOUN
dpc-3486	66	5	|	|	ADV
dpc-3486	66	6	dermatol	dermatol	ADJ
dpc-3486	66	7	pract	pract	NOUN
dpc-3486	66	8	concept	concept	NOUN
dpc-3486	66	9	.	.	PUNCT
dpc-3486	67	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	67	2	3	3	NUM
dpc-3486	67	3	test	test	NOUN
dpc-3486	67	4	was	be	AUX
dpc-3486	67	5	positive	positive	ADJ
dpc-3486	67	6	in	in	ADP
dpc-3486	67	7	210	210	NUM
dpc-3486	67	8	(	(	PUNCT
dpc-3486	67	9	54.8	54.8	NUM
dpc-3486	67	10	%	%	NOUN
dpc-3486	67	11	)	)	PUNCT
dpc-3486	67	12	patients	patient	NOUN
dpc-3486	67	13	and	and	CCONJ
dpc-3486	67	14	13	13	NUM
dpc-3486	67	15	patients	patient	NOUN
dpc-3486	67	16	whose	whose	DET
dpc-3486	67	17	pcr	pcr	NOUN
dpc-3486	67	18	tests	test	NOUN
dpc-3486	67	19	were	be	AUX
dpc-3486	67	20	negative	negative	ADJ
dpc-3486	67	21	had	have	VERB
dpc-3486	67	22	covid-19	covid-19	PROPN
dpc-3486	67	23	pneumonia	pneumonia	NOUN
dpc-3486	67	24	on	on	ADP
dpc-3486	67	25	thoracic	thoracic	NOUN
dpc-3486	68	1	ct	ct	PROPN
dpc-3486	68	2	.	.	PUNCT
dpc-3486	69	1	one	one	NUM
dpc-3486	69	2	hundred	hundred	NUM
dpc-3486	69	3	and	and	CCONJ
dpc-3486	69	4	seventy	seventy	NUM
dpc-3486	69	5	-	-	PUNCT
dpc-3486	69	6	seven	seven	NUM
dpc-3486	69	7	patients	patient	NOUN
dpc-3486	69	8	whose	whose	DET
dpc-3486	69	9	pcr	pcr	NOUN
dpc-3486	69	10	tested	test	VERB
dpc-3486	69	11	positive	positive	ADJ
dpc-3486	69	12	and	and	CCONJ
dpc-3486	69	13	8	8	NUM
dpc-3486	69	14	patients	patient	NOUN
dpc-3486	69	15	whose	whose	DET
dpc-3486	69	16	pcr	pcr	NOUN
dpc-3486	69	17	tested	test	VERB
dpc-3486	69	18	negative	negative	ADJ
dpc-3486	69	19	but	but	CCONJ
dpc-3486	69	20	had	have	VERB
dpc-3486	69	21	pneumonia	pneumonia	NOUN
dpc-3486	69	22	compatible	compatible	ADJ
dpc-3486	69	23	with	with	ADP
dpc-3486	69	24	covid-19	covid-19	PROPN
dpc-3486	69	25	had	have	VERB
dpc-3486	69	26	oral	oral	ADJ
dpc-3486	69	27	mucosal	mucosal	NOUN
dpc-3486	69	28	manifestations	manifestation	NOUN
dpc-3486	69	29	(	(	PUNCT
dpc-3486	69	30	175	175	NUM
dpc-3486	69	31	(	(	PUNCT
dpc-3486	69	32	78.4	78.4	NUM
dpc-3486	69	33	%	%	NOUN
dpc-3486	69	34	)	)	PUNCT
dpc-3486	69	35	out	out	ADP
dpc-3486	69	36	of	of	ADP
dpc-3486	69	37	223	223	NUM
dpc-3486	69	38	covid-19	covid-19	PROPN
dpc-3486	69	39	patients	patient	NOUN
dpc-3486	69	40	)	)	PUNCT
dpc-3486	69	41	.	.	PUNCT
dpc-3486	70	1	the	the	DET
dpc-3486	70	2	distribution	distribution	NOUN
dpc-3486	70	3	of	of	ADP
dpc-3486	70	4	oral	oral	ADJ
dpc-3486	70	5	mucosal	mucosal	NOUN
dpc-3486	70	6	examinations	examination	NOUN
dpc-3486	70	7	of	of	ADP
dpc-3486	70	8	patients	patient	NOUN
dpc-3486	70	9	according	accord	VERB
dpc-3486	70	10	to	to	ADP
dpc-3486	70	11	pcr	pcr	PROPN
dpc-3486	70	12	and	and	CCONJ
dpc-3486	70	13	ct	ct	NUM
dpc-3486	70	14	results	result	NOUN
dpc-3486	70	15	was	be	AUX
dpc-3486	70	16	presented	present	VERB
dpc-3486	70	17	in	in	ADP
dpc-3486	70	18	table	table	NOUN
dpc-3486	70	19	1	1	NUM
dpc-3486	70	20	.	.	PUNCT
dpc-3486	70	21	examination	examination	NOUN
dpc-3486	70	22	findings	finding	NOUN
dpc-3486	70	23	and	and	CCONJ
dpc-3486	70	24	complaints	complaint	NOUN
dpc-3486	70	25	according	accord	VERB
dpc-3486	70	26	to	to	ADP
dpc-3486	70	27	pcr	pcr	ADJ
dpc-3486	70	28	results	result	NOUN
dpc-3486	70	29	of	of	ADP
dpc-3486	70	30	patients	patient	NOUN
dpc-3486	70	31	without	without	ADP
dpc-3486	70	32	pneumonia	pneumonia	NOUN
dpc-3486	70	33	were	be	AUX
dpc-3486	70	34	evaluated	evaluate	VERB
dpc-3486	70	35	in	in	ADP
dpc-3486	70	36	table	table	NOUN
dpc-3486	70	37	2	2	NUM
dpc-3486	70	38	.	.	PUNCT
dpc-3486	71	1	the	the	DET
dpc-3486	71	2	pcr	pcr	PROPN
dpc-3486	71	3	test	test	NOUN
dpc-3486	71	4	was	be	AUX
dpc-3486	71	5	positive	positive	ADJ
dpc-3486	71	6	in	in	ADP
dpc-3486	71	7	71	71	NUM
dpc-3486	71	8	of	of	ADP
dpc-3486	71	9	139	139	NUM
dpc-3486	71	10	patients	patient	NOUN
dpc-3486	71	11	without	without	ADP
dpc-3486	71	12	pneumonia	pneumonia	NOUN
dpc-3486	71	13	.	.	PUNCT
dpc-3486	72	1	there	there	PRON
dpc-3486	72	2	was	be	VERB
dpc-3486	72	3	no	no	DET
dpc-3486	72	4	difference	difference	NOUN
dpc-3486	72	5	between	between	ADP
dpc-3486	72	6	the	the	DET
dpc-3486	72	7	two	two	NUM
dpc-3486	72	8	groups	group	NOUN
dpc-3486	72	9	(	(	PUNCT
dpc-3486	72	10	pcr	pcr	ADJ
dpc-3486	72	11	test	test	NOUN
dpc-3486	72	12	positive	positive	ADJ
dpc-3486	72	13	and	and	CCONJ
dpc-3486	72	14	negative	negative	ADJ
dpc-3486	72	15	patients	patient	NOUN
dpc-3486	72	16	without	without	ADP
dpc-3486	72	17	pneumonia	pneumonia	NOUN
dpc-3486	72	18	)	)	PUNCT
dpc-3486	72	19	in	in	ADP
dpc-3486	72	20	terms	term	NOUN
dpc-3486	72	21	of	of	ADP
dpc-3486	72	22	age	age	NOUN
dpc-3486	72	23	,	,	PUNCT
dpc-3486	72	24	gender	gender	NOUN
dpc-3486	72	25	,	,	PUNCT
dpc-3486	72	26	and	and	CCONJ
dpc-3486	72	27	duration	duration	NOUN
dpc-3486	72	28	of	of	ADP
dpc-3486	72	29	complaints	complaint	NOUN
dpc-3486	72	30	.	.	PUNCT
dpc-3486	73	1	dry	dry	ADJ
dpc-3486	73	2	mouth	mouth	NOUN
dpc-3486	73	3	sensation	sensation	NOUN
dpc-3486	73	4	(	(	PUNCT
dpc-3486	73	5	xerostomia	xerostomia	NOUN
dpc-3486	73	6	)	)	PUNCT
dpc-3486	73	7	was	be	AUX
dpc-3486	73	8	significantly	significantly	ADV
dpc-3486	73	9	higher	high	ADJ
dpc-3486	73	10	in	in	ADP
dpc-3486	73	11	patients	patient	NOUN
dpc-3486	73	12	with	with	ADP
dpc-3486	73	13	positive	positive	ADJ
dpc-3486	73	14	pcr	pcr	ADJ
dpc-3486	73	15	tests	test	NOUN
dpc-3486	73	16	(	(	PUNCT
dpc-3486	73	17	p	p	NOUN
dpc-3486	73	18	=	=	NOUN
dpc-3486	73	19	0.001	0.001	NUM
dpc-3486	73	20	)	)	PUNCT
dpc-3486	73	21	.	.	PUNCT
dpc-3486	74	1	normal	normal	ADJ
dpc-3486	74	2	oral	oral	ADJ
dpc-3486	74	3	mucosa	mucosa	NOUN
dpc-3486	74	4	findings	finding	NOUN
dpc-3486	74	5	were	be	AUX
dpc-3486	74	6	more	more	ADV
dpc-3486	74	7	common	common	ADJ
dpc-3486	74	8	in	in	ADP
dpc-3486	74	9	patients	patient	NOUN
dpc-3486	74	10	with	with	ADP
dpc-3486	74	11	negative	negative	ADJ
dpc-3486	74	12	pcr	pcr	ADJ
dpc-3486	74	13	tests	test	NOUN
dpc-3486	74	14	compared	compare	VERB
dpc-3486	74	15	to	to	ADP
dpc-3486	74	16	those	those	PRON
dpc-3486	74	17	with	with	ADP
dpc-3486	74	18	positive	positive	ADJ
dpc-3486	74	19	pcr	pcr	ADJ
dpc-3486	74	20	tests	test	NOUN
dpc-3486	74	21	(	(	PUNCT
dpc-3486	74	22	p	p	X
dpc-3486	74	23	<	<	X
dpc-3486	74	24	0.001	0.001	NUM
dpc-3486	74	25	)	)	PUNCT
dpc-3486	74	26	.	.	PUNCT
dpc-3486	75	1	it	it	PRON
dpc-3486	75	2	was	be	AUX
dpc-3486	75	3	noteworthy	noteworthy	ADJ
dpc-3486	75	4	that	that	SCONJ
dpc-3486	75	5	the	the	DET
dpc-3486	75	6	frequency	frequency	NOUN
dpc-3486	75	7	of	of	ADP
dpc-3486	75	8	microvesicles	microvesicle	NOUN
dpc-3486	75	9	on	on	ADP
dpc-3486	75	10	the	the	DET
dpc-3486	75	11	tonsils	tonsil	NOUN
dpc-3486	75	12	or	or	CCONJ
dpc-3486	75	13	pharynx	pharynx	NOUN
dpc-3486	75	14	and	and	CCONJ
dpc-3486	75	15	petechiae	petechiae	NOUN
dpc-3486	75	16	in	in	ADP
dpc-3486	75	17	the	the	DET
dpc-3486	75	18	oropharynx	oropharynx	NOUN
dpc-3486	75	19	were	be	AUX
dpc-3486	75	20	significantly	significantly	ADV
dpc-3486	75	21	higher	high	ADJ
dpc-3486	75	22	in	in	ADP
dpc-3486	75	23	those	those	PRON
dpc-3486	75	24	with	with	ADP
dpc-3486	75	25	positive	positive	ADJ
dpc-3486	75	26	pcr	pcr	ADJ
dpc-3486	75	27	tests	test	NOUN
dpc-3486	75	28	(	(	PUNCT
dpc-3486	75	29	both	both	CCONJ
dpc-3486	75	30	with	with	ADP
dpc-3486	75	31	p	p	X
dpc-3486	75	32	<	<	X
dpc-3486	75	33	0.001	0.001	NUM
dpc-3486	75	34	)	)	PUNCT
dpc-3486	75	35	.	.	PUNCT
dpc-3486	76	1	in	in	ADP
dpc-3486	76	2	addition	addition	NOUN
dpc-3486	76	3	,	,	PUNCT
dpc-3486	76	4	there	there	PRON
dpc-3486	76	5	was	be	VERB
dpc-3486	76	6	a	a	DET
dpc-3486	76	7	significant	significant	ADJ
dpc-3486	76	8	difference	difference	NOUN
dpc-3486	76	9	between	between	ADP
dpc-3486	76	10	the	the	DET
dpc-3486	76	11	patients	patient	NOUN
dpc-3486	76	12	with	with	ADP
dpc-3486	76	13	positive	positive	ADJ
dpc-3486	76	14	pcr	pcr	ADJ
dpc-3486	76	15	tests	test	NOUN
dpc-3486	76	16	and	and	CCONJ
dpc-3486	76	17	with	with	ADP
dpc-3486	76	18	negative	negative	ADJ
dpc-3486	76	19	pcr	pcr	ADJ
dpc-3486	76	20	tests	test	NOUN
dpc-3486	76	21	in	in	ADP
dpc-3486	76	22	terms	term	NOUN
dpc-3486	76	23	of	of	ADP
dpc-3486	76	24	the	the	DET
dpc-3486	76	25	presence	presence	NOUN
dpc-3486	76	26	of	of	ADP
dpc-3486	76	27	primary	primary	ADJ
dpc-3486	76	28	/	/	SYM
dpc-3486	76	29	secondary	secondary	ADJ
dpc-3486	76	30	herpes	herpe	NOUN
dpc-3486	76	31	infection	infection	NOUN
dpc-3486	76	32	,	,	PUNCT
dpc-3486	76	33	oral	oral	ADJ
dpc-3486	76	34	aphthae	aphthae	NOUN
dpc-3486	76	35	,	,	PUNCT
dpc-3486	76	36	and	and	CCONJ
dpc-3486	76	37	erythema	erythema	ADV
dpc-3486	76	38	of	of	ADP
dpc-3486	76	39	tonsils	tonsil	NOUN
dpc-3486	76	40	and	and	CCONJ
dpc-3486	76	41	pharynx	pharynx	NOUN
dpc-3486	76	42	(	(	PUNCT
dpc-3486	76	43	p	p	NOUN
dpc-3486	76	44	=	=	NOUN
dpc-3486	76	45	0.036	0.036	NUM
dpc-3486	76	46	,	,	PUNCT
dpc-3486	76	47	p	p	X
dpc-3486	76	48	=	=	NOUN
dpc-3486	76	49	0.040	0.040	NUM
dpc-3486	76	50	,	,	PUNCT
dpc-3486	76	51	p	p	X
dpc-3486	76	52	 	 	SPACE
dpc-3486	76	53	=	=	NOUN
dpc-3486	76	54	 	 	SPACE
dpc-3486	76	55	0.022	0.022	NUM
dpc-3486	76	56	,	,	PUNCT
dpc-3486	76	57	respectively	respectively	ADV
dpc-3486	76	58	)	)	PUNCT
dpc-3486	76	59	.	.	PUNCT
dpc-3486	77	1	assessment	assessment	NOUN
dpc-3486	77	2	of	of	ADP
dpc-3486	77	3	examination	examination	NOUN
dpc-3486	77	4	findings	finding	NOUN
dpc-3486	77	5	and	and	CCONJ
dpc-3486	77	6	complaints	complaint	NOUN
dpc-3486	77	7	according	accord	VERB
dpc-3486	77	8	to	to	ADP
dpc-3486	77	9	ct	ct	PROPN
dpc-3486	77	10	results	result	NOUN
dpc-3486	77	11	of	of	ADP
dpc-3486	77	12	patients	patient	NOUN
dpc-3486	77	13	with	with	ADP
dpc-3486	77	14	a	a	DET
dpc-3486	77	15	definitive	definitive	ADJ
dpc-3486	77	16	diagnosis	diagnosis	NOUN
dpc-3486	77	17	of	of	ADP
dpc-3486	77	18	covid-19	covid-19	PROPN
dpc-3486	77	19	are	be	AUX
dpc-3486	77	20	as	as	ADP
dpc-3486	77	21	table	table	NOUN
dpc-3486	77	22	3	3	NUM
dpc-3486	77	23	.	.	PUNCT
dpc-3486	78	1	no	no	DET
dpc-3486	78	2	difference	difference	NOUN
dpc-3486	78	3	was	be	AUX
dpc-3486	78	4	observed	observe	VERB
dpc-3486	78	5	between	between	ADP
dpc-3486	78	6	the	the	DET
dpc-3486	78	7	pcr	pcr	ADJ
dpc-3486	78	8	-	-	PUNCT
dpc-3486	78	9	positive	positive	ADJ
dpc-3486	78	10	patients	patient	NOUN
dpc-3486	78	11	with	with	ADP
dpc-3486	78	12	and	and	CCONJ
dpc-3486	78	13	without	without	ADP
dpc-3486	78	14	pneumonia	pneumonia	NOUN
dpc-3486	78	15	in	in	ADP
dpc-3486	78	16	terms	term	NOUN
dpc-3486	78	17	of	of	ADP
dpc-3486	78	18	complaints	complaint	NOUN
dpc-3486	78	19	and	and	CCONJ
dpc-3486	78	20	findings	finding	NOUN
dpc-3486	78	21	.	.	PUNCT
dpc-3486	79	1	parameters	parameter	NOUN
dpc-3486	79	2	with	with	ADP
dpc-3486	79	3	p	p	NOUN
dpc-3486	79	4	<	<	X
dpc-3486	79	5	0.1	0.1	NUM
dpc-3486	79	6	in	in	ADP
dpc-3486	79	7	table	table	NOUN
dpc-3486	79	8	2	2	NUM
dpc-3486	79	9	were	be	AUX
dpc-3486	79	10	subjected	subject	VERB
dpc-3486	79	11	to	to	ADP
dpc-3486	79	12	logistic	logistic	ADJ
dpc-3486	79	13	regression	regression	NOUN
dpc-3486	79	14	analysis	analysis	NOUN
dpc-3486	79	15	.	.	PUNCT
dpc-3486	80	1	tables	table	NOUN
dpc-3486	80	2	4	4	NUM
dpc-3486	80	3	and	and	CCONJ
dpc-3486	80	4	5	5	NUM
dpc-3486	80	5	show	show	VERB
dpc-3486	80	6	the	the	DET
dpc-3486	80	7	results	result	NOUN
dpc-3486	80	8	of	of	ADP
dpc-3486	80	9	univariate	univariate	ADJ
dpc-3486	80	10	and	and	CCONJ
dpc-3486	80	11	multivariate	multivariate	VERB
dpc-3486	80	12	analyzes	analyze	NOUN
dpc-3486	80	13	of	of	ADP
dpc-3486	80	14	parameters	parameter	NOUN
dpc-3486	80	15	potentially	potentially	ADV
dpc-3486	80	16	related	relate	VERB
dpc-3486	80	17	to	to	ADP
dpc-3486	80	18	pcr	pcr	NOUN
dpc-3486	80	19	positivity	positivity	NOUN
dpc-3486	80	20	,	,	PUNCT
dpc-3486	80	21	respectively	respectively	ADV
dpc-3486	80	22	.	.	PUNCT
dpc-3486	81	1	it	it	PRON
dpc-3486	81	2	was	be	AUX
dpc-3486	81	3	found	find	VERB
dpc-3486	81	4	that	that	SCONJ
dpc-3486	81	5	microvesicles	microvesicle	NOUN
dpc-3486	81	6	on	on	ADP
dpc-3486	81	7	tonsils	tonsil	NOUN
dpc-3486	81	8	or	or	CCONJ
dpc-3486	81	9	pharynx	pharynx	NOUN
dpc-3486	81	10	were	be	AUX
dpc-3486	81	11	most	most	ADV
dpc-3486	81	12	associated	associate	VERB
dpc-3486	81	13	with	with	ADP
dpc-3486	81	14	pcr	pcr	ADJ
dpc-3486	81	15	positivity	positivity	NOUN
dpc-3486	81	16	in	in	ADP
dpc-3486	81	17	patients	patient	NOUN
dpc-3486	81	18	without	without	ADP
dpc-3486	81	19	lung	lung	NOUN
dpc-3486	81	20	involvement	involvement	NOUN
dpc-3486	81	21	according	accord	VERB
dpc-3486	81	22	to	to	ADP
dpc-3486	81	23	both	both	CCONJ
dpc-3486	81	24	univariate	univariate	ADJ
dpc-3486	81	25	and	and	CCONJ
dpc-3486	81	26	multivariate	multivariate	VERB
dpc-3486	81	27	analysis	analysis	NOUN
dpc-3486	81	28	(	(	PUNCT
dpc-3486	81	29	or	or	CCONJ
dpc-3486	81	30	=	=	SYM
dpc-3486	81	31	14.11	14.11	NUM
dpc-3486	81	32	,	,	PUNCT
dpc-3486	81	33	95	95	NUM
dpc-3486	81	34	%	%	NOUN
dpc-3486	81	35	ci	ci	NOUN
dpc-3486	81	36	:	:	PUNCT
dpc-3486	82	1	[	[	X
dpc-3486	82	2	4.04-.49.32	4.04-.49.32	NUM
dpc-3486	82	3	]	]	X
dpc-3486	82	4	,	,	PUNCT
dpc-3486	82	5	p	p	X
dpc-3486	82	6	<	<	X
dpc-3486	82	7	0.001	0.001	NUM
dpc-3486	82	8	,	,	PUNCT
dpc-3486	82	9	or	or	CCONJ
dpc-3486	82	10	=	=	NOUN
dpc-3486	82	11	15.64	15.64	NUM
dpc-3486	82	12	,	,	PUNCT
dpc-3486	82	13	95	95	NUM
dpc-3486	82	14	%	%	NOUN
dpc-3486	82	15	ci	ci	NOUN
dpc-3486	82	16	:	:	PUNCT
dpc-3486	83	1	[	[	X
dpc-3486	83	2	3.38.73.45	3.38.73.45	X
dpc-3486	83	3	]	]	PUNCT
dpc-3486	83	4	,	,	PUNCT
dpc-3486	83	5	p	p	X
dpc-3486	83	6	<	<	X
dpc-3486	83	7	0.001	0.001	NUM
dpc-3486	83	8	,	,	PUNCT
dpc-3486	83	9	respectively	respectively	ADV
dpc-3486	83	10	)	)	PUNCT
dpc-3486	83	11	.	.	PUNCT
dpc-3486	84	1	additionally	additionally	ADV
dpc-3486	84	2	,	,	PUNCT
dpc-3486	84	3	both	both	DET
dpc-3486	84	4	analyses	analysis	NOUN
dpc-3486	84	5	revealed	reveal	VERB
dpc-3486	84	6	that	that	SCONJ
dpc-3486	84	7	dry	dry	ADJ
dpc-3486	84	8	mouth	mouth	NOUN
dpc-3486	84	9	sensation	sensation	NOUN
dpc-3486	84	10	(	(	PUNCT
dpc-3486	84	11	xerostomia	xerostomia	NOUN
dpc-3486	84	12	)	)	PUNCT
dpc-3486	84	13	,	,	PUNCT
dpc-3486	84	14	erythema	erythema	ADV
dpc-3486	84	15	of	of	ADP
dpc-3486	84	16	the	the	DET
dpc-3486	84	17	tonsils	tonsil	NOUN
dpc-3486	84	18	and	and	CCONJ
dpc-3486	84	19	pharynx	pharynx	NOUN
dpc-3486	84	20	,	,	PUNCT
dpc-3486	84	21	and	and	CCONJ
dpc-3486	84	22	petechiae	petechiae	NOUN
dpc-3486	84	23	in	in	ADP
dpc-3486	84	24	the	the	DET
dpc-3486	84	25	oropharynx	oropharynx	NOUN
dpc-3486	84	26	were	be	AUX
dpc-3486	84	27	more	more	ADV
dpc-3486	84	28	related	related	ADJ
dpc-3486	84	29	to	to	ADP
dpc-3486	84	30	pcr	pcr	ADJ
dpc-3486	84	31	positivity	positivity	NOUN
dpc-3486	84	32	in	in	ADP
dpc-3486	84	33	patients	patient	NOUN
dpc-3486	84	34	without	without	ADP
dpc-3486	84	35	lung	lung	NOUN
dpc-3486	84	36	involvement	involvement	NOUN
dpc-3486	84	37	(	(	PUNCT
dpc-3486	84	38	p	p	X
dpc-3486	84	39	<	<	X
dpc-3486	84	40	0.05	0.05	NUM
dpc-3486	84	41	)	)	PUNCT
dpc-3486	84	42	.	.	PUNCT
dpc-3486	85	1	univariate	univariate	ADJ
dpc-3486	85	2	analysis	analysis	NOUN
dpc-3486	85	3	showed	show	VERB
dpc-3486	85	4	that	that	SCONJ
dpc-3486	85	5	oral	oral	ADJ
dpc-3486	85	6	aphthae	aphthae	NOUN
dpc-3486	85	7	were	be	AUX
dpc-3486	85	8	also	also	ADV
dpc-3486	85	9	associated	associate	VERB
dpc-3486	85	10	with	with	ADP
dpc-3486	85	11	pcr	pcr	NOUN
dpc-3486	85	12	positivity	positivity	NOUN
dpc-3486	85	13	(	(	PUNCT
dpc-3486	85	14	or	or	CCONJ
dpc-3486	85	15	=	=	SYM
dpc-3486	85	16	2.55	2.55	NUM
dpc-3486	85	17	,	,	PUNCT
dpc-3486	85	18	95	95	NUM
dpc-3486	85	19	%	%	NOUN
dpc-3486	85	20	ci	ci	NOUN
dpc-3486	85	21	:	:	PUNCT
dpc-3486	86	1	[	[	X
dpc-3486	86	2	1.03	1.03	NUM
dpc-3486	86	3	-	-	SYM
dpc-3486	86	4	6.34	6.34	NUM
dpc-3486	86	5	]	]	PUNCT
dpc-3486	86	6	,	,	PUNCT
dpc-3486	86	7	p	p	X
dpc-3486	86	8	=	=	NOUN
dpc-3486	86	9	0.044	0.044	NUM
dpc-3486	86	10	)	)	PUNCT
dpc-3486	86	11	.	.	PUNCT
dpc-3486	87	1	while	while	SCONJ
dpc-3486	87	2	it	it	PRON
dpc-3486	87	3	was	be	AUX
dpc-3486	87	4	not	not	PART
dpc-3486	87	5	found	find	VERB
dpc-3486	87	6	that	that	SCONJ
dpc-3486	87	7	there	there	PRON
dpc-3486	87	8	was	be	VERB
dpc-3486	87	9	no	no	DET
dpc-3486	87	10	relationship	relationship	NOUN
dpc-3486	87	11	between	between	ADP
dpc-3486	87	12	primary	primary	ADJ
dpc-3486	87	13	/	/	SYM
dpc-3486	87	14	secondary	secondary	ADJ
dpc-3486	87	15	herpes	herpe	NOUN
dpc-3486	87	16	infection	infection	NOUN
dpc-3486	87	17	and	and	CCONJ
dpc-3486	87	18	pcr	pcr	NOUN
dpc-3486	87	19	positivity	positivity	NOUN
dpc-3486	87	20	according	accord	VERB
dpc-3486	87	21	to	to	ADP
dpc-3486	87	22	univariate	univariate	ADJ
dpc-3486	87	23	analysis	analysis	NOUN
dpc-3486	87	24	,	,	PUNCT
dpc-3486	87	25	table	table	NOUN
dpc-3486	87	26	1	1	NUM
dpc-3486	87	27	.	.	PUNCT
dpc-3486	88	1	distribution	distribution	NOUN
dpc-3486	88	2	of	of	ADP
dpc-3486	88	3	oral	oral	ADJ
dpc-3486	88	4	mucosal	mucosal	NOUN
dpc-3486	88	5	examinations	examination	NOUN
dpc-3486	88	6	of	of	ADP
dpc-3486	88	7	patients	patient	NOUN
dpc-3486	88	8	evaluated	evaluate	VERB
dpc-3486	88	9	for	for	ADP
dpc-3486	88	10	covid-19	covid-19	PROPN
dpc-3486	88	11	according	accord	VERB
dpc-3486	88	12	to	to	ADP
dpc-3486	88	13	 	 	SPACE
dpc-3486	88	14	pcr	pcr	PROPN
dpc-3486	88	15	and	and	CCONJ
dpc-3486	88	16	ct	ct	NUM
dpc-3486	88	17	results	result	NOUN
dpc-3486	88	18	.	.	PUNCT
dpc-3486	89	1	oral	oral	ADJ
dpc-3486	89	2	mucosa	mucosa	NOUN
dpc-3486	89	3	examination	examination	NOUN
dpc-3486	89	4	pcr	pcr	PROPN
dpc-3486	89	5	negative	negative	NOUN
dpc-3486	89	6	,	,	PUNCT
dpc-3486	89	7	n	n	PROPN
dpc-3486	89	8	(	(	PUNCT
dpc-3486	89	9	%	%	INTJ
dpc-3486	89	10	)	)	PUNCT
dpc-3486	90	1	pcr	pcr	ADJ
dpc-3486	90	2	positive	positive	ADJ
dpc-3486	90	3	,	,	PUNCT
dpc-3486	90	4	n	n	PROPN
dpc-3486	90	5	(	(	PUNCT
dpc-3486	90	6	%	%	INTJ
dpc-3486	90	7	)	)	PUNCT
dpc-3486	91	1	ct	ct	PROPN
dpc-3486	91	2	:	:	PUNCT
dpc-3486	92	1	normal/	normal/	NUM
dpc-3486	92	2	unknown	unknown	ADJ
dpc-3486	92	3	ct	ct	PROPN
dpc-3486	92	4	:	:	PUNCT
dpc-3486	92	5	covid-19	covid-19	PROPN
dpc-3486	92	6	pneumonia	pneumonia	NOUN
dpc-3486	92	7	ct	ct	NOUN
dpc-3486	92	8	:	:	PUNCT
dpc-3486	92	9	normal/	normal/	NUM
dpc-3486	92	10	unknown	unknown	ADJ
dpc-3486	92	11	ct	ct	PROPN
dpc-3486	92	12	:	:	PUNCT
dpc-3486	92	13	covid-19	covid-19	PROPN
dpc-3486	92	14	pneumonia	pneumonia	NOUN
dpc-3486	92	15	total	total	NOUN
dpc-3486	92	16	n	n	PROPN
dpc-3486	92	17	=	=	SYM
dpc-3486	92	18	383	383	NUM
dpc-3486	92	19	(	(	PUNCT
dpc-3486	92	20	n	n	NOUN
dpc-3486	92	21	=	=	NOUN
dpc-3486	92	22	160	160	NUM
dpc-3486	92	23	)	)	PUNCT
dpc-3486	92	24	(	(	PUNCT
dpc-3486	92	25	n	n	NOUN
dpc-3486	92	26	=	=	SYM
dpc-3486	92	27	13	13	NUM
dpc-3486	92	28	)	)	PUNCT
dpc-3486	92	29	(	(	PUNCT
dpc-3486	92	30	n	n	NOUN
dpc-3486	92	31	=	=	SYM
dpc-3486	92	32	168	168	NUM
dpc-3486	92	33	)	)	PUNCT
dpc-3486	92	34	(	(	PUNCT
dpc-3486	92	35	n	n	NOUN
dpc-3486	92	36	=	=	SYM
dpc-3486	92	37	42	42	NUM
dpc-3486	92	38	)	)	PUNCT
dpc-3486	93	1	normal	normal	ADJ
dpc-3486	93	2	oral	oral	ADJ
dpc-3486	93	3	mucosa	mucosa	NOUN
dpc-3486	93	4	findings	finding	VERB
dpc-3486	93	5	137	137	NUM
dpc-3486	93	6	(	(	PUNCT
dpc-3486	93	7	35.8	35.8	NUM
dpc-3486	93	8	%	%	NOUN
dpc-3486	93	9	)	)	PUNCT
dpc-3486	93	10	89	89	NUM
dpc-3486	93	11	(	(	PUNCT
dpc-3486	93	12	55.6	55.6	NUM
dpc-3486	93	13	%	%	NOUN
dpc-3486	93	14	)	)	PUNCT
dpc-3486	93	15	5	5	NUM
dpc-3486	93	16	(	(	PUNCT
dpc-3486	93	17	38.5	38.5	NUM
dpc-3486	93	18	%	%	NOUN
dpc-3486	93	19	)	)	PUNCT
dpc-3486	93	20	35	35	NUM
dpc-3486	93	21	(	(	PUNCT
dpc-3486	93	22	20.8	20.8	NUM
dpc-3486	93	23	%	%	NOUN
dpc-3486	93	24	)	)	PUNCT
dpc-3486	93	25	8	8	NUM
dpc-3486	93	26	(	(	PUNCT
dpc-3486	93	27	19.0	19.0	NUM
dpc-3486	93	28	%	%	NOUN
dpc-3486	93	29	)	)	PUNCT
dpc-3486	93	30	erythema	erythema	NOUN
dpc-3486	93	31	of	of	ADP
dpc-3486	93	32	tonsils	tonsil	NOUN
dpc-3486	93	33	and	and	CCONJ
dpc-3486	93	34	pharynx	pharynx	NOUN
dpc-3486	93	35	187	187	NUM
dpc-3486	93	36	(	(	PUNCT
dpc-3486	93	37	48.8	48.8	NUM
dpc-3486	93	38	%	%	NOUN
dpc-3486	93	39	)	)	PUNCT
dpc-3486	93	40	62	62	NUM
dpc-3486	93	41	(	(	PUNCT
dpc-3486	93	42	38.8	38.8	NUM
dpc-3486	93	43	%	%	NOUN
dpc-3486	93	44	)	)	PUNCT
dpc-3486	93	45	6	6	NUM
dpc-3486	93	46	(	(	PUNCT
dpc-3486	93	47	46.2	46.2	NUM
dpc-3486	93	48	%	%	NOUN
dpc-3486	93	49	)	)	PUNCT
dpc-3486	93	50	97	97	NUM
dpc-3486	93	51	(	(	PUNCT
dpc-3486	93	52	57.7	57.7	NUM
dpc-3486	93	53	%	%	NOUN
dpc-3486	93	54	)	)	PUNCT
dpc-3486	93	55	22	22	NUM
dpc-3486	93	56	(	(	PUNCT
dpc-3486	93	57	52.4	52.4	NUM
dpc-3486	93	58	%	%	NOUN
dpc-3486	93	59	)	)	PUNCT
dpc-3486	93	60	dry	dry	ADJ
dpc-3486	93	61	mouth	mouth	NOUN
dpc-3486	93	62	sensation	sensation	NOUN
dpc-3486	93	63	(	(	PUNCT
dpc-3486	93	64	xerostomia	xerostomia	NOUN
dpc-3486	93	65	)	)	PUNCT
dpc-3486	93	66	41	41	NUM
dpc-3486	93	67	(	(	PUNCT
dpc-3486	93	68	10.7	10.7	NUM
dpc-3486	93	69	%	%	NOUN
dpc-3486	93	70	)	)	PUNCT
dpc-3486	93	71	11	11	NUM
dpc-3486	93	72	(	(	PUNCT
dpc-3486	93	73	6.9	6.9	NUM
dpc-3486	93	74	%	%	NOUN
dpc-3486	93	75	)	)	PUNCT
dpc-3486	93	76	3	3	NUM
dpc-3486	93	77	(	(	PUNCT
dpc-3486	93	78	23.1	23.1	NUM
dpc-3486	93	79	%	%	NOUN
dpc-3486	93	80	)	)	PUNCT
dpc-3486	93	81	22	22	NUM
dpc-3486	93	82	(	(	PUNCT
dpc-3486	93	83	13.1	13.1	NUM
dpc-3486	93	84	%	%	NOUN
dpc-3486	93	85	)	)	PUNCT
dpc-3486	93	86	5	5	NUM
dpc-3486	93	87	(	(	PUNCT
dpc-3486	93	88	11.9	11.9	NUM
dpc-3486	93	89	%	%	NOUN
dpc-3486	93	90	)	)	PUNCT
dpc-3486	93	91	micro	micro	ADJ
dpc-3486	93	92	vesicles	vesicle	NOUN
dpc-3486	93	93	on	on	ADP
dpc-3486	93	94	tonsils	tonsil	NOUN
dpc-3486	93	95	or	or	CCONJ
dpc-3486	93	96	pharynx	pharynx	NOUN
dpc-3486	93	97	77	77	NUM
dpc-3486	93	98	(	(	PUNCT
dpc-3486	93	99	20.1	20.1	NUM
dpc-3486	93	100	%	%	NOUN
dpc-3486	93	101	)	)	PUNCT
dpc-3486	93	102	7	7	NUM
dpc-3486	93	103	(	(	PUNCT
dpc-3486	93	104	4.4	4.4	NUM
dpc-3486	93	105	%	%	NOUN
dpc-3486	93	106	)	)	PUNCT
dpc-3486	93	107	1	1	NUM
dpc-3486	93	108	(	(	PUNCT
dpc-3486	93	109	7.7	7.7	NUM
dpc-3486	93	110	%	%	NOUN
dpc-3486	93	111	)	)	PUNCT
dpc-3486	93	112	57	57	NUM
dpc-3486	93	113	(	(	PUNCT
dpc-3486	93	114	33.9	33.9	NUM
dpc-3486	93	115	%	%	NOUN
dpc-3486	93	116	)	)	PUNCT
dpc-3486	93	117	12	12	NUM
dpc-3486	93	118	(	(	PUNCT
dpc-3486	93	119	28.6	28.6	NUM
dpc-3486	93	120	%	%	NOUN
dpc-3486	93	121	)	)	PUNCT
dpc-3486	93	122	cryptic	cryptic	ADJ
dpc-3486	93	123	tonsillitis	tonsillitis	ADJ
dpc-3486	93	124	24	24	NUM
dpc-3486	93	125	(	(	PUNCT
dpc-3486	93	126	6.3	6.3	NUM
dpc-3486	93	127	%	%	NOUN
dpc-3486	93	128	)	)	PUNCT
dpc-3486	93	129	3	3	NUM
dpc-3486	93	130	(	(	PUNCT
dpc-3486	93	131	1.9	1.9	NUM
dpc-3486	93	132	%	%	NOUN
dpc-3486	93	133	)	)	PUNCT
dpc-3486	93	134	1	1	NUM
dpc-3486	93	135	(	(	PUNCT
dpc-3486	93	136	7.7	7.7	NUM
dpc-3486	93	137	%	%	NOUN
dpc-3486	93	138	)	)	PUNCT
dpc-3486	93	139	15	15	NUM
dpc-3486	93	140	(	(	PUNCT
dpc-3486	93	141	8.9	8.9	NUM
dpc-3486	93	142	%	%	NOUN
dpc-3486	93	143	)	)	PUNCT
dpc-3486	93	144	5	5	NUM
dpc-3486	93	145	(	(	PUNCT
dpc-3486	93	146	12.2	12.2	NUM
dpc-3486	93	147	%	%	NOUN
dpc-3486	93	148	)	)	PUNCT
dpc-3486	93	149	oral	oral	ADJ
dpc-3486	93	150	candidiasis	candidiasis	NOUN
dpc-3486	93	151	(	(	PUNCT
dpc-3486	93	152	suspected	suspect	VERB
dpc-3486	93	153	)	)	PUNCT
dpc-3486	93	154	74	74	NUM
dpc-3486	93	155	(	(	PUNCT
dpc-3486	93	156	19.3	19.3	NUM
dpc-3486	93	157	%	%	NOUN
dpc-3486	93	158	)	)	PUNCT
dpc-3486	93	159	24	24	NUM
dpc-3486	93	160	(	(	PUNCT
dpc-3486	93	161	15.0	15.0	NUM
dpc-3486	93	162	%	%	NOUN
dpc-3486	93	163	)	)	PUNCT
dpc-3486	93	164	5	5	NUM
dpc-3486	93	165	(	(	PUNCT
dpc-3486	93	166	38.5	38.5	NUM
dpc-3486	93	167	%	%	NOUN
dpc-3486	93	168	)	)	PUNCT
dpc-3486	93	169	37	37	NUM
dpc-3486	93	170	(	(	PUNCT
dpc-3486	93	171	22.0	22.0	NUM
dpc-3486	93	172	%	%	NOUN
dpc-3486	93	173	)	)	PUNCT
dpc-3486	93	174	8	8	NUM
dpc-3486	93	175	(	(	PUNCT
dpc-3486	93	176	19.0	19.0	NUM
dpc-3486	93	177	%	%	NOUN
dpc-3486	93	178	)	)	PUNCT
dpc-3486	93	179	tonsillar	tonsillar	ADJ
dpc-3486	93	180	hypertrophy	hypertrophy	NOUN
dpc-3486	93	181	57	57	NUM
dpc-3486	93	182	(	(	PUNCT
dpc-3486	93	183	14.9	14.9	NUM
dpc-3486	93	184	%	%	NOUN
dpc-3486	93	185	)	)	PUNCT
dpc-3486	93	186	18	18	NUM
dpc-3486	93	187	(	(	PUNCT
dpc-3486	93	188	11.3	11.3	NUM
dpc-3486	93	189	%	%	NOUN
dpc-3486	93	190	)	)	PUNCT
dpc-3486	93	191	4	4	NUM
dpc-3486	93	192	(	(	PUNCT
dpc-3486	93	193	30.8	30.8	NUM
dpc-3486	93	194	%	%	NOUN
dpc-3486	93	195	)	)	PUNCT
dpc-3486	93	196	25	25	NUM
dpc-3486	93	197	(	(	PUNCT
dpc-3486	93	198	14.9	14.9	NUM
dpc-3486	93	199	%	%	NOUN
dpc-3486	93	200	)	)	PUNCT
dpc-3486	93	201	10	10	NUM
dpc-3486	93	202	(	(	PUNCT
dpc-3486	93	203	23.8	23.8	NUM
dpc-3486	93	204	%	%	NOUN
dpc-3486	93	205	)	)	PUNCT
dpc-3486	93	206	petechiae	petechiae	NOUN
dpc-3486	93	207	in	in	ADP
dpc-3486	93	208	the	the	DET
dpc-3486	93	209	oropharynx	oropharynx	NOUN
dpc-3486	93	210	100	100	NUM
dpc-3486	93	211	(	(	PUNCT
dpc-3486	93	212	26.1	26.1	NUM
dpc-3486	93	213	%	%	NOUN
dpc-3486	93	214	)	)	PUNCT
dpc-3486	93	215	19	19	NUM
dpc-3486	93	216	(	(	PUNCT
dpc-3486	93	217	11.9	11.9	NUM
dpc-3486	93	218	%	%	NOUN
dpc-3486	93	219	)	)	PUNCT
dpc-3486	93	220	3	3	NUM
dpc-3486	93	221	(	(	PUNCT
dpc-3486	93	222	23.1	23.1	NUM
dpc-3486	93	223	%	%	NOUN
dpc-3486	93	224	)	)	PUNCT
dpc-3486	93	225	60	60	NUM
dpc-3486	93	226	(	(	PUNCT
dpc-3486	93	227	35.7	35.7	NUM
dpc-3486	93	228	%	%	NOUN
dpc-3486	93	229	)	)	PUNCT
dpc-3486	93	230	18	18	NUM
dpc-3486	93	231	(	(	PUNCT
dpc-3486	93	232	42.9	42.9	NUM
dpc-3486	93	233	%	%	NOUN
dpc-3486	93	234	)	)	PUNCT
dpc-3486	93	235	geographic	geographic	ADJ
dpc-3486	93	236	tongue	tongue	NOUN
dpc-3486	93	237	7	7	NUM
dpc-3486	93	238	(	(	PUNCT
dpc-3486	93	239	1.8	1.8	NUM
dpc-3486	93	240	%	%	NOUN
dpc-3486	93	241	)	)	PUNCT
dpc-3486	93	242	5	5	NUM
dpc-3486	93	243	(	(	PUNCT
dpc-3486	93	244	3.1	3.1	NUM
dpc-3486	93	245	%	%	NOUN
dpc-3486	93	246	)	)	PUNCT
dpc-3486	93	247	1	1	NUM
dpc-3486	93	248	(	(	PUNCT
dpc-3486	93	249	7.7	7.7	NUM
dpc-3486	93	250	%	%	NOUN
dpc-3486	93	251	)	)	PUNCT
dpc-3486	93	252	1	1	NUM
dpc-3486	93	253	(	(	PUNCT
dpc-3486	93	254	0.6	0.6	NUM
dpc-3486	93	255	%	%	NOUN
dpc-3486	93	256	)	)	PUNCT
dpc-3486	93	257	0	0	NUM
dpc-3486	94	1	(	(	PUNCT
dpc-3486	94	2	0.0	0.0	NUM
dpc-3486	94	3	%	%	NOUN
dpc-3486	94	4	)	)	PUNCT
dpc-3486	94	5	scrotal	scrotal	ADJ
dpc-3486	94	6	tongue	tongue	NOUN
dpc-3486	94	7	33	33	NUM
dpc-3486	94	8	(	(	PUNCT
dpc-3486	94	9	8.6	8.6	NUM
dpc-3486	94	10	%	%	NOUN
dpc-3486	94	11	)	)	PUNCT
dpc-3486	94	12	12	12	NUM
dpc-3486	94	13	(	(	PUNCT
dpc-3486	94	14	7.5	7.5	NUM
dpc-3486	94	15	%	%	NOUN
dpc-3486	94	16	)	)	PUNCT
dpc-3486	94	17	1	1	NUM
dpc-3486	94	18	(	(	PUNCT
dpc-3486	94	19	7.7	7.7	NUM
dpc-3486	94	20	%	%	NOUN
dpc-3486	94	21	)	)	PUNCT
dpc-3486	94	22	13	13	NUM
dpc-3486	94	23	(	(	PUNCT
dpc-3486	94	24	7.8	7.8	NUM
dpc-3486	94	25	%	%	NOUN
dpc-3486	94	26	)	)	PUNCT
dpc-3486	94	27	7	7	NUM
dpc-3486	94	28	(	(	PUNCT
dpc-3486	94	29	16.7	16.7	NUM
dpc-3486	94	30	%	%	NOUN
dpc-3486	94	31	)	)	PUNCT
dpc-3486	94	32	primary	primary	ADJ
dpc-3486	94	33	/	/	SYM
dpc-3486	94	34	secondary	secondary	ADJ
dpc-3486	94	35	herpes	herpe	NOUN
dpc-3486	94	36	infection	infection	NOUN
dpc-3486	94	37	22	22	NUM
dpc-3486	94	38	(	(	PUNCT
dpc-3486	94	39	5.8	5.8	NUM
dpc-3486	94	40	%	%	NOUN
dpc-3486	94	41	)	)	PUNCT
dpc-3486	94	42	3	3	NUM
dpc-3486	94	43	(	(	PUNCT
dpc-3486	94	44	1.9	1.9	NUM
dpc-3486	94	45	%	%	NOUN
dpc-3486	94	46	)	)	PUNCT
dpc-3486	94	47	0	0	NUM
dpc-3486	95	1	(	(	PUNCT
dpc-3486	95	2	0.0	0.0	NUM
dpc-3486	95	3	%	%	NOUN
dpc-3486	95	4	)	)	PUNCT
dpc-3486	95	5	15	15	NUM
dpc-3486	95	6	(	(	PUNCT
dpc-3486	95	7	9.0	9.0	NUM
dpc-3486	95	8	%	%	NOUN
dpc-3486	95	9	)	)	PUNCT
dpc-3486	95	10	4	4	NUM
dpc-3486	95	11	(	(	PUNCT
dpc-3486	95	12	9.5	9.5	NUM
dpc-3486	95	13	%	%	NOUN
dpc-3486	95	14	)	)	PUNCT
dpc-3486	95	15	oral	oral	ADJ
dpc-3486	95	16	aphthae	aphthae	NOUN
dpc-3486	95	17	66	66	NUM
dpc-3486	95	18	(	(	PUNCT
dpc-3486	95	19	17.2	17.2	NUM
dpc-3486	95	20	%	%	NOUN
dpc-3486	95	21	)	)	PUNCT
dpc-3486	95	22	15	15	NUM
dpc-3486	95	23	(	(	PUNCT
dpc-3486	95	24	9.4	9.4	NUM
dpc-3486	95	25	%	%	NOUN
dpc-3486	95	26	)	)	PUNCT
dpc-3486	95	27	4	4	NUM
dpc-3486	95	28	(	(	PUNCT
dpc-3486	95	29	30.8	30.8	NUM
dpc-3486	95	30	%	%	NOUN
dpc-3486	95	31	)	)	PUNCT
dpc-3486	95	32	34	34	NUM
dpc-3486	95	33	(	(	PUNCT
dpc-3486	95	34	20.2	20.2	NUM
dpc-3486	95	35	%	%	NOUN
dpc-3486	95	36	)	)	PUNCT
dpc-3486	95	37	13	13	NUM
dpc-3486	95	38	(	(	PUNCT
dpc-3486	95	39	31.0	31.0	NUM
dpc-3486	95	40	%	%	NOUN
dpc-3486	95	41	)	)	PUNCT
dpc-3486	95	42	cheilitis	cheilitis	NOUN
dpc-3486	95	43	or	or	CCONJ
dpc-3486	95	44	angular	angular	ADJ
dpc-3486	95	45	cheilitis	cheilitis	NOUN
dpc-3486	95	46	18	18	NUM
dpc-3486	95	47	(	(	PUNCT
dpc-3486	95	48	4.7	4.7	NUM
dpc-3486	95	49	%	%	NOUN
dpc-3486	95	50	)	)	PUNCT
dpc-3486	95	51	2	2	NUM
dpc-3486	95	52	(	(	PUNCT
dpc-3486	95	53	1.3	1.3	NUM
dpc-3486	95	54	%	%	NOUN
dpc-3486	95	55	)	)	PUNCT
dpc-3486	95	56	0	0	NUM
dpc-3486	96	1	(	(	PUNCT
dpc-3486	96	2	0.0	0.0	NUM
dpc-3486	96	3	%	%	NOUN
dpc-3486	96	4	)	)	PUNCT
dpc-3486	96	5	8	8	NUM
dpc-3486	96	6	(	(	PUNCT
dpc-3486	96	7	4.8	4.8	NUM
dpc-3486	96	8	%	%	NOUN
dpc-3486	96	9	)	)	PUNCT
dpc-3486	96	10	8	8	NUM
dpc-3486	96	11	(	(	PUNCT
dpc-3486	96	12	19.0	19.0	NUM
dpc-3486	96	13	%	%	NOUN
dpc-3486	96	14	)	)	PUNCT
dpc-3486	96	15	other	other	ADJ
dpc-3486	96	16	findings	finding	NOUN
dpc-3486	96	17	8	8	NUM
dpc-3486	96	18	(	(	PUNCT
dpc-3486	96	19	2.1	2.1	NUM
dpc-3486	96	20	%	%	NOUN
dpc-3486	96	21	)	)	PUNCT
dpc-3486	96	22	5	5	NUM
dpc-3486	96	23	(	(	PUNCT
dpc-3486	96	24	3.1	3.1	NUM
dpc-3486	96	25	%	%	NOUN
dpc-3486	96	26	)	)	PUNCT
dpc-3486	96	27	0	0	NUM
dpc-3486	96	28	(	(	PUNCT
dpc-3486	96	29	0.0	0.0	NUM
dpc-3486	96	30	%	%	NOUN
dpc-3486	96	31	)	)	PUNCT
dpc-3486	96	32	2	2	NUM
dpc-3486	96	33	(	(	PUNCT
dpc-3486	96	34	1.2	1.2	NUM
dpc-3486	96	35	%	%	NOUN
dpc-3486	96	36	)	)	PUNCT
dpc-3486	96	37	1	1	NUM
dpc-3486	96	38	(	(	PUNCT
dpc-3486	96	39	2.4	2.4	NUM
dpc-3486	96	40	%	%	NOUN
dpc-3486	96	41	)	)	PUNCT
dpc-3486	96	42	ct	ct	PROPN
dpc-3486	97	1	=	=	PUNCT
dpc-3486	97	2	computed	compute	VERB
dpc-3486	97	3	tomography	tomography	NOUN
dpc-3486	97	4	;	;	PUNCT
dpc-3486	97	5	pcr	pcr	PROPN
dpc-3486	97	6	=	=	SYM
dpc-3486	97	7	polymerase	polymerase	NOUN
dpc-3486	97	8	chain	chain	NOUN
dpc-3486	97	9	reaction	reaction	NOUN
dpc-3486	97	10	.	.	PUNCT
dpc-3486	98	1	4	4	NUM
dpc-3486	98	2	original	original	ADJ
dpc-3486	98	3	article	article	NOUN
dpc-3486	98	4	|	|	ADV
dpc-3486	98	5	dermatol	dermatol	ADJ
dpc-3486	98	6	pract	pract	NOUN
dpc-3486	98	7	concept	concept	NOUN
dpc-3486	98	8	.	.	PUNCT
dpc-3486	99	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	99	2	table	table	NOUN
dpc-3486	99	3	2	2	NUM
dpc-3486	99	4	.	.	PUNCT
dpc-3486	99	5	evaluation	evaluation	NOUN
dpc-3486	99	6	of	of	ADP
dpc-3486	99	7	examination	examination	NOUN
dpc-3486	99	8	findings	finding	NOUN
dpc-3486	99	9	according	accord	VERB
dpc-3486	99	10	to	to	ADP
dpc-3486	99	11	pcr	pcr	ADJ
dpc-3486	99	12	results	result	NOUN
dpc-3486	99	13	and	and	CCONJ
dpc-3486	99	14	complaints	complaint	NOUN
dpc-3486	99	15	of	of	ADP
dpc-3486	99	16	patients	patient	NOUN
dpc-3486	99	17	without	without	ADP
dpc-3486	99	18	pneumonia	pneumonia	NOUN
dpc-3486	99	19	.	.	PUNCT
dpc-3486	100	1	parameters	parameter	NOUN
dpc-3486	100	2	no	no	DET
dpc-3486	100	3	evidence	evidence	NOUN
dpc-3486	100	4	of	of	ADP
dpc-3486	100	5	pneumonia	pneumonia	NOUN
dpc-3486	100	6	on	on	ADP
dpc-3486	100	7	the	the	DET
dpc-3486	100	8	ct	ct	PROPN
dpc-3486	100	9	ppcr	ppcr	ADV
dpc-3486	100	10	negative	negative	ADJ
dpc-3486	100	11	(	(	PUNCT
dpc-3486	100	12	n	n	NOUN
dpc-3486	100	13	=	=	SYM
dpc-3486	100	14	68	68	NUM
dpc-3486	100	15	)	)	PUNCT
dpc-3486	100	16	pcr	pcr	ADJ
dpc-3486	100	17	positive	positive	ADJ
dpc-3486	100	18	(	(	PUNCT
dpc-3486	100	19	n	n	NOUN
dpc-3486	100	20	=	=	SYM
dpc-3486	100	21	71	71	NUM
dpc-3486	100	22	)	)	PUNCT
dpc-3486	100	23	age	age	NOUN
dpc-3486	100	24	(	(	PUNCT
dpc-3486	100	25	year	year	NOUN
dpc-3486	100	26	)	)	PUNCT
dpc-3486	100	27	;	;	PUNCT
dpc-3486	100	28	median	median	NOUN
dpc-3486	100	29	(	(	PUNCT
dpc-3486	100	30	iqr	iqr	NOUN
dpc-3486	100	31	)	)	PUNCT
dpc-3486	100	32	40	40	NUM
dpc-3486	100	33	(	(	PUNCT
dpc-3486	100	34	22.0	22.0	NUM
dpc-3486	100	35	)	)	PUNCT
dpc-3486	100	36	39	39	NUM
dpc-3486	100	37	(	(	PUNCT
dpc-3486	100	38	23	23	NUM
dpc-3486	100	39	)	)	PUNCT
dpc-3486	100	40	0.813	0.813	NUM
dpc-3486	100	41	sex	sex	NOUN
dpc-3486	100	42	,	,	PUNCT
dpc-3486	100	43	n	n	CCONJ
dpc-3486	100	44	(	(	PUNCT
dpc-3486	100	45	%	%	INTJ
dpc-3486	100	46	)	)	PUNCT
dpc-3486	100	47	woman	woman	NOUN
dpc-3486	100	48	30	30	NUM
dpc-3486	100	49	(	(	PUNCT
dpc-3486	100	50	44.1	44.1	NUM
dpc-3486	100	51	%	%	NOUN
dpc-3486	100	52	)	)	PUNCT
dpc-3486	100	53	40	40	NUM
dpc-3486	100	54	(	(	PUNCT
dpc-3486	100	55	56.3	56.3	NUM
dpc-3486	100	56	%	%	NOUN
dpc-3486	100	57	)	)	PUNCT
dpc-3486	100	58	0.150	0.150	NUM
dpc-3486	100	59	man	man	NOUN
dpc-3486	100	60	38	38	NUM
dpc-3486	100	61	(	(	PUNCT
dpc-3486	100	62	55.9	55.9	NUM
dpc-3486	100	63	%	%	NOUN
dpc-3486	100	64	)	)	PUNCT
dpc-3486	100	65	31	31	NUM
dpc-3486	100	66	(	(	PUNCT
dpc-3486	100	67	43.7	43.7	NUM
dpc-3486	100	68	%	%	NOUN
dpc-3486	100	69	)	)	PUNCT
dpc-3486	100	70	complaint	complaint	NOUN
dpc-3486	100	71	duration	duration	NOUN
dpc-3486	100	72	(	(	PUNCT
dpc-3486	100	73	day	day	PROPN
dpc-3486	100	74	)	)	PUNCT
dpc-3486	100	75	;	;	PUNCT
dpc-3486	100	76	median	median	NOUN
dpc-3486	100	77	(	(	PUNCT
dpc-3486	100	78	iqr	iqr	NOUN
dpc-3486	100	79	)	)	PUNCT
dpc-3486	100	80	4	4	NUM
dpc-3486	100	81	(	(	PUNCT
dpc-3486	100	82	2.0	2.0	NUM
dpc-3486	100	83	)	)	SYM
dpc-3486	100	84	4	4	NUM
dpc-3486	100	85	(	(	PUNCT
dpc-3486	100	86	2.0	2.0	NUM
dpc-3486	100	87	)	)	PUNCT
dpc-3486	100	88	0.796	0.796	NUM
dpc-3486	100	89	current	current	ADJ
dpc-3486	100	90	complaints	complaint	NOUN
dpc-3486	100	91	,	,	PUNCT
dpc-3486	100	92	n	n	PROPN
dpc-3486	100	93	(	(	PUNCT
dpc-3486	100	94	%	%	INTJ
dpc-3486	100	95	)	)	PUNCT
dpc-3486	100	96	throat	throat	NOUN
dpc-3486	100	97	ache	ache	ADV
dpc-3486	100	98	27	27	NUM
dpc-3486	100	99	(	(	PUNCT
dpc-3486	100	100	39.7	39.7	NUM
dpc-3486	100	101	%	%	NOUN
dpc-3486	100	102	)	)	PUNCT
dpc-3486	100	103	27	27	NUM
dpc-3486	100	104	(	(	PUNCT
dpc-3486	100	105	38.0	38.0	NUM
dpc-3486	100	106	%	%	NOUN
dpc-3486	100	107	)	)	PUNCT
dpc-3486	100	108	0.839	0.839	NUM
dpc-3486	100	109	headache	headache	NOUN
dpc-3486	100	110	29	29	NUM
dpc-3486	100	111	(	(	PUNCT
dpc-3486	100	112	42.6	42.6	NUM
dpc-3486	100	113	%	%	NOUN
dpc-3486	100	114	)	)	PUNCT
dpc-3486	100	115	28	28	NUM
dpc-3486	100	116	(	(	PUNCT
dpc-3486	100	117	39.4	39.4	NUM
dpc-3486	100	118	%	%	NOUN
dpc-3486	100	119	)	)	PUNCT
dpc-3486	100	120	0.700	0.700	NUM
dpc-3486	100	121	loss	loss	NOUN
dpc-3486	100	122	of	of	ADP
dpc-3486	100	123	taste	taste	NOUN
dpc-3486	100	124	and	and	CCONJ
dpc-3486	100	125	smell	smell	NOUN
dpc-3486	100	126	2	2	NUM
dpc-3486	100	127	(	(	PUNCT
dpc-3486	100	128	2.9	2.9	NUM
dpc-3486	100	129	%	%	NOUN
dpc-3486	100	130	)	)	PUNCT
dpc-3486	100	131	6	6	NUM
dpc-3486	100	132	(	(	PUNCT
dpc-3486	100	133	8.6	8.6	NUM
dpc-3486	100	134	%	%	NOUN
dpc-3486	100	135	)	)	PUNCT
dpc-3486	100	136	0.275	0.275	NUM
dpc-3486	100	137	back	back	ADV
dpc-3486	100	138	or	or	CCONJ
dpc-3486	100	139	chest	chest	NOUN
dpc-3486	100	140	pain	pain	NOUN
dpc-3486	100	141	31	31	NUM
dpc-3486	100	142	(	(	PUNCT
dpc-3486	100	143	45.6	45.6	NUM
dpc-3486	100	144	%	%	NOUN
dpc-3486	100	145	)	)	PUNCT
dpc-3486	100	146	43	43	NUM
dpc-3486	100	147	(	(	PUNCT
dpc-3486	100	148	60.6	60.6	NUM
dpc-3486	100	149	%	%	NOUN
dpc-3486	100	150	)	)	PUNCT
dpc-3486	100	151	0.077	0.077	NUM
dpc-3486	100	152	dry	dry	ADJ
dpc-3486	100	153	mouth	mouth	NOUN
dpc-3486	100	154	sensation	sensation	NOUN
dpc-3486	100	155	(	(	PUNCT
dpc-3486	100	156	xerostomia	xerostomia	NOUN
dpc-3486	100	157	)	)	PUNCT
dpc-3486	100	158	2	2	NUM
dpc-3486	100	159	(	(	PUNCT
dpc-3486	100	160	3.0	3.0	NUM
dpc-3486	100	161	%	%	NOUN
dpc-3486	100	162	)	)	PUNCT
dpc-3486	100	163	15	15	NUM
dpc-3486	100	164	(	(	PUNCT
dpc-3486	100	165	21.1	21.1	NUM
dpc-3486	100	166	%	%	NOUN
dpc-3486	100	167	)	)	PUNCT
dpc-3486	100	168	0.001	0.001	NUM
dpc-3486	100	169	other	other	ADJ
dpc-3486	100	170	symptoms	symptom	NOUN
dpc-3486	100	171	(	(	PUNCT
dpc-3486	100	172	typical	typical	ADJ
dpc-3486	100	173	-	-	PUNCT
dpc-3486	100	174	atypical	atypical	ADJ
dpc-3486	100	175	)	)	PUNCT
dpc-3486	100	176	64	64	NUM
dpc-3486	100	177	(	(	PUNCT
dpc-3486	100	178	94.1	94.1	NUM
dpc-3486	100	179	%	%	NOUN
dpc-3486	100	180	)	)	PUNCT
dpc-3486	100	181	69	69	NUM
dpc-3486	100	182	(	(	PUNCT
dpc-3486	100	183	97.2	97.2	NUM
dpc-3486	100	184	%	%	NOUN
dpc-3486	100	185	)	)	PUNCT
dpc-3486	100	186	0.435	0.435	NUM
dpc-3486	100	187	oral	oral	ADJ
dpc-3486	100	188	mucosa	mucosa	NOUN
dpc-3486	100	189	examination	examination	NOUN
dpc-3486	100	190	,	,	PUNCT
dpc-3486	100	191	n	n	PROPN
dpc-3486	100	192	(	(	PUNCT
dpc-3486	100	193	%	%	INTJ
dpc-3486	100	194	)	)	PUNCT
dpc-3486	100	195	normal	normal	ADJ
dpc-3486	100	196	oral	oral	ADJ
dpc-3486	100	197	mucosa	mucosa	NOUN
dpc-3486	100	198	findings	finding	VERB
dpc-3486	100	199	37	37	NUM
dpc-3486	100	200	(	(	PUNCT
dpc-3486	100	201	54.4	54.4	NUM
dpc-3486	100	202	%	%	NOUN
dpc-3486	100	203	)	)	PUNCT
dpc-3486	100	204	9	9	NUM
dpc-3486	100	205	(	(	PUNCT
dpc-3486	100	206	12.7	12.7	NUM
dpc-3486	100	207	%	%	NOUN
dpc-3486	100	208	)	)	PUNCT
dpc-3486	101	1	<	<	X
dpc-3486	101	2	0.001	0.001	NUM
dpc-3486	101	3	erythema	erythema	NOUN
dpc-3486	101	4	of	of	ADP
dpc-3486	101	5	tonsils	tonsil	NOUN
dpc-3486	101	6	and	and	CCONJ
dpc-3486	101	7	pharynx	pharynx	NOUN
dpc-3486	101	8	28	28	NUM
dpc-3486	101	9	(	(	PUNCT
dpc-3486	101	10	41.2	41.2	NUM
dpc-3486	101	11	%	%	NOUN
dpc-3486	101	12	)	)	PUNCT
dpc-3486	101	13	43	43	NUM
dpc-3486	101	14	(	(	PUNCT
dpc-3486	101	15	60.6	60.6	NUM
dpc-3486	101	16	%	%	NOUN
dpc-3486	101	17	)	)	PUNCT
dpc-3486	101	18	0.022	0.022	NUM
dpc-3486	101	19	micro	micro	ADJ
dpc-3486	101	20	vesicles	vesicle	NOUN
dpc-3486	101	21	on	on	ADP
dpc-3486	101	22	tonsils	tonsil	NOUN
dpc-3486	101	23	or	or	CCONJ
dpc-3486	101	24	pharynx	pharynx	NOUN
dpc-3486	101	25	3	3	NUM
dpc-3486	101	26	(	(	PUNCT
dpc-3486	101	27	4.4	4.4	NUM
dpc-3486	101	28	%	%	NOUN
dpc-3486	101	29	)	)	PUNCT
dpc-3486	101	30	28	28	NUM
dpc-3486	101	31	(	(	PUNCT
dpc-3486	101	32	39.4	39.4	NUM
dpc-3486	101	33	%	%	NOUN
dpc-3486	101	34	)	)	PUNCT
dpc-3486	102	1	<	<	X
dpc-3486	102	2	0.001	0.001	NUM
dpc-3486	102	3	cryptic	cryptic	ADJ
dpc-3486	102	4	tonsillitis	tonsillitis	ADJ
dpc-3486	102	5	1	1	NUM
dpc-3486	102	6	(	(	PUNCT
dpc-3486	102	7	1.5	1.5	NUM
dpc-3486	102	8	%	%	NOUN
dpc-3486	102	9	)	)	PUNCT
dpc-3486	102	10	6	6	NUM
dpc-3486	102	11	(	(	PUNCT
dpc-3486	102	12	8.5	8.5	NUM
dpc-3486	102	13	%	%	NOUN
dpc-3486	102	14	)	)	PUNCT
dpc-3486	102	15	0.116	0.116	NUM
dpc-3486	102	16	oral	oral	ADJ
dpc-3486	102	17	candidiasis	candidiasis	NOUN
dpc-3486	102	18	(	(	PUNCT
dpc-3486	102	19	suspected	suspect	VERB
dpc-3486	102	20	)	)	PUNCT
dpc-3486	102	21	13	13	NUM
dpc-3486	102	22	(	(	PUNCT
dpc-3486	102	23	19.1	19.1	NUM
dpc-3486	102	24	%	%	NOUN
dpc-3486	102	25	)	)	PUNCT
dpc-3486	102	26	20	20	NUM
dpc-3486	102	27	(	(	PUNCT
dpc-3486	102	28	28.2	28.2	NUM
dpc-3486	102	29	%	%	NOUN
dpc-3486	102	30	)	)	PUNCT
dpc-3486	102	31	0.210	0.210	NUM
dpc-3486	102	32	tonsillar	tonsillar	ADJ
dpc-3486	102	33	hypertrophy	hypertrophy	NOUN
dpc-3486	102	34	8	8	NUM
dpc-3486	102	35	(	(	PUNCT
dpc-3486	102	36	11.8	11.8	NUM
dpc-3486	102	37	%	%	NOUN
dpc-3486	102	38	)	)	PUNCT
dpc-3486	102	39	11	11	NUM
dpc-3486	102	40	(	(	PUNCT
dpc-3486	102	41	15.5	15.5	NUM
dpc-3486	102	42	%	%	NOUN
dpc-3486	102	43	)	)	PUNCT
dpc-3486	102	44	0.522	0.522	NUM
dpc-3486	102	45	petechiae	petechiae	NOUN
dpc-3486	102	46	in	in	ADP
dpc-3486	102	47	the	the	DET
dpc-3486	102	48	oropharynx	oropharynx	NOUN
dpc-3486	102	49	10	10	NUM
dpc-3486	102	50	(	(	PUNCT
dpc-3486	102	51	14.7	14.7	NUM
dpc-3486	102	52	%	%	NOUN
dpc-3486	102	53	)	)	PUNCT
dpc-3486	102	54	30	30	NUM
dpc-3486	102	55	(	(	PUNCT
dpc-3486	102	56	42.3	42.3	NUM
dpc-3486	102	57	%	%	NOUN
dpc-3486	102	58	)	)	PUNCT
dpc-3486	103	1	<	<	X
dpc-3486	103	2	0.001	0.001	NUM
dpc-3486	103	3	leukoplakia	leukoplakia	NOUN
dpc-3486	103	4	0	0	NUM
dpc-3486	103	5	(	(	PUNCT
dpc-3486	103	6	0.0	0.0	NUM
dpc-3486	103	7	%	%	NOUN
dpc-3486	103	8	)	)	PUNCT
dpc-3486	103	9	0	0	NUM
dpc-3486	104	1	(	(	PUNCT
dpc-3486	104	2	0.0	0.0	NUM
dpc-3486	104	3	%	%	NOUN
dpc-3486	104	4	)	)	PUNCT
dpc-3486	104	5	n	n	CCONJ
dpc-3486	104	6	/	/	SYM
dpc-3486	104	7	a	a	DET
dpc-3486	104	8	geographic	geographic	ADJ
dpc-3486	104	9	tongue	tongue	NOUN
dpc-3486	104	10	1	1	NUM
dpc-3486	104	11	(	(	PUNCT
dpc-3486	104	12	1.5	1.5	NUM
dpc-3486	104	13	%	%	NOUN
dpc-3486	104	14	)	)	PUNCT
dpc-3486	104	15	1	1	NUM
dpc-3486	104	16	(	(	PUNCT
dpc-3486	104	17	1.4	1.4	NUM
dpc-3486	104	18	%	%	NOUN
dpc-3486	104	19	)	)	PUNCT
dpc-3486	104	20	1.000	1.000	NUM
dpc-3486	104	21	scrotal	scrotal	ADJ
dpc-3486	104	22	tongue	tongue	NOUN
dpc-3486	104	23	7	7	NUM
dpc-3486	104	24	(	(	PUNCT
dpc-3486	104	25	10.3	10.3	NUM
dpc-3486	104	26	%	%	NOUN
dpc-3486	104	27	)	)	PUNCT
dpc-3486	104	28	5	5	NUM
dpc-3486	104	29	(	(	PUNCT
dpc-3486	104	30	7.0	7.0	NUM
dpc-3486	104	31	%	%	NOUN
dpc-3486	104	32	)	)	PUNCT
dpc-3486	104	33	0.495	0.495	NUM
dpc-3486	104	34	primary	primary	ADJ
dpc-3486	104	35	/	/	SYM
dpc-3486	104	36	secondary	secondary	ADJ
dpc-3486	104	37	herpes	herpe	NOUN
dpc-3486	104	38	infection	infection	NOUN
dpc-3486	104	39	2	2	NUM
dpc-3486	104	40	(	(	PUNCT
dpc-3486	104	41	3.0	3.0	NUM
dpc-3486	104	42	%	%	NOUN
dpc-3486	104	43	)	)	PUNCT
dpc-3486	104	44	9	9	NUM
dpc-3486	104	45	(	(	PUNCT
dpc-3486	104	46	12.7	12.7	NUM
dpc-3486	104	47	%	%	NOUN
dpc-3486	104	48	)	)	PUNCT
dpc-3486	104	49	0.036	0.036	NUM
dpc-3486	104	50	oral	oral	ADJ
dpc-3486	104	51	aphthae	aphthae	NOUN
dpc-3486	104	52	8	8	NUM
dpc-3486	104	53	(	(	PUNCT
dpc-3486	104	54	11.8	11.8	NUM
dpc-3486	104	55	%	%	NOUN
dpc-3486	104	56	)	)	PUNCT
dpc-3486	104	57	18	18	NUM
dpc-3486	104	58	(	(	PUNCT
dpc-3486	104	59	25.4	25.4	NUM
dpc-3486	104	60	%	%	NOUN
dpc-3486	104	61	)	)	PUNCT
dpc-3486	104	62	0.040	0.040	NUM
dpc-3486	104	63	cheilitis	cheilitis	NOUN
dpc-3486	104	64	or	or	CCONJ
dpc-3486	104	65	angular	angular	ADJ
dpc-3486	104	66	cheilitis	cheilitis	NOUN
dpc-3486	104	67	1	1	NUM
dpc-3486	104	68	(	(	PUNCT
dpc-3486	104	69	1.5	1.5	NUM
dpc-3486	104	70	%	%	NOUN
dpc-3486	104	71	)	)	PUNCT
dpc-3486	104	72	4	4	NUM
dpc-3486	104	73	(	(	PUNCT
dpc-3486	104	74	5.6	5.6	NUM
dpc-3486	104	75	%	%	NOUN
dpc-3486	104	76	)	)	PUNCT
dpc-3486	104	77	0.366	0.366	NUM
dpc-3486	104	78	other	other	ADJ
dpc-3486	104	79	findings	finding	NOUN
dpc-3486	104	80	3	3	NUM
dpc-3486	104	81	(	(	PUNCT
dpc-3486	104	82	4.5	4.5	NUM
dpc-3486	104	83	%	%	NOUN
dpc-3486	104	84	)	)	PUNCT
dpc-3486	104	85	2	2	NUM
dpc-3486	104	86	(	(	PUNCT
dpc-3486	104	87	2.8	2.8	NUM
dpc-3486	104	88	%	%	NOUN
dpc-3486	104	89	)	)	PUNCT
dpc-3486	104	90	0.674	0.674	NUM
dpc-3486	104	91	ct	ct	NOUN
dpc-3486	104	92	=	=	PUNCT
dpc-3486	104	93	computed	computed	ADJ
dpc-3486	104	94	tomography	tomography	NOUN
dpc-3486	104	95	;	;	PUNCT
dpc-3486	104	96	iqr	iqr	PROPN
dpc-3486	104	97	=	=	SYM
dpc-3486	104	98	inter	inter	ADJ
dpc-3486	104	99	-	-	ADJ
dpc-3486	104	100	quartile	quartile	ADJ
dpc-3486	104	101	range	range	NOUN
dpc-3486	104	102	;	;	PUNCT
dpc-3486	104	103	n	n	CCONJ
dpc-3486	104	104	/	/	SYM
dpc-3486	104	105	a	a	DET
dpc-3486	104	106	=	=	NOUN
dpc-3486	104	107	not	not	PART
dpc-3486	104	108	applicable	applicable	ADJ
dpc-3486	104	109	;	;	PUNCT
dpc-3486	104	110	pcr	pcr	ADJ
dpc-3486	104	111	=	=	SYM
dpc-3486	104	112	polymerase	polymerase	NOUN
dpc-3486	104	113	chain	chain	NOUN
dpc-3486	104	114	reaction	reaction	NOUN
dpc-3486	104	115	.	.	PUNCT
dpc-3486	105	1	they	they	PRON
dpc-3486	105	2	were	be	AUX
dpc-3486	105	3	related	relate	VERB
dpc-3486	105	4	in	in	ADP
dpc-3486	105	5	multivariate	multivariate	NOUN
dpc-3486	105	6	analysis	analysis	NOUN
dpc-3486	105	7	(	(	PUNCT
dpc-3486	105	8	or	or	CCONJ
dpc-3486	105	9	=	=	SYM
dpc-3486	105	10	11.15	11.15	NUM
dpc-3486	105	11	,	,	PUNCT
dpc-3486	105	12	95	95	NUM
dpc-3486	105	13	%	%	NOUN
dpc-3486	105	14	ci	ci	NOUN
dpc-3486	105	15	:	:	PUNCT
dpc-3486	106	1	[	[	X
dpc-3486	106	2	1.57	1.57	NUM
dpc-3486	106	3	-	-	SYM
dpc-3486	106	4	97.53	97.53	NUM
dpc-3486	106	5	]	]	PUNCT
dpc-3486	106	6	,	,	PUNCT
dpc-3486	106	7	p	p	X
dpc-3486	106	8	=	=	PROPN
dpc-3486	106	9	0.029	0.029	NUM
dpc-3486	106	10	,	,	PUNCT
dpc-3486	106	11	table	table	NOUN
dpc-3486	106	12	5	5	NUM
dpc-3486	106	13	)	)	PUNCT
dpc-3486	106	14	.	.	PUNCT
dpc-3486	107	1	moreover	moreover	ADV
dpc-3486	107	2	,	,	PUNCT
dpc-3486	107	3	pcr	pcr	ADJ
dpc-3486	107	4	positivity	positivity	NOUN
dpc-3486	107	5	is	be	AUX
dpc-3486	107	6	nearly	nearly	ADV
dpc-3486	107	7	8	8	NUM
dpc-3486	107	8	times	time	NOUN
dpc-3486	107	9	higher	high	ADJ
dpc-3486	107	10	in	in	ADP
dpc-3486	107	11	patients	patient	NOUN
dpc-3486	107	12	with	with	ADP
dpc-3486	107	13	any	any	DET
dpc-3486	107	14	oral	oral	ADJ
dpc-3486	107	15	mucosa	mucosa	NOUN
dpc-3486	107	16	findings	finding	NOUN
dpc-3486	107	17	(	(	PUNCT
dpc-3486	107	18	or	or	CCONJ
dpc-3486	107	19	=	=	SYM
dpc-3486	107	20	8.22	8.22	NUM
dpc-3486	107	21	,	,	PUNCT
dpc-3486	107	22	95	95	NUM
dpc-3486	107	23	%	%	NOUN
dpc-3486	107	24	ci	ci	NOUN
dpc-3486	107	25	:	:	PUNCT
dpc-3486	108	1	[	[	X
dpc-3486	108	2	3.53	3.53	NUM
dpc-3486	108	3	19.17	19.17	NUM
dpc-3486	108	4	]	]	PUNCT
dpc-3486	108	5	,	,	PUNCT
dpc-3486	108	6	p	p	X
dpc-3486	108	7	<	<	X
dpc-3486	108	8	0.001	0.001	NUM
dpc-3486	108	9	)	)	PUNCT
dpc-3486	108	10	.	.	PUNCT
dpc-3486	109	1	lung	lung	NOUN
dpc-3486	109	2	involvement	involvement	NOUN
dpc-3486	109	3	in	in	ADP
dpc-3486	109	4	patients	patient	NOUN
dpc-3486	109	5	with	with	ADP
dpc-3486	109	6	pcr	pcr	ADJ
dpc-3486	109	7	positivity	positivity	NOUN
dpc-3486	109	8	is	be	AUX
dpc-3486	109	9	related	relate	VERB
dpc-3486	109	10	to	to	ADP
dpc-3486	109	11	only	only	ADV
dpc-3486	109	12	cheilitis	cheilitis	NOUN
dpc-3486	109	13	or	or	CCONJ
dpc-3486	109	14	angular	angular	ADJ
dpc-3486	109	15	cheilitis	cheilitis	NOUN
dpc-3486	109	16	(	(	PUNCT
dpc-3486	109	17	or	or	CCONJ
dpc-3486	109	18	=	=	SYM
dpc-3486	109	19	3.94	3.94	NUM
dpc-3486	109	20	,	,	PUNCT
dpc-3486	109	21	95	95	NUM
dpc-3486	109	22	%	%	NOUN
dpc-3486	109	23	ci	ci	NOUN
dpc-3486	109	24	:	:	PUNCT
dpc-3486	110	1	[	[	X
dpc-3486	110	2	1.1114.02	1.1114.02	X
dpc-3486	110	3	]	]	X
dpc-3486	110	4	,	,	PUNCT
dpc-3486	110	5	p	p	NOUN
dpc-3486	110	6	=	=	NOUN
dpc-3486	110	7	0.034	0.034	NUM
dpc-3486	110	8	,	,	PUNCT
dpc-3486	110	9	table	table	NOUN
dpc-3486	110	10	4	4	NUM
dpc-3486	110	11	)	)	PUNCT
dpc-3486	110	12	.	.	PUNCT
dpc-3486	111	1	conclusions	conclusion	NOUN
dpc-3486	111	2	enanthema	enanthema	NOUN
dpc-3486	111	3	and	and	CCONJ
dpc-3486	111	4	various	various	ADJ
dpc-3486	111	5	oral	oral	ADJ
dpc-3486	111	6	lesions	lesion	NOUN
dpc-3486	111	7	are	be	AUX
dpc-3486	111	8	among	among	ADP
dpc-3486	111	9	the	the	DET
dpc-3486	111	10	typical	typical	ADJ
dpc-3486	111	11	symptoms	symptom	NOUN
dpc-3486	111	12	of	of	ADP
dpc-3486	111	13	many	many	ADJ
dpc-3486	111	14	viral	viral	ADJ
dpc-3486	111	15	diseases	disease	NOUN
dpc-3486	111	16	[	[	X
dpc-3486	111	17	5	5	NUM
dpc-3486	111	18	]	]	PUNCT
dpc-3486	111	19	.	.	PUNCT
dpc-3486	112	1	in	in	ADP
dpc-3486	112	2	a	a	DET
dpc-3486	112	3	large	large	ADJ
dpc-3486	112	4	series	series	NOUN
dpc-3486	112	5	of	of	ADP
dpc-3486	112	6	patients	patient	NOUN
dpc-3486	112	7	with	with	ADP
dpc-3486	112	8	atypical	atypical	ADJ
dpc-3486	112	9	exanthems	exanthem	NOUN
dpc-3486	112	10	,	,	PUNCT
dpc-3486	112	11	erythematous	erythematous	ADJ
dpc-3486	112	12	-	-	PUNCT
dpc-3486	112	13	vesicular	vesicular	ADJ
dpc-3486	112	14	and	and	CCONJ
dpc-3486	112	15	petechial	petechial	ADJ
dpc-3486	112	16	patterns	pattern	NOUN
dpc-3486	112	17	were	be	AUX
dpc-3486	112	18	found	find	VERB
dpc-3486	112	19	most	most	ADV
dpc-3486	112	20	commonly	commonly	ADV
dpc-3486	112	21	associated	associate	VERB
dpc-3486	112	22	with	with	ADP
dpc-3486	112	23	viral	viral	ADJ
dpc-3486	112	24	infections	infection	NOUN
dpc-3486	112	25	[	[	X
dpc-3486	112	26	11	11	NUM
dpc-3486	112	27	]	]	PUNCT
dpc-3486	112	28	.	.	PUNCT
dpc-3486	113	1	up	up	ADP
dpc-3486	113	2	to	to	ADP
dpc-3486	113	3	date	date	NOUN
dpc-3486	113	4	,	,	PUNCT
dpc-3486	113	5	numerous	numerous	ADJ
dpc-3486	113	6	oral	oral	ADJ
dpc-3486	113	7	mucosal	mucosal	NOUN
dpc-3486	113	8	lesions	lesion	NOUN
dpc-3486	113	9	associated	associate	VERB
dpc-3486	113	10	with	with	ADP
dpc-3486	113	11	covid-19	covid-19	PROPN
dpc-3486	113	12	infection	infection	NOUN
dpc-3486	113	13	have	have	AUX
dpc-3486	113	14	been	be	AUX
dpc-3486	113	15	reported	report	VERB
dpc-3486	113	16	[	[	PUNCT
dpc-3486	113	17	5	5	NUM
dpc-3486	113	18	-	-	NUM
dpc-3486	113	19	9,12	9,12	NUM
dpc-3486	113	20	-	-	SYM
dpc-3486	113	21	15	15	NUM
dpc-3486	113	22	]	]	PUNCT
dpc-3486	113	23	.	.	PUNCT
dpc-3486	114	1	however	however	ADV
dpc-3486	114	2	,	,	PUNCT
dpc-3486	114	3	it	it	PRON
dpc-3486	114	4	remains	remain	VERB
dpc-3486	114	5	unclear	unclear	ADJ
dpc-3486	114	6	whether	whether	SCONJ
dpc-3486	114	7	oral	oral	ADJ
dpc-3486	114	8	manifestations	manifestation	NOUN
dpc-3486	114	9	develop	develop	VERB
dpc-3486	114	10	directly	directly	ADV
dpc-3486	114	11	from	from	ADP
dpc-3486	114	12	the	the	DET
dpc-3486	114	13	sars	sar	NOUN
dpc-3486	114	14	-	-	PUNCT
dpc-3486	114	15	cov-2	cov-2	NOUN
dpc-3486	114	16	infection	infection	NOUN
dpc-3486	114	17	or	or	CCONJ
dpc-3486	114	18	due	due	ADP
dpc-3486	114	19	to	to	ADP
dpc-3486	114	20	systemic	systemic	ADJ
dpc-3486	114	21	consequences	consequence	NOUN
dpc-3486	114	22	of	of	ADP
dpc-3486	114	23	covid-19	covid-19	PROPN
dpc-3486	114	24	,	,	PUNCT
dpc-3486	114	25	given	give	VERB
dpc-3486	114	26	the	the	DET
dpc-3486	114	27	possibility	possibility	NOUN
dpc-3486	114	28	of	of	ADP
dpc-3486	114	29	co	co	NOUN
dpc-3486	114	30	-	-	NOUN
dpc-3486	114	31	infection	infection	NOUN
dpc-3486	114	32	and	and	CCONJ
dpc-3486	114	33	impaired	impaired	ADJ
dpc-3486	114	34	immune	immune	ADJ
dpc-3486	114	35	response	response	NOUN
dpc-3486	114	36	or	or	CCONJ
dpc-3486	114	37	drug	drug	NOUN
dpc-3486	114	38	side	side	NOUN
dpc-3486	114	39	effects	effect	NOUN
dpc-3486	114	40	[	[	X
dpc-3486	114	41	9	9	NUM
dpc-3486	114	42	]	]	PUNCT
dpc-3486	114	43	.	.	PUNCT
dpc-3486	115	1	the	the	DET
dpc-3486	115	2	prevalence	prevalence	NOUN
dpc-3486	115	3	of	of	ADP
dpc-3486	115	4	oral	oral	ADJ
dpc-3486	115	5	cavity	cavity	NOUN
dpc-3486	115	6	signs	sign	NOUN
dpc-3486	115	7	of	of	ADP
dpc-3486	115	8	covid-19	covid-19	PROPN
dpc-3486	115	9	is	be	AUX
dpc-3486	115	10	not	not	PART
dpc-3486	115	11	known	know	VERB
dpc-3486	115	12	,	,	PUNCT
dpc-3486	115	13	but	but	CCONJ
dpc-3486	115	14	it	it	PRON
dpc-3486	115	15	was	be	AUX
dpc-3486	115	16	reported	report	VERB
dpc-3486	115	17	that	that	SCONJ
dpc-3486	115	18	oral	oral	ADJ
dpc-3486	115	19	manifestations	manifestation	NOUN
dpc-3486	115	20	were	be	AUX
dpc-3486	115	21	present	present	ADJ
dpc-3486	115	22	in	in	ADP
dpc-3486	115	23	25.65	25.65	NUM
dpc-3486	115	24	%	%	NOUN
dpc-3486	115	25	of	of	ADP
dpc-3486	115	26	666	666	NUM
dpc-3486	115	27	patients	patient	NOUN
dpc-3486	115	28	in	in	ADP
dpc-3486	115	29	a	a	DET
dpc-3486	115	30	large	large	ADJ
dpc-3486	115	31	study	study	NOUN
dpc-3486	116	1	[	[	X
dpc-3486	116	2	16	16	NUM
dpc-3486	116	3	]	]	PUNCT
dpc-3486	116	4	.	.	PUNCT
dpc-3486	117	1	mild	mild	ADJ
dpc-3486	117	2	severity	severity	NOUN
dpc-3486	117	3	of	of	ADP
dpc-3486	117	4	the	the	DET
dpc-3486	117	5	disease	disease	NOUN
dpc-3486	117	6	was	be	AUX
dpc-3486	117	7	assumed	assume	VERB
dpc-3486	117	8	to	to	PART
dpc-3486	117	9	be	be	AUX
dpc-3486	117	10	associated	associate	VERB
dpc-3486	117	11	with	with	ADP
dpc-3486	117	12	no	no	DET
dpc-3486	117	13	or	or	CCONJ
dpc-3486	117	14	minor	minor	ADJ
dpc-3486	117	15	symptoms	symptom	NOUN
dpc-3486	117	16	[	[	X
dpc-3486	117	17	16	16	NUM
dpc-3486	117	18	]	]	PUNCT
dpc-3486	117	19	.	.	PUNCT
dpc-3486	118	1	in	in	ADP
dpc-3486	118	2	the	the	DET
dpc-3486	118	3	present	present	ADJ
dpc-3486	118	4	study	study	NOUN
dpc-3486	118	5	,	,	PUNCT
dpc-3486	118	6	there	there	PRON
dpc-3486	118	7	were	be	VERB
dpc-3486	118	8	normal	normal	ADJ
dpc-3486	118	9	oral	oral	ADJ
dpc-3486	118	10	mucosa	mucosa	NOUN
dpc-3486	118	11	findings	finding	NOUN
dpc-3486	118	12	in	in	ADP
dpc-3486	118	13	21.5	21.5	NUM
dpc-3486	118	14	%	%	NOUN
dpc-3486	118	15	of	of	ADP
dpc-3486	118	16	223	223	NUM
dpc-3486	118	17	patients	patient	NOUN
dpc-3486	118	18	with	with	ADP
dpc-3486	118	19	confirmed	confirm	VERB
dpc-3486	118	20	covid-19	covid-19	PROPN
dpc-3486	118	21	.	.	PUNCT
dpc-3486	119	1	according	accord	VERB
dpc-3486	119	2	to	to	ADP
dpc-3486	119	3	our	our	PRON
dpc-3486	119	4	study	study	NOUN
dpc-3486	119	5	results	result	NOUN
dpc-3486	119	6	,	,	PUNCT
dpc-3486	119	7	the	the	DET
dpc-3486	119	8	most	most	ADV
dpc-3486	119	9	common	common	ADJ
dpc-3486	119	10	oral	oral	ADJ
dpc-3486	119	11	manifestations	manifestation	NOUN
dpc-3486	119	12	associated	associate	VERB
dpc-3486	119	13	with	with	ADP
dpc-3486	119	14	covid-19	covid-19	PROPN
dpc-3486	119	15	were	be	AUX
dpc-3486	119	16	erythema	erythema	ADJ
dpc-3486	119	17	of	of	ADP
dpc-3486	119	18	original	original	ADJ
dpc-3486	119	19	article	article	NOUN
dpc-3486	119	20	|	|	ADV
dpc-3486	119	21	dermatol	dermatol	ADJ
dpc-3486	119	22	pract	pract	NOUN
dpc-3486	119	23	concept	concept	NOUN
dpc-3486	119	24	.	.	PUNCT
dpc-3486	120	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	120	2	5	5	NUM
dpc-3486	120	3	table	table	NOUN
dpc-3486	120	4	3	3	NUM
dpc-3486	120	5	.	.	PUNCT
dpc-3486	120	6	evaluation	evaluation	NOUN
dpc-3486	120	7	of	of	ADP
dpc-3486	120	8	examination	examination	NOUN
dpc-3486	120	9	findings	finding	NOUN
dpc-3486	120	10	according	accord	VERB
dpc-3486	120	11	to	to	ADP
dpc-3486	120	12	ct	ct	PROPN
dpc-3486	120	13	results	result	NOUN
dpc-3486	120	14	and	and	CCONJ
dpc-3486	120	15	complaints	complaint	NOUN
dpc-3486	120	16	of	of	ADP
dpc-3486	120	17	patients	patient	NOUN
dpc-3486	120	18	with	with	ADP
dpc-3486	120	19	a	a	DET
dpc-3486	120	20	definitive	definitive	ADJ
dpc-3486	120	21	diagnosis	diagnosis	NOUN
dpc-3486	120	22	of	of	ADP
dpc-3486	120	23	covid-19	covid-19	PROPN
dpc-3486	120	24	.	.	PUNCT
dpc-3486	121	1	parameters	parameter	NOUN
dpc-3486	121	2	patients	patient	NOUN
dpc-3486	121	3	with	with	ADP
dpc-3486	121	4	pcr	pcr	ADJ
dpc-3486	121	5	positive	positive	ADJ
dpc-3486	121	6	pct	pct	NOUN
dpc-3486	121	7	:	:	PUNCT
dpc-3486	121	8	normal	normal	ADJ
dpc-3486	121	9	(	(	PUNCT
dpc-3486	121	10	n	n	NOUN
dpc-3486	121	11	=	=	SYM
dpc-3486	121	12	71	71	NUM
dpc-3486	121	13	)	)	PUNCT
dpc-3486	121	14	ct	ct	PROPN
dpc-3486	121	15	:	:	PUNCT
dpc-3486	121	16	pneumonia	pneumonia	NOUN
dpc-3486	121	17	(	(	PUNCT
dpc-3486	121	18	n	n	NOUN
dpc-3486	121	19	=	=	SYM
dpc-3486	121	20	42	42	NUM
dpc-3486	121	21	)	)	PUNCT
dpc-3486	121	22	age	age	NOUN
dpc-3486	121	23	(	(	PUNCT
dpc-3486	121	24	year	year	NOUN
dpc-3486	121	25	)	)	PUNCT
dpc-3486	121	26	;	;	PUNCT
dpc-3486	121	27	median	median	NOUN
dpc-3486	121	28	(	(	PUNCT
dpc-3486	121	29	iqr	iqr	NOUN
dpc-3486	121	30	)	)	PUNCT
dpc-3486	121	31	39	39	NUM
dpc-3486	121	32	(	(	PUNCT
dpc-3486	121	33	23	23	NUM
dpc-3486	121	34	)	)	PUNCT
dpc-3486	121	35	49(21	49(21	NUM
dpc-3486	121	36	)	)	PUNCT
dpc-3486	121	37	0.058	0.058	NUM
dpc-3486	121	38	sex	sex	NOUN
dpc-3486	121	39	,	,	PUNCT
dpc-3486	121	40	n	n	CCONJ
dpc-3486	121	41	(	(	PUNCT
dpc-3486	121	42	%	%	INTJ
dpc-3486	121	43	)	)	PUNCT
dpc-3486	121	44	woman	woman	NOUN
dpc-3486	121	45	40	40	NUM
dpc-3486	121	46	(	(	PUNCT
dpc-3486	121	47	56.3	56.3	NUM
dpc-3486	121	48	%	%	NOUN
dpc-3486	121	49	)	)	PUNCT
dpc-3486	121	50	21	21	NUM
dpc-3486	121	51	(	(	PUNCT
dpc-3486	121	52	50.0	50.0	NUM
dpc-3486	121	53	%	%	NOUN
dpc-3486	121	54	)	)	PUNCT
dpc-3486	121	55	0.514	0.514	NUM
dpc-3486	121	56	man	man	NOUN
dpc-3486	121	57	31	31	NUM
dpc-3486	121	58	(	(	PUNCT
dpc-3486	121	59	43.7	43.7	NUM
dpc-3486	121	60	%	%	NOUN
dpc-3486	121	61	)	)	PUNCT
dpc-3486	121	62	21	21	NUM
dpc-3486	121	63	(	(	PUNCT
dpc-3486	121	64	50.0	50.0	NUM
dpc-3486	121	65	%	%	NOUN
dpc-3486	121	66	)	)	PUNCT
dpc-3486	121	67	complaint	complaint	NOUN
dpc-3486	121	68	duration	duration	NOUN
dpc-3486	121	69	(	(	PUNCT
dpc-3486	121	70	day	day	PROPN
dpc-3486	121	71	)	)	PUNCT
dpc-3486	121	72	;	;	PUNCT
dpc-3486	121	73	median	median	NOUN
dpc-3486	121	74	(	(	PUNCT
dpc-3486	121	75	iqr	iqr	NOUN
dpc-3486	121	76	)	)	PUNCT
dpc-3486	121	77	4	4	NUM
dpc-3486	121	78	(	(	PUNCT
dpc-3486	121	79	2	2	NUM
dpc-3486	121	80	)	)	PUNCT
dpc-3486	121	81	5	5	NUM
dpc-3486	121	82	(	(	PUNCT
dpc-3486	121	83	4	4	NUM
dpc-3486	121	84	)	)	PUNCT
dpc-3486	121	85	0.074	0.074	NUM
dpc-3486	121	86	current	current	ADJ
dpc-3486	121	87	complaints	complaint	NOUN
dpc-3486	121	88	,	,	PUNCT
dpc-3486	121	89	n	n	PROPN
dpc-3486	121	90	(	(	PUNCT
dpc-3486	121	91	%	%	INTJ
dpc-3486	121	92	)	)	PUNCT
dpc-3486	121	93	throat	throat	NOUN
dpc-3486	121	94	ache	ache	ADV
dpc-3486	121	95	27	27	NUM
dpc-3486	121	96	(	(	PUNCT
dpc-3486	121	97	38.0	38.0	NUM
dpc-3486	121	98	%	%	NOUN
dpc-3486	121	99	)	)	PUNCT
dpc-3486	121	100	9	9	NUM
dpc-3486	121	101	(	(	PUNCT
dpc-3486	121	102	21.4	21.4	NUM
dpc-3486	121	103	%	%	NOUN
dpc-3486	121	104	)	)	PUNCT
dpc-3486	121	105	0.067	0.067	NUM
dpc-3486	121	106	headache	headache	NOUN
dpc-3486	121	107	28	28	NUM
dpc-3486	121	108	(	(	PUNCT
dpc-3486	121	109	39.4	39.4	NUM
dpc-3486	121	110	%	%	NOUN
dpc-3486	121	111	)	)	PUNCT
dpc-3486	121	112	16	16	NUM
dpc-3486	121	113	(	(	PUNCT
dpc-3486	121	114	38.1	38.1	NUM
dpc-3486	121	115	%	%	NOUN
dpc-3486	121	116	)	)	PUNCT
dpc-3486	121	117	0.888	0.888	NUM
dpc-3486	121	118	loss	loss	NOUN
dpc-3486	121	119	of	of	ADP
dpc-3486	121	120	taste	taste	NOUN
dpc-3486	121	121	and	and	CCONJ
dpc-3486	121	122	smell	smell	VERB
dpc-3486	121	123	6	6	NUM
dpc-3486	121	124	(	(	PUNCT
dpc-3486	121	125	8.6	8.6	NUM
dpc-3486	121	126	%	%	NOUN
dpc-3486	121	127	)	)	PUNCT
dpc-3486	121	128	6	6	NUM
dpc-3486	121	129	(	(	PUNCT
dpc-3486	121	130	14.3	14.3	NUM
dpc-3486	121	131	%	%	NOUN
dpc-3486	121	132	)	)	PUNCT
dpc-3486	121	133	0.361	0.361	NUM
dpc-3486	121	134	back	back	ADV
dpc-3486	121	135	or	or	CCONJ
dpc-3486	121	136	chest	chest	NOUN
dpc-3486	121	137	pain	pain	NOUN
dpc-3486	121	138	43	43	NUM
dpc-3486	121	139	(	(	PUNCT
dpc-3486	121	140	60.6	60.6	NUM
dpc-3486	121	141	%	%	NOUN
dpc-3486	121	142	)	)	PUNCT
dpc-3486	121	143	26	26	NUM
dpc-3486	121	144	(	(	PUNCT
dpc-3486	121	145	61.9	61.9	NUM
dpc-3486	121	146	%	%	NOUN
dpc-3486	121	147	)	)	PUNCT
dpc-3486	121	148	0.988	0.988	NUM
dpc-3486	121	149	other	other	ADJ
dpc-3486	121	150	symptoms	symptom	NOUN
dpc-3486	121	151	(	(	PUNCT
dpc-3486	121	152	typical	typical	ADJ
dpc-3486	121	153	-	-	PUNCT
dpc-3486	121	154	atypical	atypical	ADJ
dpc-3486	121	155	)	)	PUNCT
dpc-3486	121	156	69	69	NUM
dpc-3486	121	157	(	(	PUNCT
dpc-3486	121	158	97.2	97.2	NUM
dpc-3486	121	159	%	%	NOUN
dpc-3486	121	160	)	)	PUNCT
dpc-3486	121	161	40	40	NUM
dpc-3486	121	162	(	(	PUNCT
dpc-3486	121	163	95.2	95.2	NUM
dpc-3486	121	164	%	%	NOUN
dpc-3486	121	165	)	)	PUNCT
dpc-3486	121	166	0.627	0.627	NUM
dpc-3486	121	167	dry	dry	ADJ
dpc-3486	121	168	mouth	mouth	NOUN
dpc-3486	121	169	sensation	sensation	NOUN
dpc-3486	121	170	(	(	PUNCT
dpc-3486	121	171	xerostomia	xerostomia	NOUN
dpc-3486	121	172	)	)	PUNCT
dpc-3486	121	173	15	15	NUM
dpc-3486	121	174	(	(	PUNCT
dpc-3486	121	175	21.1	21.1	NUM
dpc-3486	121	176	%	%	NOUN
dpc-3486	121	177	)	)	PUNCT
dpc-3486	121	178	5	5	NUM
dpc-3486	121	179	(	(	PUNCT
dpc-3486	121	180	11.9	11.9	NUM
dpc-3486	121	181	%	%	NOUN
dpc-3486	121	182	)	)	PUNCT
dpc-3486	121	183	0.122	0.122	NUM
dpc-3486	121	184	oral	oral	ADJ
dpc-3486	121	185	mucosa	mucosa	NOUN
dpc-3486	121	186	examination	examination	NOUN
dpc-3486	121	187	,	,	PUNCT
dpc-3486	121	188	n	n	PROPN
dpc-3486	121	189	(	(	PUNCT
dpc-3486	121	190	%	%	INTJ
dpc-3486	121	191	)	)	PUNCT
dpc-3486	121	192	normal	normal	ADJ
dpc-3486	121	193	oral	oral	ADJ
dpc-3486	121	194	mucosa	mucosa	NOUN
dpc-3486	121	195	findings	finding	NOUN
dpc-3486	121	196	9	9	NUM
dpc-3486	121	197	(	(	PUNCT
dpc-3486	121	198	12.7	12.7	NUM
dpc-3486	121	199	%	%	NOUN
dpc-3486	121	200	)	)	PUNCT
dpc-3486	121	201	8	8	NUM
dpc-3486	121	202	(	(	PUNCT
dpc-3486	121	203	19.0	19.0	NUM
dpc-3486	121	204	%	%	NOUN
dpc-3486	121	205	)	)	PUNCT
dpc-3486	121	206	0.360	0.360	NUM
dpc-3486	121	207	erythema	erythema	NOUN
dpc-3486	121	208	of	of	ADP
dpc-3486	121	209	tonsils	tonsil	NOUN
dpc-3486	121	210	and	and	CCONJ
dpc-3486	121	211	pharynx	pharynx	NOUN
dpc-3486	121	212	43	43	NUM
dpc-3486	121	213	(	(	PUNCT
dpc-3486	121	214	60.6	60.6	NUM
dpc-3486	121	215	%	%	NOUN
dpc-3486	121	216	)	)	PUNCT
dpc-3486	121	217	22	22	NUM
dpc-3486	121	218	(	(	PUNCT
dpc-3486	121	219	52.4	52.4	NUM
dpc-3486	121	220	%	%	NOUN
dpc-3486	121	221	)	)	PUNCT
dpc-3486	121	222	0.395	0.395	NUM
dpc-3486	121	223	micro	micro	ADJ
dpc-3486	121	224	vesicles	vesicle	NOUN
dpc-3486	121	225	on	on	ADP
dpc-3486	121	226	tonsils	tonsil	NOUN
dpc-3486	121	227	or	or	CCONJ
dpc-3486	121	228	pharynx	pharynx	NOUN
dpc-3486	121	229	28	28	NUM
dpc-3486	121	230	(	(	PUNCT
dpc-3486	121	231	39.4	39.4	NUM
dpc-3486	121	232	%	%	NOUN
dpc-3486	121	233	)	)	PUNCT
dpc-3486	121	234	12	12	NUM
dpc-3486	121	235	(	(	PUNCT
dpc-3486	121	236	28.6	28.6	NUM
dpc-3486	121	237	%	%	NOUN
dpc-3486	121	238	)	)	PUNCT
dpc-3486	121	239	0.243	0.243	NUM
dpc-3486	121	240	cryptic	cryptic	ADJ
dpc-3486	121	241	tonsillitis	tonsillitis	NOUN
dpc-3486	121	242	6	6	NUM
dpc-3486	121	243	(	(	PUNCT
dpc-3486	121	244	8.5	8.5	NUM
dpc-3486	121	245	%	%	NOUN
dpc-3486	121	246	)	)	PUNCT
dpc-3486	121	247	5	5	NUM
dpc-3486	121	248	(	(	PUNCT
dpc-3486	121	249	12.2	12.2	NUM
dpc-3486	121	250	%	%	NOUN
dpc-3486	121	251	)	)	PUNCT
dpc-3486	121	252	0.527	0.527	NUM
dpc-3486	121	253	*	*	PUNCT
dpc-3486	121	254	oral	oral	ADJ
dpc-3486	121	255	candidiasis	candidiasis	NOUN
dpc-3486	121	256	(	(	PUNCT
dpc-3486	121	257	suspected	suspect	VERB
dpc-3486	121	258	)	)	PUNCT
dpc-3486	121	259	20	20	NUM
dpc-3486	121	260	(	(	PUNCT
dpc-3486	121	261	28.2	28.2	NUM
dpc-3486	121	262	%	%	NOUN
dpc-3486	121	263	)	)	PUNCT
dpc-3486	121	264	8	8	NUM
dpc-3486	121	265	(	(	PUNCT
dpc-3486	121	266	19.0	19.0	NUM
dpc-3486	121	267	%	%	NOUN
dpc-3486	121	268	)	)	PUNCT
dpc-3486	121	269	0.278	0.278	NUM
dpc-3486	121	270	tonsillar	tonsillar	ADJ
dpc-3486	121	271	hypertrophy	hypertrophy	NOUN
dpc-3486	121	272	11	11	NUM
dpc-3486	121	273	(	(	PUNCT
dpc-3486	121	274	15.5	15.5	NUM
dpc-3486	121	275	%	%	NOUN
dpc-3486	121	276	)	)	PUNCT
dpc-3486	121	277	10	10	NUM
dpc-3486	121	278	(	(	PUNCT
dpc-3486	121	279	23.8	23.8	NUM
dpc-3486	121	280	%	%	NOUN
dpc-3486	121	281	)	)	PUNCT
dpc-3486	121	282	0.272	0.272	NUM
dpc-3486	121	283	petechiae	petechiae	NOUN
dpc-3486	121	284	in	in	ADP
dpc-3486	121	285	the	the	DET
dpc-3486	121	286	oropharynx	oropharynx	NOUN
dpc-3486	121	287	30	30	NUM
dpc-3486	121	288	(	(	PUNCT
dpc-3486	121	289	42.3	42.3	NUM
dpc-3486	121	290	%	%	NOUN
dpc-3486	121	291	)	)	PUNCT
dpc-3486	121	292	18	18	NUM
dpc-3486	121	293	(	(	PUNCT
dpc-3486	121	294	42.9	42.9	NUM
dpc-3486	121	295	%	%	NOUN
dpc-3486	121	296	)	)	PUNCT
dpc-3486	121	297	0.950	0.950	NUM
dpc-3486	121	298	leukoplakia	leukoplakia	NOUN
dpc-3486	121	299	0	0	NUM
dpc-3486	121	300	(	(	PUNCT
dpc-3486	121	301	0.0	0.0	NUM
dpc-3486	121	302	%	%	NOUN
dpc-3486	121	303	)	)	PUNCT
dpc-3486	121	304	0	0	NUM
dpc-3486	122	1	(	(	PUNCT
dpc-3486	122	2	0.0	0.0	NUM
dpc-3486	122	3	%	%	NOUN
dpc-3486	122	4	)	)	PUNCT
dpc-3486	122	5	n	n	CCONJ
dpc-3486	122	6	/	/	SYM
dpc-3486	122	7	a	a	DET
dpc-3486	122	8	geographic	geographic	ADJ
dpc-3486	122	9	tongue	tongue	NOUN
dpc-3486	122	10	1	1	NUM
dpc-3486	122	11	(	(	PUNCT
dpc-3486	122	12	1.4	1.4	NUM
dpc-3486	122	13	%	%	NOUN
dpc-3486	122	14	)	)	PUNCT
dpc-3486	122	15	0	0	NUM
dpc-3486	123	1	(	(	PUNCT
dpc-3486	123	2	0.0	0.0	NUM
dpc-3486	123	3	%	%	NOUN
dpc-3486	123	4	)	)	PUNCT
dpc-3486	123	5	1.000	1.000	NUM
dpc-3486	123	6	scrotal	scrotal	ADJ
dpc-3486	123	7	tongue	tongue	NOUN
dpc-3486	123	8	5	5	NUM
dpc-3486	123	9	(	(	PUNCT
dpc-3486	123	10	7.0	7.0	NUM
dpc-3486	123	11	%	%	NOUN
dpc-3486	123	12	)	)	PUNCT
dpc-3486	123	13	7	7	NUM
dpc-3486	123	14	(	(	PUNCT
dpc-3486	123	15	16.7	16.7	NUM
dpc-3486	123	16	%	%	NOUN
dpc-3486	123	17	)	)	PUNCT
dpc-3486	123	18	0.125	0.125	NUM
dpc-3486	123	19	primary	primary	ADJ
dpc-3486	123	20	/	/	SYM
dpc-3486	123	21	secondary	secondary	ADJ
dpc-3486	123	22	herpes	herpe	NOUN
dpc-3486	123	23	infection	infection	NOUN
dpc-3486	123	24	9	9	NUM
dpc-3486	123	25	(	(	PUNCT
dpc-3486	123	26	12.7	12.7	NUM
dpc-3486	123	27	%	%	NOUN
dpc-3486	123	28	)	)	PUNCT
dpc-3486	123	29	4	4	NUM
dpc-3486	123	30	(	(	PUNCT
dpc-3486	123	31	9.5	9.5	NUM
dpc-3486	123	32	%	%	NOUN
dpc-3486	123	33	)	)	PUNCT
dpc-3486	123	34	0.764	0.764	NUM
dpc-3486	123	35	oral	oral	ADJ
dpc-3486	123	36	aphthae	aphthae	NOUN
dpc-3486	123	37	18	18	NUM
dpc-3486	123	38	(	(	PUNCT
dpc-3486	123	39	25.4	25.4	NUM
dpc-3486	123	40	%	%	NOUN
dpc-3486	123	41	)	)	PUNCT
dpc-3486	123	42	13	13	NUM
dpc-3486	123	43	(	(	PUNCT
dpc-3486	123	44	31.0	31.0	NUM
dpc-3486	123	45	%	%	NOUN
dpc-3486	123	46	)	)	PUNCT
dpc-3486	123	47	0.519	0.519	NUM
dpc-3486	123	48	cheilitis	cheilitis	NOUN
dpc-3486	123	49	or	or	CCONJ
dpc-3486	123	50	angular	angular	ADJ
dpc-3486	123	51	cheilitis	cheilitis	NOUN
dpc-3486	123	52	4	4	NUM
dpc-3486	123	53	(	(	PUNCT
dpc-3486	123	54	5.6	5.6	NUM
dpc-3486	123	55	%	%	NOUN
dpc-3486	123	56	)	)	PUNCT
dpc-3486	123	57	8	8	NUM
dpc-3486	123	58	(	(	PUNCT
dpc-3486	123	59	19.0	19.0	NUM
dpc-3486	123	60	%	%	NOUN
dpc-3486	123	61	)	)	PUNCT
dpc-3486	123	62	0.054	0.054	NUM
dpc-3486	123	63	other	other	ADJ
dpc-3486	123	64	findings	finding	NOUN
dpc-3486	123	65	2	2	NUM
dpc-3486	123	66	(	(	PUNCT
dpc-3486	123	67	2.8	2.8	NUM
dpc-3486	123	68	%	%	NOUN
dpc-3486	123	69	)	)	PUNCT
dpc-3486	123	70	1	1	NUM
dpc-3486	123	71	(	(	PUNCT
dpc-3486	123	72	2.4	2.4	NUM
dpc-3486	123	73	%	%	NOUN
dpc-3486	123	74	)	)	PUNCT
dpc-3486	123	75	1.000	1.000	NUM
dpc-3486	123	76	ct	ct	NOUN
dpc-3486	123	77	=	=	PUNCT
dpc-3486	123	78	computed	computed	ADJ
dpc-3486	123	79	tomography	tomography	NOUN
dpc-3486	123	80	;	;	PUNCT
dpc-3486	123	81	iqr	iqr	PROPN
dpc-3486	123	82	=	=	SYM
dpc-3486	123	83	inter	inter	ADJ
dpc-3486	123	84	-	-	ADJ
dpc-3486	123	85	quartile	quartile	ADJ
dpc-3486	123	86	range	range	NOUN
dpc-3486	123	87	;	;	PUNCT
dpc-3486	123	88	n	n	CCONJ
dpc-3486	123	89	/	/	SYM
dpc-3486	123	90	a	a	PRON
dpc-3486	123	91	=	=	NOUN
dpc-3486	123	92	not	not	PART
dpc-3486	123	93	applicable	applicable	ADJ
dpc-3486	123	94	;	;	PUNCT
dpc-3486	123	95	pcr	pcr	ADJ
dpc-3486	123	96	=	=	SYM
dpc-3486	123	97	polymerase	polymerase	NOUN
dpc-3486	123	98	chain	chain	NOUN
dpc-3486	123	99	reaction	reaction	NOUN
dpc-3486	123	100	.	.	PUNCT
dpc-3486	124	1	tonsils	tonsil	NOUN
dpc-3486	124	2	and	and	CCONJ
dpc-3486	124	3	pharynx	pharynx	NOUN
dpc-3486	124	4	(	(	PUNCT
dpc-3486	124	5	56.0	56.0	NUM
dpc-3486	124	6	%	%	NOUN
dpc-3486	124	7	)	)	PUNCT
dpc-3486	124	8	,	,	PUNCT
dpc-3486	124	9	petechiae	petechiae	NOUN
dpc-3486	124	10	in	in	ADP
dpc-3486	124	11	the	the	DET
dpc-3486	124	12	oropharynx	oropharynx	NOUN
dpc-3486	124	13	(	(	PUNCT
dpc-3486	124	14	36.3	36.3	NUM
dpc-3486	124	15	%	%	NOUN
dpc-3486	124	16	)	)	PUNCT
dpc-3486	124	17	,	,	PUNCT
dpc-3486	124	18	microvesicles	microvesicle	NOUN
dpc-3486	124	19	on	on	ADP
dpc-3486	124	20	tonsils	tonsil	NOUN
dpc-3486	124	21	or	or	CCONJ
dpc-3486	124	22	pharynx	pharynx	NOUN
dpc-3486	124	23	(	(	PUNCT
dpc-3486	124	24	31.8	31.8	NUM
dpc-3486	124	25	%	%	NOUN
dpc-3486	124	26	)	)	PUNCT
dpc-3486	124	27	,	,	PUNCT
dpc-3486	124	28	oral	oral	ADJ
dpc-3486	124	29	aphthae	aphthae	NOUN
dpc-3486	124	30	(	(	PUNCT
dpc-3486	124	31	22.8	22.8	NUM
dpc-3486	124	32	%	%	NOUN
dpc-3486	124	33	)	)	PUNCT
dpc-3486	124	34	,	,	PUNCT
dpc-3486	124	35	oral	oral	ADJ
dpc-3486	124	36	candidiasis	candidiasis	NOUN
dpc-3486	124	37	(	(	PUNCT
dpc-3486	124	38	suspected	suspect	VERB
dpc-3486	124	39	)	)	PUNCT
dpc-3486	124	40	(	(	PUNCT
dpc-3486	124	41	22.4	22.4	NUM
dpc-3486	124	42	%	%	NOUN
dpc-3486	124	43	)	)	PUNCT
dpc-3486	124	44	,	,	PUNCT
dpc-3486	124	45	and	and	CCONJ
dpc-3486	124	46	dry	dry	ADJ
dpc-3486	124	47	mouth	mouth	NOUN
dpc-3486	124	48	sensation	sensation	NOUN
dpc-3486	124	49	(	(	PUNCT
dpc-3486	124	50	xerostomia	xerostomia	NOUN
dpc-3486	124	51	)	)	PUNCT
dpc-3486	124	52	(	(	PUNCT
dpc-3486	124	53	15.6	15.6	NUM
dpc-3486	124	54	%	%	NOUN
dpc-3486	124	55	)	)	PUNCT
dpc-3486	124	56	,	,	PUNCT
dpc-3486	124	57	primary	primary	ADJ
dpc-3486	124	58	/	/	SYM
dpc-3486	124	59	secondary	secondary	ADJ
dpc-3486	124	60	herpes	herpe	NOUN
dpc-3486	124	61	infection	infection	NOUN
dpc-3486	124	62	(	(	PUNCT
dpc-3486	124	63	8.5	8.5	NUM
dpc-3486	124	64	%	%	NOUN
dpc-3486	124	65	)	)	PUNCT
dpc-3486	124	66	.	.	PUNCT
dpc-3486	125	1	oral	oral	ADJ
dpc-3486	125	2	lesions	lesion	NOUN
dpc-3486	125	3	described	describe	VERB
dpc-3486	125	4	in	in	ADP
dpc-3486	125	5	patients	patient	NOUN
dpc-3486	125	6	with	with	ADP
dpc-3486	125	7	covid-19	covid-19	PROPN
dpc-3486	125	8	in	in	ADP
dpc-3486	125	9	the	the	DET
dpc-3486	125	10	literature	literature	NOUN
dpc-3486	125	11	were	be	AUX
dpc-3486	125	12	highly	highly	ADV
dpc-3486	125	13	heterogeneous	heterogeneous	ADJ
dpc-3486	125	14	.	.	PUNCT
dpc-3486	126	1	in	in	ADP
dpc-3486	126	2	a	a	DET
dpc-3486	126	3	few	few	ADJ
dpc-3486	126	4	studies	study	NOUN
dpc-3486	126	5	,	,	PUNCT
dpc-3486	126	6	oral	oral	ADJ
dpc-3486	126	7	vesiculobullous	vesiculobullous	ADJ
dpc-3486	126	8	lesions	lesion	NOUN
dpc-3486	126	9	and	and	CCONJ
dpc-3486	126	10	erosions	erosion	NOUN
dpc-3486	126	11	on	on	ADP
dpc-3486	126	12	the	the	DET
dpc-3486	126	13	tongue	tongue	NOUN
dpc-3486	126	14	and	and	CCONJ
dpc-3486	126	15	buccal	buccal	ADJ
dpc-3486	126	16	mucosa	mucosa	NOUN
dpc-3486	126	17	,	,	PUNCT
dpc-3486	126	18	widespread	widespread	ADJ
dpc-3486	126	19	erythema	erythema	NOUN
dpc-3486	126	20	appeared	appear	VERB
dpc-3486	126	21	on	on	ADP
dpc-3486	126	22	the	the	DET
dpc-3486	126	23	hard	hard	ADJ
dpc-3486	126	24	palate	palate	NOUN
dpc-3486	126	25	and	and	CCONJ
dpc-3486	126	26	oropharynx	oropharynx	NOUN
dpc-3486	126	27	,	,	PUNCT
dpc-3486	126	28	and	and	CCONJ
dpc-3486	126	29	petechiae	petechiae	NOUN
dpc-3486	126	30	on	on	ADP
dpc-3486	126	31	the	the	DET
dpc-3486	126	32	lower	low	ADJ
dpc-3486	126	33	lip	lip	NOUN
dpc-3486	126	34	,	,	PUNCT
dpc-3486	126	35	palate	palate	VERB
dpc-3486	126	36	,	,	PUNCT
dpc-3486	126	37	and	and	CCONJ
dpc-3486	126	38	oropharynx	oropharynx	NOUN
dpc-3486	126	39	,	,	PUNCT
dpc-3486	126	40	herpes	herpe	NOUN
dpc-3486	126	41	simplex	simplex	NOUN
dpc-3486	126	42	lesion	lesion	NOUN
dpc-3486	126	43	in	in	ADP
dpc-3486	126	44	the	the	DET
dpc-3486	126	45	lip	lip	NOUN
dpc-3486	126	46	semi	semi	ADJ
dpc-3486	126	47	mucosa	mucosa	PROPN
dpc-3486	126	48	were	be	AUX
dpc-3486	126	49	reported	report	VERB
dpc-3486	126	50	[	[	PUNCT
dpc-3486	126	51	7,17	7,17	NOUN
dpc-3486	126	52	-	-	SYM
dpc-3486	126	53	19	19	NUM
dpc-3486	126	54	]	]	PUNCT
dpc-3486	126	55	.	.	PUNCT
dpc-3486	127	1	jimenez	jimenez	PROPN
dpc-3486	127	2	-	-	PUNCT
dpc-3486	127	3	cauhe	cauhe	PROPN
dpc-3486	127	4	et	et	PROPN
dpc-3486	127	5	al	al	PROPN
dpc-3486	127	6	presented	present	VERB
dpc-3486	127	7	5	5	NUM
dpc-3486	127	8	patients	patient	NOUN
dpc-3486	127	9	with	with	ADP
dpc-3486	127	10	covid-19	covid-19	PROPN
dpc-3486	127	11	who	who	PRON
dpc-3486	127	12	had	have	VERB
dpc-3486	127	13	petechiae	petechiae	NOUN
dpc-3486	127	14	on	on	ADP
dpc-3486	127	15	tonsils	tonsil	NOUN
dpc-3486	127	16	[	[	X
dpc-3486	127	17	20	20	NUM
dpc-3486	127	18	]	]	PUNCT
dpc-3486	127	19	.	.	PUNCT
dpc-3486	128	1	egido	egido	PROPN
dpc-3486	128	2	-	-	PUNCT
dpc-3486	128	3	moreno	moreno	PROPN
dpc-3486	128	4	et	et	PROPN
dpc-3486	128	5	al	al	PROPN
dpc-3486	128	6	stated	state	VERB
dpc-3486	128	7	that	that	SCONJ
dpc-3486	128	8	the	the	DET
dpc-3486	128	9	most	most	ADV
dpc-3486	128	10	prevalent	prevalent	ADJ
dpc-3486	128	11	lesions	lesion	NOUN
dpc-3486	128	12	were	be	AUX
dpc-3486	128	13	ulcers	ulcer	NOUN
dpc-3486	128	14	,	,	PUNCT
dpc-3486	128	15	aphthous	aphthous	ADJ
dpc-3486	128	16	-	-	PUNCT
dpc-3486	128	17	like	like	ADJ
dpc-3486	128	18	lesions	lesion	NOUN
dpc-3486	128	19	,	,	PUNCT
dpc-3486	128	20	or	or	CCONJ
dpc-3486	128	21	erosions	erosion	NOUN
dpc-3486	128	22	,	,	PUNCT
dpc-3486	128	23	followed	follow	VERB
dpc-3486	128	24	by	by	ADP
dpc-3486	128	25	macules	macule	NOUN
dpc-3486	128	26	and	and	CCONJ
dpc-3486	128	27	petechiae	petechiae	NOUN
dpc-3486	128	28	,	,	PUNCT
dpc-3486	128	29	plaques	plaque	NOUN
dpc-3486	128	30	bullae	bullae	NOUN
dpc-3486	128	31	,	,	PUNCT
dpc-3486	128	32	gingival	gingival	NOUN
dpc-3486	128	33	abnormalities	abnormality	NOUN
dpc-3486	128	34	,	,	PUNCT
dpc-3486	128	35	and	and	CCONJ
dpc-3486	128	36	finally	finally	ADV
dpc-3486	128	37	blisters	blister	NOUN
dpc-3486	128	38	and	and	CCONJ
dpc-3486	128	39	pustules	pustule	NOUN
dpc-3486	128	40	in	in	ADP
dpc-3486	128	41	their	their	PRON
dpc-3486	128	42	study	study	NOUN
dpc-3486	128	43	  	  	SPACE
dpc-3486	129	1	[	[	X
dpc-3486	129	2	12	12	NUM
dpc-3486	129	3	]	]	PUNCT
dpc-3486	129	4	.	.	PUNCT
dpc-3486	130	1	martín	martín	PROPN
dpc-3486	130	2	carreras	carreras	PROPN
dpc-3486	130	3	-	-	PUNCT
dpc-3486	130	4	presas	presas	PROPN
dpc-3486	130	5	et	et	NOUN
dpc-3486	130	6	al	al	PROPN
dpc-3486	130	7	reported	report	VERB
dpc-3486	130	8	different	different	ADJ
dpc-3486	130	9	types	type	NOUN
dpc-3486	130	10	of	of	ADP
dpc-3486	130	11	oral	oral	ADJ
dpc-3486	130	12	mucosal	mucosal	NOUN
dpc-3486	130	13	lesions	lesion	NOUN
dpc-3486	130	14	(	(	PUNCT
dpc-3486	130	15	ulcer	ulcer	NOUN
dpc-3486	130	16	,	,	PUNCT
dpc-3486	130	17	vesicle	vesicle	NOUN
dpc-3486	130	18	,	,	PUNCT
dpc-3486	130	19	bulla	bulla	NOUN
dpc-3486	130	20	,	,	PUNCT
dpc-3486	130	21	and	and	CCONJ
dpc-3486	130	22	desquamative	desquamative	ADJ
dpc-3486	130	23	gingivitis	gingivitis	NOUN
dpc-3486	130	24	)	)	PUNCT
dpc-3486	130	25	in	in	ADP
dpc-3486	130	26	patients	patient	NOUN
dpc-3486	130	27	with	with	ADP
dpc-3486	130	28	covid-19	covid-19	PROPN
dpc-3486	131	1	[	[	X
dpc-3486	131	2	21	21	NUM
dpc-3486	131	3	]	]	PUNCT
dpc-3486	131	4	.	.	PUNCT
dpc-3486	132	1	tuter	tuter	NOUN
dpc-3486	132	2	et	et	PROPN
dpc-3486	132	3	al	al	PROPN
dpc-3486	132	4	showed	show	VERB
dpc-3486	132	5	that	that	SCONJ
dpc-3486	132	6	dry	dry	ADJ
dpc-3486	132	7	mouth	mouth	NOUN
dpc-3486	132	8	is	be	AUX
dpc-3486	132	9	the	the	DET
dpc-3486	132	10	most	most	ADV
dpc-3486	132	11	common	common	ADJ
dpc-3486	132	12	and	and	CCONJ
dpc-3486	132	13	oral	oral	ADJ
dpc-3486	132	14	ulcers	ulcer	NOUN
dpc-3486	132	15	and	and	CCONJ
dpc-3486	132	16	tongue	tongue	NOUN
dpc-3486	132	17	lesions	lesion	NOUN
dpc-3486	132	18	are	be	AUX
dpc-3486	132	19	the	the	DET
dpc-3486	132	20	second	second	ADJ
dpc-3486	132	21	common	common	ADJ
dpc-3486	132	22	oral	oral	ADJ
dpc-3486	132	23	manifestation	manifestation	NOUN
dpc-3486	132	24	in	in	ADP
dpc-3486	132	25	covid-19	covid-19	PROPN
dpc-3486	132	26	patients	patient	NOUN
dpc-3486	132	27	[	[	X
dpc-3486	132	28	13	13	NUM
dpc-3486	132	29	]	]	PUNCT
dpc-3486	132	30	.	.	PUNCT
dpc-3486	133	1	cuevas	cuevas	PROPN
dpc-3486	133	2	-	-	PUNCT
dpc-3486	133	3	gonzalez	gonzalez	PROPN
dpc-3486	133	4	et	et	PROPN
dpc-3486	133	5	al	al	PROPN
dpc-3486	133	6	stated	state	VERB
dpc-3486	133	7	that	that	SCONJ
dpc-3486	133	8	the	the	DET
dpc-3486	133	9	most	most	ADV
dpc-3486	133	10	common	common	ADJ
dpc-3486	133	11	main	main	ADJ
dpc-3486	133	12	oral	oral	ADJ
dpc-3486	133	13	manifestations	manifestation	NOUN
dpc-3486	133	14	related	relate	VERB
dpc-3486	133	15	to	to	ADP
dpc-3486	133	16	sars	sar	NOUN
dpc-3486	133	17	-	-	PUNCT
dpc-3486	133	18	cov-2	cov-2	PART
dpc-3486	133	19	were	be	AUX
dpc-3486	133	20	dysgeusia	dysgeusia	NOUN
dpc-3486	133	21	,	,	PUNCT
dpc-3486	133	22	dry	dry	ADJ
dpc-3486	133	23	mouth	mouth	NOUN
dpc-3486	133	24	,	,	PUNCT
dpc-3486	133	25	burning	burn	VERB
dpc-3486	133	26	mouth	mouth	NOUN
dpc-3486	133	27	,	,	PUNCT
dpc-3486	133	28	ulcerative	ulcerative	ADJ
dpc-3486	133	29	lesions	lesion	NOUN
dpc-3486	133	30	,	,	PUNCT
dpc-3486	133	31	and	and	CCONJ
dpc-3486	133	32	candida	candida	NOUN
dpc-3486	133	33	albicans	albican	VERB
dpc-3486	133	34	infections	infection	NOUN
dpc-3486	133	35	in	in	ADP
dpc-3486	133	36	their	their	PRON
dpc-3486	133	37	systematic	systematic	ADJ
dpc-3486	133	38	review	review	NOUN
dpc-3486	133	39	including	include	VERB
dpc-3486	133	40	a	a	DET
dpc-3486	133	41	total	total	NOUN
dpc-3486	133	42	of	of	ADP
dpc-3486	133	43	18	18	NUM
dpc-3486	133	44	studies	study	NOUN
dpc-3486	133	45	[	[	X
dpc-3486	133	46	6	6	NUM
dpc-3486	133	47	]	]	PUNCT
dpc-3486	133	48	.	.	PUNCT
dpc-3486	134	1	a	a	DET
dpc-3486	134	2	review	review	NOUN
dpc-3486	134	3	article	article	NOUN
dpc-3486	134	4	revealed	reveal	VERB
dpc-3486	134	5	that	that	SCONJ
dpc-3486	134	6	aphthous	aphthous	ADJ
dpc-3486	134	7	-	-	PUNCT
dpc-3486	134	8	like	like	ADJ
dpc-3486	134	9	lesions	lesion	NOUN
dpc-3486	134	10	,	,	PUNCT
dpc-3486	134	11	herpetiform	herpetiform	NOUN
dpc-3486	134	12	lesions	lesion	NOUN
dpc-3486	134	13	,	,	PUNCT
dpc-3486	134	14	candidiasis	candidiasis	NOUN
dpc-3486	134	15	,	,	PUNCT
dpc-3486	134	16	and	and	CCONJ
dpc-3486	134	17	oral	oral	ADJ
dpc-3486	134	18	lesions	lesion	NOUN
dpc-3486	134	19	of	of	ADP
dpc-3486	134	20	kawasaki	kawasaki	PROPN
dpc-3486	134	21	-	-	PUNCT
dpc-3486	134	22	like	like	ADJ
dpc-3486	134	23	disease	disease	NOUN
dpc-3486	134	24	are	be	AUX
dpc-3486	134	25	the	the	DET
dpc-3486	134	26	most	most	ADV
dpc-3486	134	27	common	common	ADJ
dpc-3486	134	28	oral	oral	ADJ
dpc-3486	134	29	manifestations	manifestation	NOUN
dpc-3486	134	30	of	of	ADP
dpc-3486	134	31	covid-19	covid-19	PROPN
dpc-3486	135	1	[	[	X
dpc-3486	135	2	22	22	NUM
dpc-3486	135	3	]	]	PUNCT
dpc-3486	135	4	.	.	PUNCT
dpc-3486	136	1	our	our	PRON
dpc-3486	136	2	findings	finding	NOUN
dpc-3486	136	3	were	be	AUX
dpc-3486	136	4	partially	partially	ADV
dpc-3486	136	5	compatible	compatible	ADJ
dpc-3486	136	6	with	with	ADP
dpc-3486	136	7	the	the	DET
dpc-3486	136	8	literature	literature	NOUN
dpc-3486	136	9	.	.	PUNCT
dpc-3486	137	1	6	6	NUM
dpc-3486	137	2	original	original	ADJ
dpc-3486	137	3	article	article	NOUN
dpc-3486	137	4	|	|	ADV
dpc-3486	137	5	dermatol	dermatol	ADJ
dpc-3486	137	6	pract	pract	NOUN
dpc-3486	137	7	concept	concept	NOUN
dpc-3486	137	8	.	.	PUNCT
dpc-3486	138	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	138	2	table	table	NOUN
dpc-3486	138	3	4	4	NUM
dpc-3486	138	4	.	.	PUNCT
dpc-3486	138	5	evaluation	evaluation	NOUN
dpc-3486	138	6	of	of	ADP
dpc-3486	138	7	examination	examination	NOUN
dpc-3486	138	8	findings	finding	NOUN
dpc-3486	138	9	related	relate	VERB
dpc-3486	138	10	to	to	ADP
dpc-3486	138	11	pcr	pcr	ADJ
dpc-3486	138	12	result	result	NOUN
dpc-3486	138	13	and	and	CCONJ
dpc-3486	138	14	lung	lung	NOUN
dpc-3486	138	15	involvement	involvement	NOUN
dpc-3486	138	16	with	with	ADP
dpc-3486	138	17	 	 	SPACE
dpc-3486	138	18	univariate	univariate	ADJ
dpc-3486	138	19	logistic	logistic	ADJ
dpc-3486	138	20	regression	regression	NOUN
dpc-3486	138	21	analysis	analysis	NOUN
dpc-3486	138	22	univariate	univariate	ADJ
dpc-3486	138	23	logistic	logistic	ADJ
dpc-3486	138	24	regression	regression	NOUN
dpc-3486	138	25	analysis	analysis	NOUN
dpc-3486	138	26	βi	βi	PRON
dpc-3486	138	27	odds	odd	VERB
dpc-3486	138	28	ratio	ratio	NOUN
dpc-3486	138	29	95	95	NUM
dpc-3486	138	30	%	%	NOUN
dpc-3486	138	31	ci	ci	NOUN
dpc-3486	138	32	wald	wald	NOUN
dpc-3486	138	33	value	value	NOUN
dpc-3486	138	34	p	p	PROPN
dpc-3486	138	35	r2lower	r2lower	NOUN
dpc-3486	138	36	upper	upper	ADJ
dpc-3486	138	37	pcr	pcr	NOUN
dpc-3486	138	38	positivity	positivity	NOUN
dpc-3486	138	39	in	in	ADP
dpc-3486	138	40	patients	patient	NOUN
dpc-3486	138	41	without	without	ADP
dpc-3486	138	42	lung	lung	NOUN
dpc-3486	138	43	involvement	involvement	NOUN
dpc-3486	138	44	(	(	PUNCT
dpc-3486	138	45	n	n	NOUN
dpc-3486	138	46	=	=	SYM
dpc-3486	138	47	71/139	71/139	NUM
dpc-3486	138	48	)	)	PUNCT
dpc-3486	138	49	back	back	ADV
dpc-3486	138	50	or	or	CCONJ
dpc-3486	138	51	chest	chest	NOUN
dpc-3486	138	52	pain	pain	NOUN
dpc-3486	138	53	0.61	0.61	NUM
dpc-3486	138	54	1.83	1.83	NUM
dpc-3486	138	55	0.93	0.93	NUM
dpc-3486	138	56	3.60	3.60	NUM
dpc-3486	138	57	3.11	3.11	NUM
dpc-3486	138	58	0.078	0.078	NUM
dpc-3486	138	59	0.02	0.02	NUM
dpc-3486	138	60	dry	dry	ADJ
dpc-3486	138	61	mouth	mouth	NOUN
dpc-3486	138	62	sensation	sensation	NOUN
dpc-3486	138	63	(	(	PUNCT
dpc-3486	138	64	xerostomia	xerostomia	NOUN
dpc-3486	138	65	)	)	PUNCT
dpc-3486	138	66	2.16	2.16	NUM
dpc-3486	138	67	8.71	8.71	NUM
dpc-3486	138	68	1.91	1.91	NUM
dpc-3486	138	69	39.72	39.72	NUM
dpc-3486	138	70	7.81	7.81	NUM
dpc-3486	138	71	0.005	0.005	NUM
dpc-3486	138	72	0.08	0.08	NUM
dpc-3486	138	73	any	any	DET
dpc-3486	138	74	oral	oral	ADJ
dpc-3486	138	75	mucosa	mucosa	NOUN
dpc-3486	138	76	findings	finding	VERB
dpc-3486	138	77	2.11	2.11	NUM
dpc-3486	138	78	8.22	8.22	NUM
dpc-3486	138	79	3.53	3.53	NUM
dpc-3486	138	80	19.17	19.17	NUM
dpc-3486	138	81	23.80	23.80	NUM
dpc-3486	138	82	<	<	X
dpc-3486	138	83	0.001	0.001	NUM
dpc-3486	138	84	0.19	0.19	NUM
dpc-3486	138	85	erythema	erythema	NOUN
dpc-3486	138	86	of	of	ADP
dpc-3486	138	87	tonsils	tonsil	NOUN
dpc-3486	138	88	and	and	CCONJ
dpc-3486	138	89	pharynx	pharynx	NOUN
dpc-3486	138	90	0.79	0.79	NUM
dpc-3486	138	91	2.19	2.19	NUM
dpc-3486	138	92	1.11	1.11	NUM
dpc-3486	138	93	4.32	4.32	NUM
dpc-3486	138	94	5.16	5.16	NUM
dpc-3486	138	95	0.023	0.023	NUM
dpc-3486	138	96	0.04	0.04	NUM
dpc-3486	138	97	micro	micro	ADJ
dpc-3486	138	98	vesicles	vesicle	NOUN
dpc-3486	138	99	on	on	ADP
dpc-3486	138	100	tonsils	tonsil	NOUN
dpc-3486	138	101	or	or	CCONJ
dpc-3486	138	102	pharynx	pharynx	NOUN
dpc-3486	138	103	2.65	2.65	NUM
dpc-3486	138	104	14.11	14.11	NUM
dpc-3486	138	105	4.04	4.04	NUM
dpc-3486	138	106	49.32	49.32	NUM
dpc-3486	138	107	17.18	17.18	NUM
dpc-3486	138	108	<	<	X
dpc-3486	138	109	0.001	0.001	NUM
dpc-3486	138	110	0.18	0.18	NUM
dpc-3486	138	111	petechiae	petechia	NOUN
dpc-3486	138	112	in	in	ADP
dpc-3486	138	113	the	the	DET
dpc-3486	138	114	oropharynx	oropharynx	NOUN
dpc-3486	138	115	1.45	1.45	NUM
dpc-3486	138	116	4.24	4.24	NUM
dpc-3486	138	117	1.87	1.87	NUM
dpc-3486	138	118	9.63	9.63	NUM
dpc-3486	138	119	11.94	11.94	NUM
dpc-3486	138	120	0.001	0.001	NUM
dpc-3486	138	121	0.09	0.09	NUM
dpc-3486	138	122	primary	primary	ADJ
dpc-3486	138	123	/	/	SYM
dpc-3486	138	124	secondary	secondary	ADJ
dpc-3486	138	125	herpes	herpe	NOUN
dpc-3486	138	126	infection	infection	NOUN
dpc-3486	138	127	1.55	1.55	NUM
dpc-3486	138	128	4.72	4.72	NUM
dpc-3486	138	129	0.98	0.98	NUM
dpc-3486	138	130	22.70	22.70	NUM
dpc-3486	138	131	3.75	3.75	NUM
dpc-3486	138	132	0.053	0.053	NUM
dpc-3486	138	133	0.03	0.03	NUM
dpc-3486	138	134	oral	oral	ADJ
dpc-3486	138	135	aphthae	aphthae	NOUN
dpc-3486	138	136	0.94	0.94	NUM
dpc-3486	138	137	2.55	2.55	NUM
dpc-3486	138	138	1.03	1.03	NUM
dpc-3486	138	139	6.34	6.34	NUM
dpc-3486	138	140	4.05	4.05	NUM
dpc-3486	138	141	0.044	0.044	NUM
dpc-3486	138	142	0.03	0.03	NUM
dpc-3486	138	143	lung	lung	NOUN
dpc-3486	138	144	involvement	involvement	NOUN
dpc-3486	138	145	in	in	ADP
dpc-3486	138	146	patients	patient	NOUN
dpc-3486	138	147	with	with	ADP
dpc-3486	138	148	pcr	pcr	NOUN
dpc-3486	138	149	positivity	positivity	NOUN
dpc-3486	138	150	(	(	PUNCT
dpc-3486	138	151	n	n	NOUN
dpc-3486	138	152	=	=	SYM
dpc-3486	138	153	42/113	42/113	NUM
dpc-3486	138	154	)	)	PUNCT
dpc-3486	138	155	age	age	NOUN
dpc-3486	138	156	(	(	PUNCT
dpc-3486	138	157	year	year	NOUN
dpc-3486	138	158	)	)	PUNCT
dpc-3486	138	159	0.30	0.30	NUM
dpc-3486	138	160	1.03	1.03	NUM
dpc-3486	138	161	0.99	0.99	NUM
dpc-3486	138	162	1.06	1.06	NUM
dpc-3486	138	163	3.48	3.48	NUM
dpc-3486	138	164	0.062	0.062	NUM
dpc-3486	138	165	0.03	0.03	NUM
dpc-3486	138	166	complaint	complaint	NOUN
dpc-3486	138	167	duration	duration	NOUN
dpc-3486	138	168	(	(	PUNCT
dpc-3486	138	169	day	day	NOUN
dpc-3486	138	170	)	)	PUNCT
dpc-3486	138	171	0.16	0.16	NUM
dpc-3486	138	172	1.17	1.17	NUM
dpc-3486	138	173	0.99	0.99	NUM
dpc-3486	138	174	1.38	1.38	NUM
dpc-3486	138	175	3.42	3.42	NUM
dpc-3486	138	176	0.064	0.064	NUM
dpc-3486	138	177	0.03	0.03	NUM
dpc-3486	138	178	cheilitis	cheilitis	NOUN
dpc-3486	138	179	or	or	CCONJ
dpc-3486	138	180	angular	angular	ADJ
dpc-3486	138	181	cheilitis	cheilitis	NOUN
dpc-3486	138	182	1.37	1.37	NUM
dpc-3486	138	183	3.94	3.94	NUM
dpc-3486	138	184	1.11	1.11	NUM
dpc-3486	138	185	14.02	14.02	NUM
dpc-3486	138	186	4.49	4.49	NUM
dpc-3486	138	187	0.034	0.034	NUM
dpc-3486	138	188	0.04	0.04	NUM
dpc-3486	138	189	pcr=	pcr=	PROPN
dpc-3486	138	190	polymerase	polymerase	NOUN
dpc-3486	138	191	chain	chain	NOUN
dpc-3486	138	192	reaction	reaction	NOUN
dpc-3486	138	193	.	.	PUNCT
dpc-3486	139	1	table	table	NOUN
dpc-3486	139	2	5	5	NUM
dpc-3486	139	3	.	.	PUNCT
dpc-3486	140	1	evaluation	evaluation	NOUN
dpc-3486	140	2	of	of	ADP
dpc-3486	140	3	examination	examination	NOUN
dpc-3486	140	4	findings	finding	NOUN
dpc-3486	140	5	related	relate	VERB
dpc-3486	140	6	to	to	ADP
dpc-3486	140	7	pcr	pcr	ADJ
dpc-3486	140	8	result	result	NOUN
dpc-3486	140	9	with	with	ADP
dpc-3486	140	10	multivariate	multivariate	NOUN
dpc-3486	140	11	logistic	logistic	ADJ
dpc-3486	140	12	regression	regression	NOUN
dpc-3486	140	13	analysis	analysis	NOUN
dpc-3486	140	14	.	.	PUNCT
dpc-3486	141	1	multivariate	multivariate	NOUN
dpc-3486	141	2	logistic	logistic	ADJ
dpc-3486	141	3	regression	regression	NOUN
dpc-3486	141	4	analysis	analysis	NOUN
dpc-3486	141	5	βi	βi	PRON
dpc-3486	141	6	odds	odd	VERB
dpc-3486	141	7	ratio	ratio	NOUN
dpc-3486	141	8	95	95	NUM
dpc-3486	141	9	%	%	NOUN
dpc-3486	141	10	ci	ci	NOUN
dpc-3486	141	11	wald	wald	NOUN
dpc-3486	141	12	value	value	NOUN
dpc-3486	141	13	p	p	PROPN
dpc-3486	141	14	r2lower	r2lower	NOUN
dpc-3486	141	15	upper	upper	ADJ
dpc-3486	141	16	pcr	pcr	NOUN
dpc-3486	141	17	positivity	positivity	NOUN
dpc-3486	141	18	in	in	ADP
dpc-3486	141	19	patients	patient	NOUN
dpc-3486	141	20	without	without	ADP
dpc-3486	141	21	lung	lung	NOUN
dpc-3486	141	22	involvement	involvement	NOUN
dpc-3486	141	23	;	;	PUNCT
dpc-3486	141	24	step	step	NOUN
dpc-3486	141	25	4	4	NUM
dpc-3486	141	26	(	(	PUNCT
dpc-3486	141	27	n	n	NOUN
dpc-3486	141	28	=	=	SYM
dpc-3486	141	29	71/139	71/139	ADJ
dpc-3486	141	30	)	)	PUNCT
dpc-3486	141	31	dry	dry	ADJ
dpc-3486	141	32	mouth	mouth	NOUN
dpc-3486	141	33	sensation	sensation	NOUN
dpc-3486	141	34	(	(	PUNCT
dpc-3486	141	35	xerostomia	xerostomia	NOUN
dpc-3486	141	36	)	)	PUNCT
dpc-3486	141	37	2.14	2.14	NUM
dpc-3486	141	38	8.48	8.48	NUM
dpc-3486	141	39	1.67	1.67	NUM
dpc-3486	141	40	43.11	43.11	NUM
dpc-3486	141	41	6.65	6.65	NUM
dpc-3486	141	42	0.010	0.010	NUM
dpc-3486	141	43	0.32	0.32	NUM
dpc-3486	141	44	micro	micro	ADJ
dpc-3486	141	45	vesicles	vesicle	NOUN
dpc-3486	141	46	on	on	ADP
dpc-3486	141	47	tonsils	tonsil	NOUN
dpc-3486	141	48	or	or	CCONJ
dpc-3486	141	49	pharynx	pharynx	NOUN
dpc-3486	141	50	2.75	2.75	NUM
dpc-3486	141	51	15.64	15.64	NUM
dpc-3486	141	52	3.38	3.38	NUM
dpc-3486	141	53	72.45	72.45	NUM
dpc-3486	141	54	12.36	12.36	NUM
dpc-3486	141	55	<	<	NOUN
dpc-3486	141	56	0.001	0.001	NUM
dpc-3486	141	57	petechiae	petechiae	NOUN
dpc-3486	141	58	in	in	ADP
dpc-3486	141	59	the	the	DET
dpc-3486	141	60	oropharynx	oropharynx	NOUN
dpc-3486	141	61	1.05	1.05	NUM
dpc-3486	141	62	2.86	2.86	NUM
dpc-3486	141	63	1.10	1.10	NUM
dpc-3486	141	64	7.44	7.44	NUM
dpc-3486	141	65	4.63	4.63	NUM
dpc-3486	141	66	0.032	0.032	NUM
dpc-3486	141	67	primary	primary	ADJ
dpc-3486	141	68	/	/	SYM
dpc-3486	141	69	secondary	secondary	ADJ
dpc-3486	141	70	herpes	herpe	NOUN
dpc-3486	141	71	infection	infection	NOUN
dpc-3486	141	72	2.41	2.41	NUM
dpc-3486	141	73	11.15	11.15	NUM
dpc-3486	141	74	1.27	1.27	NUM
dpc-3486	141	75	97.53	97.53	NUM
dpc-3486	141	76	4.75	4.75	NUM
dpc-3486	141	77	0.029	0.029	NUM
dpc-3486	141	78	multivariate	multivariate	NOUN
dpc-3486	141	79	analysis	analysis	NOUN
dpc-3486	141	80	was	be	AUX
dpc-3486	141	81	performed	perform	VERB
dpc-3486	141	82	using	use	VERB
dpc-3486	141	83	the	the	DET
dpc-3486	141	84	“	"	PUNCT
dpc-3486	141	85	backward	backward	ADJ
dpc-3486	141	86	:	:	PUNCT
dpc-3486	141	87	wald	wald	ADJ
dpc-3486	141	88	”	"	PUNCT
dpc-3486	141	89	method	method	NOUN
dpc-3486	141	90	.	.	PUNCT
dpc-3486	142	1	it	it	PRON
dpc-3486	142	2	was	be	AUX
dpc-3486	142	3	carried	carry	VERB
dpc-3486	142	4	out	out	ADP
dpc-3486	142	5	with	with	ADP
dpc-3486	142	6	examination	examination	NOUN
dpc-3486	142	7	findings	finding	NOUN
dpc-3486	142	8	such	such	ADJ
dpc-3486	142	9	as	as	ADP
dpc-3486	142	10	“	"	PUNCT
dpc-3486	142	11	back	back	ADJ
dpc-3486	142	12	or	or	CCONJ
dpc-3486	142	13	chest	chest	NOUN
dpc-3486	142	14	pain	pain	NOUN
dpc-3486	142	15	,	,	PUNCT
dpc-3486	142	16	dry	dry	ADJ
dpc-3486	142	17	mouth	mouth	NOUN
dpc-3486	142	18	sensation	sensation	NOUN
dpc-3486	142	19	,	,	PUNCT
dpc-3486	142	20	erythema	erythema	ADV
dpc-3486	142	21	of	of	ADP
dpc-3486	142	22	tonsils	tonsil	NOUN
dpc-3486	142	23	and	and	CCONJ
dpc-3486	142	24	pharynx	pharynx	NOUN
dpc-3486	142	25	,	,	PUNCT
dpc-3486	142	26	microvesicles	microvesicle	NOUN
dpc-3486	142	27	on	on	ADP
dpc-3486	142	28	tonsils	tonsil	NOUN
dpc-3486	142	29	or	or	CCONJ
dpc-3486	142	30	pharynx	pharynx	NOUN
dpc-3486	142	31	,	,	PUNCT
dpc-3486	142	32	petechiae	petechiae	NOUN
dpc-3486	142	33	in	in	ADP
dpc-3486	142	34	the	the	DET
dpc-3486	142	35	oropharynx	oropharynx	NOUN
dpc-3486	142	36	,	,	PUNCT
dpc-3486	142	37	primary/	primary/	NUM
dpc-3486	142	38	secondary	secondary	ADJ
dpc-3486	142	39	herpes	herpe	NOUN
dpc-3486	142	40	infection	infection	NOUN
dpc-3486	142	41	,	,	PUNCT
dpc-3486	142	42	oral	oral	ADJ
dpc-3486	142	43	aphthae	aphthae	NOUN
dpc-3486	142	44	”	"	PUNCT
dpc-3486	142	45	with	with	ADP
dpc-3486	142	46	a	a	DET
dpc-3486	142	47	significance	significance	NOUN
dpc-3486	142	48	level	level	NOUN
dpc-3486	142	49	of	of	ADP
dpc-3486	142	50	p<0.01	p<0.01	PROPN
dpc-3486	142	51	.	.	PUNCT
dpc-3486	142	52	pcr	pcr	PROPN
dpc-3486	142	53	=	=	SYM
dpc-3486	142	54	polymerase	polymerase	NOUN
dpc-3486	142	55	chain	chain	NOUN
dpc-3486	142	56	reaction	reaction	NOUN
dpc-3486	142	57	.	.	PUNCT
dpc-3486	143	1	to	to	ADP
dpc-3486	143	2	date	date	NOUN
dpc-3486	143	3	,	,	PUNCT
dpc-3486	143	4	reports	report	NOUN
dpc-3486	143	5	generally	generally	ADV
dpc-3486	143	6	provide	provide	VERB
dpc-3486	143	7	information	information	NOUN
dpc-3486	143	8	about	about	ADP
dpc-3486	143	9	the	the	DET
dpc-3486	143	10	signs	sign	NOUN
dpc-3486	143	11	and	and	CCONJ
dpc-3486	143	12	symptoms	symptom	NOUN
dpc-3486	143	13	of	of	ADP
dpc-3486	143	14	the	the	DET
dpc-3486	143	15	oral	oral	ADJ
dpc-3486	143	16	mucosa	mucosa	NOUN
dpc-3486	143	17	in	in	ADP
dpc-3486	143	18	patients	patient	NOUN
dpc-3486	143	19	with	with	ADP
dpc-3486	143	20	covid-19	covid-19	PROPN
dpc-3486	143	21	;	;	PUNCT
dpc-3486	143	22	however	however	ADV
dpc-3486	143	23	,	,	PUNCT
dpc-3486	143	24	the	the	DET
dpc-3486	143	25	relationship	relationship	NOUN
dpc-3486	143	26	between	between	ADP
dpc-3486	143	27	pcr	pcr	NOUN
dpc-3486	143	28	positivity	positivity	NOUN
dpc-3486	143	29	and	and	CCONJ
dpc-3486	143	30	pneumonia	pneumonia	NOUN
dpc-3486	143	31	and	and	CCONJ
dpc-3486	143	32	the	the	DET
dpc-3486	143	33	oral	oral	ADJ
dpc-3486	143	34	signs	sign	NOUN
dpc-3486	143	35	and	and	CCONJ
dpc-3486	143	36	symptoms	symptom	NOUN
dpc-3486	143	37	has	have	AUX
dpc-3486	143	38	not	not	PART
dpc-3486	143	39	yet	yet	ADV
dpc-3486	143	40	been	be	AUX
dpc-3486	143	41	studied	study	VERB
dpc-3486	143	42	.	.	PUNCT
dpc-3486	144	1	in	in	ADP
dpc-3486	144	2	the	the	DET
dpc-3486	144	3	present	present	ADJ
dpc-3486	144	4	study	study	NOUN
dpc-3486	144	5	,	,	PUNCT
dpc-3486	144	6	it	it	PRON
dpc-3486	144	7	was	be	AUX
dpc-3486	144	8	found	find	VERB
dpc-3486	144	9	that	that	SCONJ
dpc-3486	144	10	microvesicles	microvesicle	NOUN
dpc-3486	144	11	on	on	ADP
dpc-3486	144	12	the	the	DET
dpc-3486	144	13	tonsils	tonsil	NOUN
dpc-3486	144	14	or	or	CCONJ
dpc-3486	144	15	pharynx	pharynx	NOUN
dpc-3486	144	16	were	be	AUX
dpc-3486	144	17	most	most	ADV
dpc-3486	144	18	associated	associate	VERB
dpc-3486	144	19	with	with	ADP
dpc-3486	144	20	pcr	pcr	ADJ
dpc-3486	144	21	positivity	positivity	NOUN
dpc-3486	144	22	in	in	ADP
dpc-3486	144	23	patients	patient	NOUN
dpc-3486	144	24	without	without	ADP
dpc-3486	144	25	lung	lung	NOUN
dpc-3486	144	26	involvement	involvement	NOUN
dpc-3486	144	27	(	(	PUNCT
dpc-3486	144	28	p	p	X
dpc-3486	144	29	 	 	SPACE
dpc-3486	144	30	<	<	X
dpc-3486	144	31	0.001	0.001	NUM
dpc-3486	144	32	)	)	PUNCT
dpc-3486	144	33	.	.	PUNCT
dpc-3486	145	1	petechiae	petechiae	NOUN
dpc-3486	145	2	in	in	ADP
dpc-3486	145	3	the	the	DET
dpc-3486	145	4	oropharynx	oropharynx	NOUN
dpc-3486	145	5	,	,	PUNCT
dpc-3486	145	6	dry	dry	ADJ
dpc-3486	145	7	mouth	mouth	NOUN
dpc-3486	145	8	sensation	sensation	NOUN
dpc-3486	145	9	(	(	PUNCT
dpc-3486	145	10	xerostomia	xerostomia	NOUN
dpc-3486	145	11	)	)	PUNCT
dpc-3486	145	12	,	,	PUNCT
dpc-3486	145	13	erythema	erythema	ADV
dpc-3486	145	14	of	of	ADP
dpc-3486	145	15	tonsils	tonsil	NOUN
dpc-3486	145	16	and	and	CCONJ
dpc-3486	145	17	pharynx	pharynx	NOUN
dpc-3486	145	18	,	,	PUNCT
dpc-3486	145	19	oral	oral	ADJ
dpc-3486	145	20	aphthae	aphthae	NOUN
dpc-3486	145	21	,	,	PUNCT
dpc-3486	145	22	and	and	CCONJ
dpc-3486	145	23	primary	primary	ADJ
dpc-3486	145	24	/	/	SYM
dpc-3486	145	25	secondary	secondary	ADJ
dpc-3486	145	26	herpes	herpe	NOUN
dpc-3486	145	27	infection	infection	NOUN
dpc-3486	145	28	were	be	AUX
dpc-3486	145	29	also	also	ADV
dpc-3486	145	30	related	relate	VERB
dpc-3486	145	31	to	to	ADP
dpc-3486	145	32	pcr	pcr	ADJ
dpc-3486	145	33	positivity	positivity	NOUN
dpc-3486	145	34	(	(	PUNCT
dpc-3486	145	35	p	p	X
dpc-3486	145	36	<	<	X
dpc-3486	145	37	0.05	0.05	NUM
dpc-3486	145	38	)	)	PUNCT
dpc-3486	145	39	.	.	PUNCT
dpc-3486	146	1	cheilitis	cheilitis	NOUN
dpc-3486	146	2	or	or	CCONJ
dpc-3486	146	3	angular	angular	ADJ
dpc-3486	146	4	cheilitis	cheilitis	NOUN
dpc-3486	146	5	were	be	AUX
dpc-3486	146	6	the	the	DET
dpc-3486	146	7	only	only	ADJ
dpc-3486	146	8	oral	oral	ADJ
dpc-3486	146	9	signs	sign	NOUN
dpc-3486	146	10	associated	associate	VERB
dpc-3486	146	11	with	with	ADP
dpc-3486	146	12	lung	lung	NOUN
dpc-3486	146	13	involvement	involvement	NOUN
dpc-3486	146	14	in	in	ADP
dpc-3486	146	15	patients	patient	NOUN
dpc-3486	146	16	with	with	ADP
dpc-3486	146	17	pcr	pcr	NOUN
dpc-3486	146	18	positivity	positivity	NOUN
dpc-3486	146	19	(	(	PUNCT
dpc-3486	146	20	p	p	NOUN
dpc-3486	146	21	=	=	NOUN
dpc-3486	146	22	0.034	0.034	NUM
dpc-3486	146	23	)	)	PUNCT
dpc-3486	146	24	.	.	PUNCT
dpc-3486	147	1	the	the	DET
dpc-3486	147	2	patients	patient	NOUN
dpc-3486	147	3	with	with	ADP
dpc-3486	147	4	negative	negative	ADJ
dpc-3486	147	5	pcr	pcr	ADJ
dpc-3486	147	6	tests	test	NOUN
dpc-3486	147	7	had	have	VERB
dpc-3486	147	8	more	more	ADV
dpc-3486	147	9	common	common	ADJ
dpc-3486	147	10	normal	normal	ADJ
dpc-3486	147	11	oral	oral	ADJ
dpc-3486	147	12	mucosa	mucosa	NOUN
dpc-3486	147	13	(	(	PUNCT
dpc-3486	147	14	p	p	X
dpc-3486	147	15	<	<	X
dpc-3486	147	16	0.001	0.001	NUM
dpc-3486	147	17	)	)	PUNCT
dpc-3486	147	18	.	.	PUNCT
dpc-3486	148	1	various	various	ADJ
dpc-3486	148	2	hypotheses	hypothesis	NOUN
dpc-3486	148	3	have	have	AUX
dpc-3486	148	4	been	be	AUX
dpc-3486	148	5	recommended	recommend	VERB
dpc-3486	148	6	for	for	ADP
dpc-3486	148	7	the	the	DET
dpc-3486	148	8	etiology	etiology	NOUN
dpc-3486	148	9	of	of	ADP
dpc-3486	148	10	oral	oral	ADJ
dpc-3486	148	11	lesions	lesion	NOUN
dpc-3486	148	12	.	.	PUNCT
dpc-3486	149	1	according	accord	VERB
dpc-3486	149	2	to	to	ADP
dpc-3486	149	3	some	some	DET
dpc-3486	149	4	authors	author	NOUN
dpc-3486	149	5	,	,	PUNCT
dpc-3486	149	6	the	the	DET
dpc-3486	149	7	lesions	lesion	NOUN
dpc-3486	149	8	arise	arise	VERB
dpc-3486	149	9	directly	directly	ADV
dpc-3486	149	10	from	from	ADP
dpc-3486	149	11	the	the	DET
dpc-3486	149	12	disease	disease	NOUN
dpc-3486	149	13	.	.	PUNCT
dpc-3486	150	1	the	the	DET
dpc-3486	150	2	expression	expression	NOUN
dpc-3486	150	3	of	of	ADP
dpc-3486	150	4	ace2	ace2	NOUN
dpc-3486	150	5	and	and	CCONJ
dpc-3486	150	6	transmembrane	transmembrane	ADJ
dpc-3486	150	7	serine	serine	NOUN
dpc-3486	150	8	protease	protease	NOUN
dpc-3486	150	9	(	(	PUNCT
dpc-3486	150	10	tmrpss2	tmrpss2	ADJ
dpc-3486	150	11	)	)	PUNCT
dpc-3486	150	12	are	be	AUX
dpc-3486	150	13	confirmed	confirm	VERB
dpc-3486	150	14	in	in	ADP
dpc-3486	150	15	oral	oral	ADJ
dpc-3486	150	16	mucosal	mucosal	ADJ
dpc-3486	150	17	epithelia	epithelium	NOUN
dpc-3486	150	18	and	and	CCONJ
dpc-3486	150	19	salivary	salivary	ADJ
dpc-3486	150	20	glands	gland	NOUN
dpc-3486	150	21	,	,	PUNCT
dpc-3486	150	22	approving	approve	VERB
dpc-3486	150	23	evidence	evidence	NOUN
dpc-3486	150	24	of	of	ADP
dpc-3486	150	25	sars	sar	NOUN
dpc-3486	150	26	-	-	PUNCT
dpc-3486	150	27	cov-2	cov-2	NOUN
dpc-3486	150	28	direct	direct	ADJ
dpc-3486	150	29	infection	infection	NOUN
dpc-3486	150	30	  	  	SPACE
dpc-3486	151	1	[	[	X
dpc-3486	151	2	23	23	NUM
dpc-3486	151	3	]	]	PUNCT
dpc-3486	151	4	.	.	PUNCT
dpc-3486	152	1	in	in	ADP
dpc-3486	152	2	addition	addition	NOUN
dpc-3486	152	3	,	,	PUNCT
dpc-3486	152	4	since	since	SCONJ
dpc-3486	152	5	the	the	DET
dpc-3486	152	6	oral	oral	ADJ
dpc-3486	152	7	mucosa	mucosa	NOUN
dpc-3486	152	8	was	be	AUX
dpc-3486	152	9	the	the	DET
dpc-3486	152	10	first	first	ADJ
dpc-3486	152	11	to	to	PART
dpc-3486	152	12	be	be	AUX
dpc-3486	152	13	infected	infect	VERB
dpc-3486	152	14	with	with	ADP
dpc-3486	152	15	sars	sar	NOUN
dpc-3486	152	16	-	-	PUNCT
dpc-3486	152	17	cov-2	cov-2	NOUN
dpc-3486	152	18	,	,	PUNCT
dpc-3486	152	19	it	it	PRON
dpc-3486	152	20	was	be	AUX
dpc-3486	152	21	suggested	suggest	VERB
dpc-3486	152	22	that	that	SCONJ
dpc-3486	152	23	oral	oral	ADJ
dpc-3486	152	24	lesions	lesion	NOUN
dpc-3486	152	25	could	could	AUX
dpc-3486	152	26	be	be	AUX
dpc-3486	152	27	the	the	DET
dpc-3486	152	28	first	first	ADJ
dpc-3486	152	29	symptom	symptom	NOUN
dpc-3486	152	30	of	of	ADP
dpc-3486	152	31	covid-19	covid-19	PROPN
dpc-3486	153	1	[	[	X
dpc-3486	153	2	24	24	NUM
dpc-3486	153	3	]	]	PUNCT
dpc-3486	153	4	.	.	PUNCT
dpc-3486	154	1	a	a	DET
dpc-3486	154	2	study	study	NOUN
dpc-3486	154	3	has	have	AUX
dpc-3486	154	4	revealed	reveal	VERB
dpc-3486	154	5	that	that	SCONJ
dpc-3486	154	6	viruses	virus	NOUN
dpc-3486	154	7	affect	affect	VERB
dpc-3486	154	8	epithelial	epithelial	ADJ
dpc-3486	154	9	cells	cell	NOUN
dpc-3486	154	10	and	and	CCONJ
dpc-3486	154	11	damage	damage	NOUN
dpc-3486	154	12	tissue	tissue	NOUN
dpc-3486	154	13	integrity	integrity	NOUN
dpc-3486	154	14	by	by	ADP
dpc-3486	154	15	causing	cause	VERB
dpc-3486	154	16	inflammatory	inflammatory	ADJ
dpc-3486	154	17	reactions	reaction	NOUN
dpc-3486	154	18	[	[	X
dpc-3486	154	19	25	25	NUM
dpc-3486	154	20	]	]	PUNCT
dpc-3486	154	21	.	.	PUNCT
dpc-3486	155	1	it	it	PRON
dpc-3486	155	2	was	be	AUX
dpc-3486	155	3	suggested	suggest	VERB
dpc-3486	155	4	that	that	SCONJ
dpc-3486	155	5	sars	sar	NOUN
dpc-3486	155	6	-	-	PUNCT
dpc-3486	155	7	cov-2	cov-2	PART
dpc-3486	155	8	infects	infect	NOUN
dpc-3486	155	9	salivary	salivary	VERB
dpc-3486	155	10	glands	gland	NOUN
dpc-3486	155	11	,	,	PUNCT
dpc-3486	155	12	resulting	result	VERB
dpc-3486	155	13	in	in	ADP
dpc-3486	155	14	hyposalivation	hyposalivation	NOUN
dpc-3486	155	15	,	,	PUNCT
dpc-3486	155	16	taste	taste	VERB
dpc-3486	155	17	disorders	disorder	NOUN
dpc-3486	155	18	,	,	PUNCT
dpc-3486	155	19	xerostomia	xerostomia	NOUN
dpc-3486	155	20	,	,	PUNCT
dpc-3486	155	21	and	and	CCONJ
dpc-3486	155	22	halitosis	halitosis	NOUN
dpc-3486	155	23	  	  	SPACE
dpc-3486	156	1	[	[	X
dpc-3486	156	2	23	23	NUM
dpc-3486	156	3	]	]	PUNCT
dpc-3486	156	4	.	.	PUNCT
dpc-3486	157	1	according	accord	VERB
dpc-3486	157	2	to	to	ADP
dpc-3486	157	3	our	our	PRON
dpc-3486	157	4	study	study	NOUN
dpc-3486	157	5	results	result	NOUN
dpc-3486	157	6	,	,	PUNCT
dpc-3486	157	7	we	we	PRON
dpc-3486	157	8	can	can	AUX
dpc-3486	157	9	make	make	VERB
dpc-3486	157	10	the	the	DET
dpc-3486	157	11	following	follow	VERB
dpc-3486	157	12	comment	comment	NOUN
dpc-3486	157	13	:	:	PUNCT
dpc-3486	157	14	for	for	ADP
dpc-3486	157	15	covid-19	covid-19	PROPN
dpc-3486	157	16	,	,	PUNCT
dpc-3486	157	17	a	a	DET
dpc-3486	157	18	pcr	pcr	ADJ
dpc-3486	157	19	swab	swab	NOUN
dpc-3486	157	20	is	be	AUX
dpc-3486	157	21	obtained	obtain	VERB
dpc-3486	157	22	from	from	ADP
dpc-3486	157	23	the	the	DET
dpc-3486	157	24	tonsillar	tonsillar	ADJ
dpc-3486	157	25	-	-	PUNCT
dpc-3486	157	26	pharynx	pharynx	NOUN
dpc-3486	157	27	and	and	CCONJ
dpc-3486	157	28	nasopharynx	nasopharynx	NOUN
dpc-3486	157	29	[	[	X
dpc-3486	157	30	8	8	NUM
dpc-3486	157	31	]	]	PUNCT
dpc-3486	157	32	.	.	PUNCT
dpc-3486	158	1	thus	thus	ADV
dpc-3486	158	2	,	,	PUNCT
dpc-3486	158	3	tonsillar	tonsillar	ADJ
dpc-3486	158	4	-	-	PUNCT
dpc-3486	158	5	pharynx	pharynx	NOUN
dpc-3486	158	6	lesions	lesion	NOUN
dpc-3486	158	7	such	such	ADJ
dpc-3486	158	8	as	as	ADP
dpc-3486	158	9	microvesicles	microvesicle	NOUN
dpc-3486	158	10	on	on	ADP
dpc-3486	158	11	the	the	DET
dpc-3486	158	12	tonsils	tonsil	NOUN
dpc-3486	158	13	or	or	CCONJ
dpc-3486	158	14	pharynx	pharynx	NOUN
dpc-3486	158	15	,	,	PUNCT
dpc-3486	158	16	petechiae	petechiae	NOUN
dpc-3486	158	17	in	in	ADP
dpc-3486	158	18	the	the	DET
dpc-3486	158	19	oropharynx	oropharynx	NOUN
dpc-3486	158	20	,	,	PUNCT
dpc-3486	158	21	erythema	erythema	ADV
dpc-3486	158	22	of	of	ADP
dpc-3486	158	23	tonsils	tonsil	NOUN
dpc-3486	158	24	and	and	CCONJ
dpc-3486	158	25	pharynx	pharynx	NOUN
dpc-3486	158	26	,	,	PUNCT
dpc-3486	158	27	oral	oral	ADJ
dpc-3486	158	28	aphthae	aphthae	NOUN
dpc-3486	158	29	(	(	PUNCT
dpc-3486	158	30	only	only	ADV
dpc-3486	158	31	on	on	ADP
dpc-3486	158	32	the	the	DET
dpc-3486	158	33	tonsillar	tonsillar	ADJ
dpc-3486	158	34	-	-	PUNCT
dpc-3486	158	35	pharynx	pharynx	NOUN
dpc-3486	158	36	)	)	PUNCT
dpc-3486	158	37	which	which	PRON
dpc-3486	158	38	were	be	AUX
dpc-3486	158	39	related	relate	VERB
dpc-3486	158	40	to	to	ADP
dpc-3486	158	41	pcr	pcr	ADJ
dpc-3486	158	42	original	original	ADJ
dpc-3486	158	43	article	article	NOUN
dpc-3486	158	44	|	|	ADV
dpc-3486	158	45	dermatol	dermatol	ADJ
dpc-3486	158	46	pract	pract	NOUN
dpc-3486	158	47	concept	concept	NOUN
dpc-3486	158	48	.	.	PUNCT
dpc-3486	159	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	159	2	7	7	NUM
dpc-3486	159	3	5	5	NUM
dpc-3486	159	4	.	.	PUNCT
dpc-3486	160	1	petrescu	petrescu	VERB
dpc-3486	160	2	n	n	CCONJ
dpc-3486	160	3	,	,	PUNCT
dpc-3486	160	4	lucaciu	lucaciu	ADJ
dpc-3486	160	5	o	o	NOUN
dpc-3486	160	6	,	,	PUNCT
dpc-3486	160	7	roman	roman	ADJ
dpc-3486	160	8	a.	a.	NOUN
dpc-3486	160	9	oral	oral	ADJ
dpc-3486	160	10	mucosa	mucosa	NOUN
dpc-3486	160	11	lesions	lesion	NOUN
dpc-3486	160	12	in	in	ADP
dpc-3486	160	13	covid-19	covid-19	PROPN
dpc-3486	160	14	.	.	PUNCT
dpc-3486	161	1	oral	oral	ADJ
dpc-3486	161	2	dis	dis	PROPN
dpc-3486	161	3	.	.	PUNCT
dpc-3486	162	1	2022;28	2022;28	NUM
dpc-3486	162	2	suppl	suppl	ADJ
dpc-3486	162	3	1(suppl	1(suppl	PRON
dpc-3486	162	4	1):935	1):935	NUM
dpc-3486	162	5	-	-	SYM
dpc-3486	162	6	936	936	NUM
dpc-3486	162	7	.	.	PUNCT
dpc-3486	162	8	doi	doi	NOUN
dpc-3486	162	9	:	:	PUNCT
dpc-3486	162	10	10.1111	10.1111	NUM
dpc-3486	162	11	/	/	SYM
dpc-3486	162	12	odi.13499	odi.13499	NUM
dpc-3486	162	13	.	.	PUNCT
dpc-3486	163	1	pmid	pmid	NOUN
dpc-3486	163	2	:	:	PUNCT
dpc-3486	163	3	32558983	32558983	NUM
dpc-3486	163	4	.	.	PUNCT
dpc-3486	164	1	pmcid	pmcid	ADJ
dpc-3486	164	2	:	:	PUNCT
dpc-3486	164	3	pmc7323044	pmc7323044	NOUN
dpc-3486	164	4	.	.	PUNCT
dpc-3486	165	1	6	6	X
dpc-3486	165	2	.	.	X
dpc-3486	165	3	erbaş	erbaş	PROPN
dpc-3486	165	4	gs	gs	PROPN
dpc-3486	165	5	,	,	PUNCT
dpc-3486	165	6	botsali	botsali	PROPN
dpc-3486	165	7	a	a	PRON
dpc-3486	165	8	,	,	PUNCT
dpc-3486	165	9	erden	erden	NOUN
dpc-3486	165	10	n	n	CCONJ
dpc-3486	165	11	,	,	PUNCT
dpc-3486	165	12	arı	arı	PRON
dpc-3486	165	13	c	c	NOUN
dpc-3486	165	14	,	,	PUNCT
dpc-3486	165	15	et	et	PROPN
dpc-3486	165	16	al	al	PROPN
dpc-3486	165	17	.	.	PUNCT
dpc-3486	166	1	covid-19	covid-19	PROPN
dpc-3486	166	2	-	-	PUNCT
dpc-3486	166	3	related	relate	VERB
dpc-3486	166	4	oral	oral	ADJ
dpc-3486	166	5	mucosa	mucosa	NOUN
dpc-3486	166	6	lesions	lesion	NOUN
dpc-3486	166	7	among	among	ADP
dpc-3486	166	8	confirmed	confirm	VERB
dpc-3486	166	9	sars	sar	NOUN
dpc-3486	166	10	-	-	PUNCT
dpc-3486	166	11	cov-2	cov-2	NOUN
dpc-3486	166	12	patients	patient	NOUN
dpc-3486	166	13	:	:	PUNCT
dpc-3486	166	14	a	a	DET
dpc-3486	166	15	systematic	systematic	ADJ
dpc-3486	166	16	review	review	NOUN
dpc-3486	166	17	.	.	PUNCT
dpc-3486	167	1	int	int	NOUN
dpc-3486	167	2	j	j	PROPN
dpc-3486	167	3	dermatol	dermatol	NOUN
dpc-3486	167	4	.	.	PUNCT
dpc-3486	168	1	2022;61(1):20	2022;61(1):20	NUM
dpc-3486	168	2	-	-	SYM
dpc-3486	168	3	32	32	NUM
dpc-3486	168	4	.	.	PUNCT
dpc-3486	169	1	doi	doi	NOUN
dpc-3486	169	2	:	:	PUNCT
dpc-3486	169	3	10.1111	10.1111	NUM
dpc-3486	169	4	/	/	SYM
dpc-3486	169	5	ijd.15889	ijd.15889	NOUN
dpc-3486	169	6	.	.	PUNCT
dpc-3486	170	1	pmid	pmid	NOUN
dpc-3486	170	2	:	:	PUNCT
dpc-3486	170	3	34549816	34549816	NUM
dpc-3486	170	4	.	.	PUNCT
dpc-3486	171	1	pmcid	pmcid	NOUN
dpc-3486	171	2	:	:	PUNCT
dpc-3486	171	3	pmc8652904	pmc8652904	VERB
dpc-3486	171	4	.	.	PUNCT
dpc-3486	172	1	7	7	X
dpc-3486	172	2	.	.	X
dpc-3486	172	3	cuevas	cuevas	PROPN
dpc-3486	172	4	-	-	PUNCT
dpc-3486	172	5	gonzalez	gonzalez	PROPN
dpc-3486	172	6	mv	mv	PROPN
dpc-3486	172	7	,	,	PUNCT
dpc-3486	172	8	espinosa	espinosa	PROPN
dpc-3486	172	9	-	-	PUNCT
dpc-3486	172	10	cristóbal	cristóbal	PROPN
dpc-3486	172	11	lf	lf	PROPN
dpc-3486	172	12	,	,	PUNCT
dpc-3486	172	13	donohue	donohue	PROPN
dpc-3486	172	14	-	-	PUNCT
dpc-3486	172	15	cornejo	cornejo	PROPN
dpc-3486	172	16	a	a	PROPN
dpc-3486	172	17	,	,	PUNCT
dpc-3486	172	18	et	et	PROPN
dpc-3486	172	19	al	al	PROPN
dpc-3486	172	20	.	.	PUNCT
dpc-3486	173	1	covid-19	covid-19	PROPN
dpc-3486	173	2	and	and	CCONJ
dpc-3486	173	3	its	its	PRON
dpc-3486	173	4	manifestations	manifestation	NOUN
dpc-3486	173	5	in	in	ADP
dpc-3486	173	6	the	the	DET
dpc-3486	173	7	oral	oral	ADJ
dpc-3486	173	8	cavity	cavity	NOUN
dpc-3486	173	9	:	:	PUNCT
dpc-3486	173	10	a	a	DET
dpc-3486	173	11	systematic	systematic	ADJ
dpc-3486	173	12	review	review	NOUN
dpc-3486	173	13	.	.	PUNCT
dpc-3486	174	1	medicine	medicine	NOUN
dpc-3486	174	2	(	(	PUNCT
dpc-3486	174	3	baltimore	baltimore	PROPN
dpc-3486	174	4	)	)	PUNCT
dpc-3486	174	5	.	.	PUNCT
dpc-3486	175	1	2021;100(51):e28327	2021;100(51):e28327	NOUN
dpc-3486	175	2	.	.	PUNCT
dpc-3486	176	1	doi	doi	NOUN
dpc-3486	176	2	:	:	PUNCT
dpc-3486	176	3	10.1097	10.1097	NUM
dpc-3486	176	4	/	/	SYM
dpc-3486	176	5	md.0000000000028327	md.0000000000028327	PROPN
dpc-3486	176	6	.	.	PUNCT
dpc-3486	177	1	pmid	pmid	NOUN
dpc-3486	177	2	:	:	PUNCT
dpc-3486	177	3	34941133	34941133	NUM
dpc-3486	177	4	.	.	PUNCT
dpc-3486	178	1	pmcid	pmcid	NOUN
dpc-3486	178	2	:	:	PUNCT
dpc-3486	178	3	pmc8701462	pmc8701462	NOUN
dpc-3486	178	4	.	.	PUNCT
dpc-3486	179	1	8	8	X
dpc-3486	179	2	.	.	X
dpc-3486	179	3	piccolo	piccolo	PROPN
dpc-3486	179	4	v	v	PROPN
dpc-3486	179	5	,	,	PUNCT
dpc-3486	179	6	bassi	bassi	PROPN
dpc-3486	179	7	a	a	X
dpc-3486	179	8	,	,	PUNCT
dpc-3486	179	9	grimalt	grimalt	ADJ
dpc-3486	179	10	r	r	NOUN
dpc-3486	179	11	,	,	PUNCT
dpc-3486	179	12	et	et	PROPN
dpc-3486	179	13	al	al	PROPN
dpc-3486	179	14	.	.	PROPN
dpc-3486	180	1	lingua	lingua	PROPN
dpc-3486	180	2	villosa	villosa	PROPN
dpc-3486	180	3	nigra	nigra	PROPN
dpc-3486	180	4	in	in	ADP
dpc-3486	180	5	a	a	DET
dpc-3486	180	6	child	child	NOUN
dpc-3486	180	7	after	after	ADP
dpc-3486	180	8	covid	covid	PROPN
dpc-3486	180	9	:	:	PUNCT
dpc-3486	180	10	review	review	NOUN
dpc-3486	180	11	and	and	CCONJ
dpc-3486	180	12	differential	differential	ADJ
dpc-3486	180	13	diagnosis	diagnosis	NOUN
dpc-3486	180	14	with	with	ADP
dpc-3486	180	15	oral	oral	ADJ
dpc-3486	180	16	pigmentations	pigmentation	NOUN
dpc-3486	180	17	of	of	ADP
dpc-3486	180	18	childhood	childhood	NOUN
dpc-3486	180	19	.	.	PUNCT
dpc-3486	181	1	j	j	PROPN
dpc-3486	181	2	eur	eur	PROPN
dpc-3486	181	3	acad	acad	PROPN
dpc-3486	181	4	dermatol	dermatol	NOUN
dpc-3486	181	5	venereol	venereol	NOUN
dpc-3486	181	6	.	.	PUNCT
dpc-3486	182	1	2023	2023	NUM
dpc-3486	182	2	mar	mar	PROPN
dpc-3486	182	3	27	27	NUM
dpc-3486	182	4	.	.	PUNCT
dpc-3486	183	1	doi	doi	NOUN
dpc-3486	183	2	:	:	PUNCT
dpc-3486	183	3	10.1111	10.1111	NUM
dpc-3486	183	4	/	/	SYM
dpc-3486	183	5	jdv.19070	jdv.19070	ADP
dpc-3486	183	6	.	.	PUNCT
dpc-3486	184	1	pmid	pmid	NOUN
dpc-3486	184	2	:	:	PUNCT
dpc-3486	184	3	36974423	36974423	NUM
dpc-3486	184	4	.	.	PUNCT
dpc-3486	185	1	9	9	X
dpc-3486	185	2	.	.	X
dpc-3486	185	3	amorim	amorim	PROPN
dpc-3486	185	4	dos	dos	PROPN
dpc-3486	185	5	santos	santos	PROPN
dpc-3486	185	6	j	j	PROPN
dpc-3486	185	7	,	,	PUNCT
dpc-3486	185	8	normando	normando	PROPN
dpc-3486	185	9	agc	agc	PROPN
dpc-3486	185	10	,	,	PUNCT
dpc-3486	185	11	et	et	PROPN
dpc-3486	185	12	al	al	PROPN
dpc-3486	185	13	.	.	PUNCT
dpc-3486	185	14	oral	oral	ADJ
dpc-3486	185	15	manifestations	manifestation	NOUN
dpc-3486	185	16	in	in	ADP
dpc-3486	185	17	patients	patient	NOUN
dpc-3486	185	18	with	with	ADP
dpc-3486	185	19	covid-19	covid-19	PROPN
dpc-3486	185	20	:	:	PUNCT
dpc-3486	185	21	a	a	DET
dpc-3486	185	22	living	live	VERB
dpc-3486	185	23	systematic	systematic	ADJ
dpc-3486	185	24	review	review	NOUN
dpc-3486	185	25	.	.	PUNCT
dpc-3486	186	1	j	j	PROPN
dpc-3486	186	2	dent	dent	NOUN
dpc-3486	186	3	res	re	NOUN
dpc-3486	186	4	.	.	PUNCT
dpc-3486	187	1	2021;100(2):141	2021;100(2):141	X
dpc-3486	187	2	-	-	SYM
dpc-3486	187	3	154	154	NUM
dpc-3486	187	4	.	.	PUNCT
dpc-3486	188	1	doi	doi	NOUN
dpc-3486	188	2	:	:	PUNCT
dpc-3486	188	3	10.1177/0022034520957289	10.1177/0022034520957289	NUM
dpc-3486	188	4	.	.	PUNCT
dpc-3486	189	1	pmid	pmid	NOUN
dpc-3486	189	2	:	:	PUNCT
dpc-3486	189	3	32914677	32914677	NUM
dpc-3486	189	4	.	.	PUNCT
dpc-3486	190	1	10	10	NUM
dpc-3486	190	2	.	.	X
dpc-3486	190	3	goudouris	goudouris	PROPN
dpc-3486	190	4	es	es	PROPN
dpc-3486	190	5	.	.	PUNCT
dpc-3486	190	6	laboratory	laboratory	NOUN
dpc-3486	190	7	diagnosis	diagnosis	NOUN
dpc-3486	190	8	of	of	ADP
dpc-3486	190	9	covid-19	covid-19	PROPN
dpc-3486	190	10	.	.	PUNCT
dpc-3486	191	1	j	j	PROPN
dpc-3486	191	2	pediatr	pediatr	PROPN
dpc-3486	191	3	(	(	PUNCT
dpc-3486	191	4	rio	rio	PROPN
dpc-3486	191	5	j	j	PROPN
dpc-3486	191	6	)	)	PUNCT
dpc-3486	191	7	.	.	PUNCT
dpc-3486	192	1	2021;97(1):7	2021;97(1):7	NUM
dpc-3486	192	2	-	-	SYM
dpc-3486	192	3	12	12	NUM
dpc-3486	192	4	.	.	PUNCT
dpc-3486	193	1	doi	doi	NOUN
dpc-3486	193	2	:	:	PUNCT
dpc-3486	193	3	10.1016	10.1016	NUM
dpc-3486	193	4	/	/	SYM
dpc-3486	193	5	j.jped.2020.08.001	j.jped.2020.08.001	PROPN
dpc-3486	193	6	.	.	PUNCT
dpc-3486	194	1	pmid	pmid	NOUN
dpc-3486	194	2	:	:	PUNCT
dpc-3486	194	3	32882235	32882235	NUM
dpc-3486	194	4	.	.	PUNCT
dpc-3486	195	1	pmcid	pmcid	ADJ
dpc-3486	195	2	:	:	PUNCT
dpc-3486	195	3	pmc7456621	pmc7456621	NOUN
dpc-3486	195	4	.	.	PUNCT
dpc-3486	196	1	11	11	NUM
dpc-3486	196	2	.	.	PUNCT
dpc-3486	197	1	drago	drago	PROPN
dpc-3486	197	2	f	f	PROPN
dpc-3486	197	3	,	,	PUNCT
dpc-3486	197	4	paolino	paolino	PROPN
dpc-3486	197	5	s	s	PROPN
dpc-3486	197	6	,	,	PUNCT
dpc-3486	197	7	rebora	rebora	VERB
dpc-3486	197	8	a	a	PRON
dpc-3486	197	9	,	,	PUNCT
dpc-3486	197	10	et	et	PROPN
dpc-3486	197	11	al	al	PROPN
dpc-3486	197	12	.	.	PUNCT
dpc-3486	198	1	the	the	DET
dpc-3486	198	2	challenge	challenge	NOUN
dpc-3486	198	3	of	of	ADP
dpc-3486	198	4	diagnosing	diagnose	VERB
dpc-3486	198	5	atypical	atypical	ADJ
dpc-3486	198	6	exanthems	exanthem	NOUN
dpc-3486	198	7	:	:	PUNCT
dpc-3486	198	8	a	a	DET
dpc-3486	198	9	clinico	clinico	NOUN
dpc-3486	198	10	-	-	PUNCT
dpc-3486	198	11	laboratory	laboratory	NOUN
dpc-3486	198	12	study	study	NOUN
dpc-3486	198	13	.	.	PUNCT
dpc-3486	199	1	j	j	PROPN
dpc-3486	199	2	am	be	AUX
dpc-3486	199	3	acad	acad	ADJ
dpc-3486	199	4	dermatol	dermatol	NOUN
dpc-3486	199	5	.	.	PUNCT
dpc-3486	200	1	2012;67(6):1282	2012;67(6):1282	PROPN
dpc-3486	200	2	-	-	PUNCT
dpc-3486	200	3	1288	1288	NUM
dpc-3486	200	4	.	.	PUNCT
dpc-3486	201	1	doi	doi	NOUN
dpc-3486	201	2	:	:	PUNCT
dpc-3486	201	3	10.1016	10.1016	NUM
dpc-3486	201	4	/	/	SYM
dpc-3486	201	5	j	j	PROPN
dpc-3486	201	6	.jaad.2012.04.014	.jaad.2012.04.014	PUNCT
dpc-3486	201	7	.	.	PUNCT
dpc-3486	202	1	pmid	pmid	NOUN
dpc-3486	202	2	:	:	PUNCT
dpc-3486	202	3	22627037	22627037	NUM
dpc-3486	202	4	.	.	PUNCT
dpc-3486	203	1	12	12	NUM
dpc-3486	203	2	.	.	PUNCT
dpc-3486	204	1	egido	egido	PROPN
dpc-3486	204	2	-	-	PUNCT
dpc-3486	204	3	moreno	moreno	PROPN
dpc-3486	204	4	s	s	PROPN
dpc-3486	204	5	,	,	PUNCT
dpc-3486	204	6	valls	valls	PROPN
dpc-3486	204	7	-	-	PUNCT
dpc-3486	204	8	roca	roca	PROPN
dpc-3486	204	9	-	-	PUNCT
dpc-3486	204	10	umbert	umbert	PROPN
dpc-3486	204	11	j	j	PROPN
dpc-3486	204	12	,	,	PUNCT
dpc-3486	204	13	jané	jané	PROPN
dpc-3486	204	14	-	-	PUNCT
dpc-3486	204	15	salas	salas	PROPN
dpc-3486	204	16	e	e	PROPN
dpc-3486	204	17	,	,	PUNCT
dpc-3486	204	18	lópez	lópez	NOUN
dpc-3486	204	19	-	-	PUNCT
dpc-3486	204	20	lópez	lópez	PROPN
dpc-3486	204	21	 	 	SPACE
dpc-3486	204	22	j	j	PROPN
dpc-3486	204	23	,	,	PUNCT
dpc-3486	204	24	estrugo	estrugo	PROPN
dpc-3486	204	25	-	-	PUNCT
dpc-3486	204	26	devesa	devesa	PROPN
dpc-3486	204	27	a.	a.	NOUN
dpc-3486	204	28	covid-19	covid-19	PROPN
dpc-3486	204	29	and	and	CCONJ
dpc-3486	204	30	oral	oral	ADJ
dpc-3486	204	31	lesions	lesion	NOUN
dpc-3486	204	32	,	,	PUNCT
dpc-3486	204	33	short	short	ADJ
dpc-3486	204	34	communication	communication	NOUN
dpc-3486	204	35	and	and	CCONJ
dpc-3486	204	36	review	review	NOUN
dpc-3486	204	37	.	.	PUNCT
dpc-3486	205	1	j	j	PROPN
dpc-3486	205	2	clin	clin	PROPN
dpc-3486	205	3	exp	exp	PROPN
dpc-3486	205	4	dent	dent	NOUN
dpc-3486	205	5	.	.	PUNCT
dpc-3486	206	1	2021;13(3):e287	2021;13(3):e287	NUM
dpc-3486	206	2	-	-	PUNCT
dpc-3486	206	3	e294	e294	PROPN
dpc-3486	206	4	.	.	PUNCT
dpc-3486	206	5	doi	doi	NOUN
dpc-3486	206	6	:	:	PUNCT
dpc-3486	206	7	10.4317	10.4317	NUM
dpc-3486	206	8	/	/	SYM
dpc-3486	206	9	jced.57981	jced.57981	PROPN
dpc-3486	206	10	.	.	PUNCT
dpc-3486	207	1	pmid	pmid	NOUN
dpc-3486	207	2	:	:	PUNCT
dpc-3486	207	3	33680331	33680331	NUM
dpc-3486	207	4	.	.	PUNCT
dpc-3486	208	1	pmcid	pmcid	ADJ
dpc-3486	208	2	:	:	PUNCT
dpc-3486	208	3	pmc7920556	pmc7920556	ADJ
dpc-3486	208	4	.	.	PUNCT
dpc-3486	209	1	13	13	NUM
dpc-3486	209	2	.	.	X
dpc-3486	209	3	tuter	tuter	NOUN
dpc-3486	209	4	g	g	PROPN
dpc-3486	209	5	,	,	PUNCT
dpc-3486	209	6	yerebakan	yerebakan	PROPN
dpc-3486	209	7	m	m	PROPN
dpc-3486	209	8	,	,	PUNCT
dpc-3486	209	9	celik	celik	VERB
dpc-3486	209	10	b	b	NUM
dpc-3486	209	11	,	,	PUNCT
dpc-3486	209	12	kara	kara	PROPN
dpc-3486	209	13	g.	g.	PROPN
dpc-3486	209	14	oral	oral	ADJ
dpc-3486	209	15	manifestations	manifestation	NOUN
dpc-3486	209	16	in	in	ADP
dpc-3486	209	17	sars	sar	NOUN
dpc-3486	209	18	-	-	PUNCT
dpc-3486	209	19	cov-2	cov-2	PART
dpc-3486	209	20	infection	infection	NOUN
dpc-3486	209	21	.	.	PUNCT
dpc-3486	210	1	med	med	ADJ
dpc-3486	210	2	oral	oral	ADJ
dpc-3486	210	3	patol	patol	NOUN
dpc-3486	210	4	oral	oral	ADJ
dpc-3486	210	5	cir	cir	NOUN
dpc-3486	210	6	bucal	bucal	NOUN
dpc-3486	210	7	.	.	PUNCT
dpc-3486	211	1	2022;27(4):e330	2022;27(4):e330	NOUN
dpc-3486	211	2	-	-	PUNCT
dpc-3486	211	3	e339	e339	PROPN
dpc-3486	211	4	.	.	PUNCT
dpc-3486	211	5	doi	doi	NOUN
dpc-3486	211	6	:	:	PUNCT
dpc-3486	211	7	10.4317	10.4317	NUM
dpc-3486	211	8	/	/	SYM
dpc-3486	211	9	medoral.25259	medoral.25259	PROPN
dpc-3486	211	10	.	.	PUNCT
dpc-3486	211	11	pmid	pmid	NOUN
dpc-3486	211	12	:	:	PUNCT
dpc-3486	211	13	35717616	35717616	NUM
dpc-3486	211	14	.	.	PUNCT
dpc-3486	212	1	pmcid	pmcid	NOUN
dpc-3486	212	2	:	:	PUNCT
dpc-3486	212	3	pmc9271340	pmc9271340	NOUN
dpc-3486	212	4	.	.	PUNCT
dpc-3486	213	1	14	14	NUM
dpc-3486	213	2	.	.	PUNCT
dpc-3486	214	1	doceda	doceda	PROPN
dpc-3486	214	2	mv	mv	PROPN
dpc-3486	214	3	,	,	PUNCT
dpc-3486	214	4	gavriiloglou	gavriiloglou	PROPN
dpc-3486	214	5	m	m	PROPN
dpc-3486	214	6	,	,	PUNCT
dpc-3486	214	7	petit	petit	PROPN
dpc-3486	214	8	c	c	PROPN
dpc-3486	214	9	,	,	PUNCT
dpc-3486	214	10	huck	huck	PROPN
dpc-3486	214	11	o.	o.	PROPN
dpc-3486	214	12	oral	oral	ADJ
dpc-3486	214	13	health	health	NOUN
dpc-3486	214	14	implications	implication	NOUN
dpc-3486	214	15	of	of	ADP
dpc-3486	214	16	sars	sar	NOUN
dpc-3486	214	17	-	-	PUNCT
dpc-3486	214	18	cov-2	cov-2	NOUN
dpc-3486	214	19	/	/	SYM
dpc-3486	214	20	covid-19	covid-19	PROPN
dpc-3486	214	21	:	:	PUNCT
dpc-3486	214	22	a	a	DET
dpc-3486	214	23	systematic	systematic	ADJ
dpc-3486	214	24	review	review	NOUN
dpc-3486	214	25	.	.	PUNCT
dpc-3486	215	1	oral	oral	ADJ
dpc-3486	215	2	health	health	PROPN
dpc-3486	215	3	prev	prev	PROPN
dpc-3486	215	4	dent	dent	NOUN
dpc-3486	215	5	.	.	PUNCT
dpc-3486	216	1	2022;20(1):207	2022;20(1):207	NOUN
dpc-3486	216	2	-	-	SYM
dpc-3486	216	3	218	218	NUM
dpc-3486	216	4	.	.	PUNCT
dpc-3486	217	1	doi	doi	NOUN
dpc-3486	217	2	:	:	PUNCT
dpc-3486	217	3	10.3290	10.3290	NUM
dpc-3486	217	4	/	/	SYM
dpc-3486	217	5	j	j	PROPN
dpc-3486	217	6	.ohpd.b2960801	.ohpd.b2960801	PROPN
dpc-3486	217	7	.	.	PUNCT
dpc-3486	218	1	pmid	pmid	NOUN
dpc-3486	218	2	:	:	PUNCT
dpc-3486	218	3	35481345	35481345	NUM
dpc-3486	218	4	.	.	PUNCT
dpc-3486	219	1	15	15	NUM
dpc-3486	219	2	.	.	X
dpc-3486	219	3	reis	reis	NOUN
dpc-3486	219	4	vp	vp	PROPN
dpc-3486	219	5	,	,	PUNCT
dpc-3486	219	6	bezerra	bezerra	PROPN
dpc-3486	219	7	ar	ar	PROPN
dpc-3486	219	8	,	,	PUNCT
dpc-3486	219	9	maia	maia	PROPN
dpc-3486	219	10	abp	abp	PROPN
dpc-3486	219	11	,	,	PUNCT
dpc-3486	219	12	marques	marques	PROPN
dpc-3486	219	13	lc	lc	PROPN
dpc-3486	219	14	,	,	PUNCT
dpc-3486	219	15	conde	conde	PROPN
dpc-3486	219	16	dc	dc	PROPN
dpc-3486	219	17	.	.	PUNCT
dpc-3486	220	1	an	an	DET
dpc-3486	220	2	integrative	integrative	ADJ
dpc-3486	220	3	review	review	NOUN
dpc-3486	220	4	of	of	ADP
dpc-3486	220	5	oral	oral	ADJ
dpc-3486	220	6	manifestations	manifestation	NOUN
dpc-3486	220	7	in	in	ADP
dpc-3486	220	8	patients	patient	NOUN
dpc-3486	220	9	with	with	ADP
dpc-3486	220	10	covid-19	covid-19	PROPN
dpc-3486	220	11	:	:	PUNCT
dpc-3486	220	12	signs	sign	NOUN
dpc-3486	220	13	directly	directly	ADV
dpc-3486	220	14	related	relate	VERB
dpc-3486	220	15	to	to	ADP
dpc-3486	220	16	sars	sar	NOUN
dpc-3486	220	17	-	-	PUNCT
dpc-3486	220	18	cov-2	cov-2	PART
dpc-3486	220	19	infection	infection	NOUN
dpc-3486	220	20	or	or	CCONJ
dpc-3486	220	21	secondary	secondary	ADJ
dpc-3486	220	22	findings	finding	NOUN
dpc-3486	220	23	?	?	PUNCT
dpc-3486	221	1	int	int	NOUN
dpc-3486	221	2	j	j	PROPN
dpc-3486	221	3	dermatol	dermatol	NOUN
dpc-3486	221	4	.	.	PUNCT
dpc-3486	222	1	2022;61(3):278	2022;61(3):278	NUM
dpc-3486	222	2	-	-	SYM
dpc-3486	222	3	290	290	NUM
dpc-3486	222	4	.	.	PUNCT
dpc-3486	223	1	doi	doi	NOUN
dpc-3486	223	2	:	:	PUNCT
dpc-3486	223	3	10.1111	10.1111	NUM
dpc-3486	223	4	/	/	SYM
dpc-3486	223	5	ijd.15881	ijd.15881	PROPN
dpc-3486	223	6	.	.	PUNCT
dpc-3486	224	1	pmid	pmid	NOUN
dpc-3486	224	2	:	:	PUNCT
dpc-3486	224	3	34541674	34541674	NUM
dpc-3486	224	4	.	.	PUNCT
dpc-3486	225	1	pmcid	pmcid	NOUN
dpc-3486	225	2	:	:	PUNCT
dpc-3486	225	3	pmc8653326	pmc8653326	VERB
dpc-3486	225	4	.	.	PUNCT
dpc-3486	226	1	16	16	NUM
dpc-3486	226	2	.	.	PUNCT
dpc-3486	227	1	nuno	nuno	PROPN
dpc-3486	227	2	-	-	PUNCT
dpc-3486	227	3	gonzalez	gonzalez	PROPN
dpc-3486	227	4	a	a	PRON
dpc-3486	227	5	,	,	PUNCT
dpc-3486	227	6	martin	martin	PROPN
dpc-3486	227	7	-	-	PUNCT
dpc-3486	227	8	carrillo	carrillo	PROPN
dpc-3486	227	9	p	p	NOUN
dpc-3486	227	10	,	,	PUNCT
dpc-3486	227	11	magaletsky	magaletsky	PROPN
dpc-3486	227	12	k	k	PROPN
dpc-3486	227	13	,	,	PUNCT
dpc-3486	227	14	et	et	PROPN
dpc-3486	227	15	al	al	PROPN
dpc-3486	227	16	.	.	PUNCT
dpc-3486	228	1	prevalence	prevalence	NOUN
dpc-3486	228	2	of	of	ADP
dpc-3486	228	3	mucocutaneous	mucocutaneous	ADJ
dpc-3486	228	4	manifestations	manifestation	NOUN
dpc-3486	228	5	in	in	ADP
dpc-3486	228	6	666	666	NUM
dpc-3486	228	7	patients	patient	NOUN
dpc-3486	228	8	with	with	ADP
dpc-3486	228	9	covid-19	covid-19	PROPN
dpc-3486	228	10	in	in	ADP
dpc-3486	228	11	a	a	DET
dpc-3486	228	12	field	field	NOUN
dpc-3486	228	13	hospital	hospital	NOUN
dpc-3486	228	14	in	in	ADP
dpc-3486	228	15	spain	spain	PROPN
dpc-3486	228	16	:	:	PUNCT
dpc-3486	228	17	oral	oral	ADJ
dpc-3486	228	18	and	and	CCONJ
dpc-3486	228	19	palmoplantar	palmoplantar	NOUN
dpc-3486	228	20	findings	finding	NOUN
dpc-3486	228	21	.	.	PUNCT
dpc-3486	229	1	br	br	PROPN
dpc-3486	229	2	j	j	PROPN
dpc-3486	229	3	dermatol	dermatol	NOUN
dpc-3486	229	4	.	.	PUNCT
dpc-3486	230	1	2021;184(1):184	2021;184(1):184	NUM
dpc-3486	230	2	-	-	SYM
dpc-3486	230	3	185	185	NUM
dpc-3486	230	4	.	.	PUNCT
dpc-3486	231	1	doi	doi	NOUN
dpc-3486	231	2	:	:	PUNCT
dpc-3486	231	3	10.1111	10.1111	NUM
dpc-3486	231	4	/bjd.19564	/bjd.19564	NOUN
dpc-3486	231	5	.	.	PUNCT
dpc-3486	232	1	pmid	pmid	NOUN
dpc-3486	232	2	:	:	PUNCT
dpc-3486	232	3	32969503	32969503	NUM
dpc-3486	232	4	.	.	PUNCT
dpc-3486	233	1	pmcid	pmcid	NOUN
dpc-3486	233	2	:	:	PUNCT
dpc-3486	233	3	pmc7537506	pmc7537506	NOUN
dpc-3486	233	4	.	.	PUNCT
dpc-3486	234	1	17	17	NUM
dpc-3486	234	2	.	.	PUNCT
dpc-3486	235	1	aghazadeh	aghazadeh	PROPN
dpc-3486	235	2	n	n	PROPN
dpc-3486	235	3	,	,	PUNCT
dpc-3486	235	4	homayouni	homayouni	PROPN
dpc-3486	235	5	m	m	PROPN
dpc-3486	235	6	,	,	PUNCT
dpc-3486	235	7	sartori	sartori	NOUN
dpc-3486	235	8	-	-	PUNCT
dpc-3486	235	9	valinotti	valinotti	PROPN
dpc-3486	235	10	jc	jc	PROPN
dpc-3486	235	11	.	.	PROPN
dpc-3486	235	12	oral	oral	ADJ
dpc-3486	235	13	vesicles	vesicle	NOUN
dpc-3486	235	14	and	and	CCONJ
dpc-3486	235	15	acral	acral	ADJ
dpc-3486	235	16	erythema	erythema	NOUN
dpc-3486	235	17	:	:	PUNCT
dpc-3486	235	18	report	report	NOUN
dpc-3486	235	19	of	of	ADP
dpc-3486	235	20	a	a	DET
dpc-3486	235	21	cutaneous	cutaneous	ADJ
dpc-3486	235	22	manifestation	manifestation	NOUN
dpc-3486	235	23	of	of	ADP
dpc-3486	235	24	covid-19	covid-19	PROPN
dpc-3486	235	25	.	.	PUNCT
dpc-3486	236	1	int	int	PROPN
dpc-3486	236	2	j	j	PROPN
dpc-3486	236	3	dermatol	dermatol	NOUN
dpc-3486	236	4	.	.	PUNCT
dpc-3486	237	1	2020;59(9):1153	2020;59(9):1153	NUM
dpc-3486	237	2	-	-	SYM
dpc-3486	237	3	1154	1154	NUM
dpc-3486	237	4	.	.	PUNCT
dpc-3486	238	1	doi	doi	NOUN
dpc-3486	238	2	:	:	PUNCT
dpc-3486	238	3	10.1111	10.1111	NUM
dpc-3486	238	4	/	/	SYM
dpc-3486	238	5	ijd.15047	ijd.15047	NOUN
dpc-3486	238	6	.	.	PUNCT
dpc-3486	239	1	pmid	pmid	NOUN
dpc-3486	239	2	:	:	PUNCT
dpc-3486	239	3	32710552	32710552	NUM
dpc-3486	239	4	.	.	PUNCT
dpc-3486	240	1	18	18	NUM
dpc-3486	240	2	.	.	PUNCT
dpc-3486	240	3	cebeci	cebeci	PROPN
dpc-3486	240	4	kahraman	kahraman	PROPN
dpc-3486	240	5	f	f	PROPN
dpc-3486	240	6	,	,	PUNCT
dpc-3486	240	7	çaşkurlu	çaşkurlu	PROPN
dpc-3486	240	8	h.	h.	PROPN
dpc-3486	240	9	mucosal	mucosal	NOUN
dpc-3486	240	10	involvement	involvement	NOUN
dpc-3486	240	11	in	in	ADP
dpc-3486	240	12	a	a	DET
dpc-3486	240	13	covid-19	covid-19	PROPN
dpc-3486	240	14	-	-	PUNCT
dpc-3486	240	15	positive	positive	ADJ
dpc-3486	240	16	patient	patient	NOUN
dpc-3486	240	17	:	:	PUNCT
dpc-3486	240	18	a	a	DET
dpc-3486	240	19	case	case	NOUN
dpc-3486	240	20	report	report	NOUN
dpc-3486	240	21	.	.	PUNCT
dpc-3486	241	1	dermatol	dermatol	NOUN
dpc-3486	241	2	ther	ther	ADV
dpc-3486	241	3	.	.	PUNCT
dpc-3486	242	1	2020;33(4):e13797	2020;33(4):e13797	NUM
dpc-3486	242	2	.	.	PUNCT
dpc-3486	242	3	doi	doi	PROPN
dpc-3486	242	4	:	:	PUNCT
dpc-3486	242	5	10.1111	10.1111	NUM
dpc-3486	242	6	/	/	SYM
dpc-3486	242	7	dth.13797	dth.13797	NOUN
dpc-3486	242	8	.	.	PUNCT
dpc-3486	243	1	pmid	pmid	NOUN
dpc-3486	243	2	:	:	PUNCT
dpc-3486	243	3	32520428	32520428	NUM
dpc-3486	243	4	.	.	PUNCT
dpc-3486	244	1	pmcid	pmcid	NOUN
dpc-3486	244	2	:	:	PUNCT
dpc-3486	244	3	pmc7300528	pmc7300528	NOUN
dpc-3486	244	4	.	.	PUNCT
dpc-3486	245	1	19	19	NUM
dpc-3486	245	2	.	.	PUNCT
dpc-3486	246	1	kitakawa	kitakawa	PROPN
dpc-3486	246	2	d	d	PROPN
dpc-3486	246	3	,	,	PUNCT
dpc-3486	246	4	oliveira	oliveira	PROPN
dpc-3486	246	5	fe	fe	PROPN
dpc-3486	246	6	,	,	PUNCT
dpc-3486	246	7	neves	neves	PROPN
dpc-3486	246	8	de	de	PROPN
dpc-3486	246	9	castro	castro	PROPN
dpc-3486	246	10	p	p	PRON
dpc-3486	246	11	,	,	PUNCT
dpc-3486	246	12	carvalho	carvalho	PROPN
dpc-3486	246	13	lfcs	lfcs	PROPN
dpc-3486	246	14	.	.	PUNCT
dpc-3486	247	1	short	short	ADJ
dpc-3486	247	2	report	report	NOUN
dpc-3486	247	3	herpes	herpe	NOUN
dpc-3486	247	4	simplex	simplex	NOUN
dpc-3486	247	5	lesion	lesion	NOUN
dpc-3486	247	6	in	in	ADP
dpc-3486	247	7	the	the	DET
dpc-3486	247	8	lip	lip	NOUN
dpc-3486	247	9	semimucosa	semimucosa	NOUN
dpc-3486	247	10	in	in	ADP
dpc-3486	247	11	a	a	DET
dpc-3486	247	12	covid-19	covid-19	PROPN
dpc-3486	247	13	patient	patient	NOUN
dpc-3486	247	14	.	.	PUNCT
dpc-3486	248	1	eur	eur	PROPN
dpc-3486	248	2	rev	rev	PROPN
dpc-3486	248	3	med	med	PROPN
dpc-3486	248	4	pharmacol	pharmacol	PROPN
dpc-3486	248	5	sci	sci	PROPN
dpc-3486	248	6	.	.	PUNCT
dpc-3486	248	7	positivity	positivity	PROPN
dpc-3486	248	8	according	accord	VERB
dpc-3486	248	9	to	to	ADP
dpc-3486	248	10	our	our	PRON
dpc-3486	248	11	study	study	NOUN
dpc-3486	248	12	could	could	AUX
dpc-3486	248	13	suggest	suggest	VERB
dpc-3486	248	14	the	the	DET
dpc-3486	248	15	direct	direct	ADJ
dpc-3486	248	16	effect	effect	NOUN
dpc-3486	248	17	of	of	ADP
dpc-3486	248	18	sars	sar	NOUN
dpc-3486	248	19	-	-	PUNCT
dpc-3486	248	20	cov-2	cov-2	NOUN
dpc-3486	248	21	.	.	PUNCT
dpc-3486	249	1	however	however	ADV
dpc-3486	249	2	,	,	PUNCT
dpc-3486	249	3	dry	dry	ADJ
dpc-3486	249	4	mouth	mouth	NOUN
dpc-3486	249	5	probably	probably	ADV
dpc-3486	249	6	occurs	occur	VERB
dpc-3486	249	7	secondary	secondary	ADJ
dpc-3486	249	8	to	to	ADP
dpc-3486	249	9	involvement	involvement	NOUN
dpc-3486	249	10	of	of	ADP
dpc-3486	249	11	the	the	DET
dpc-3486	249	12	salivary	salivary	ADJ
dpc-3486	249	13	glands	gland	NOUN
dpc-3486	249	14	and	and	CCONJ
dpc-3486	249	15	herpes	herpe	NOUN
dpc-3486	249	16	infections	infection	NOUN
dpc-3486	249	17	may	may	AUX
dpc-3486	249	18	be	be	AUX
dpc-3486	249	19	an	an	DET
dpc-3486	249	20	opportunistic	opportunistic	ADJ
dpc-3486	249	21	coinfection	coinfection	NOUN
dpc-3486	249	22	.	.	PUNCT
dpc-3486	250	1	nevertheless	nevertheless	ADV
dpc-3486	250	2	,	,	PUNCT
dpc-3486	250	3	as	as	SCONJ
dpc-3486	250	4	these	these	DET
dpc-3486	250	5	lesions	lesion	NOUN
dpc-3486	250	6	were	be	AUX
dpc-3486	250	7	associated	associate	VERB
dpc-3486	250	8	with	with	ADP
dpc-3486	250	9	pcr	pcr	NOUN
dpc-3486	250	10	positivity	positivity	NOUN
dpc-3486	250	11	,	,	PUNCT
dpc-3486	250	12	the	the	DET
dpc-3486	250	13	presence	presence	NOUN
dpc-3486	250	14	of	of	ADP
dpc-3486	250	15	these	these	DET
dpc-3486	250	16	findings	finding	NOUN
dpc-3486	250	17	may	may	AUX
dpc-3486	250	18	indicate	indicate	VERB
dpc-3486	250	19	the	the	DET
dpc-3486	250	20	presence	presence	NOUN
dpc-3486	250	21	of	of	ADP
dpc-3486	250	22	the	the	DET
dpc-3486	250	23	virus	virus	NOUN
dpc-3486	250	24	in	in	ADP
dpc-3486	250	25	the	the	DET
dpc-3486	250	26	tonsillar	tonsillar	ADJ
dpc-3486	250	27	-	-	PUNCT
dpc-3486	250	28	pharynx	pharynx	NOUN
dpc-3486	250	29	.	.	PUNCT
dpc-3486	251	1	some	some	DET
dpc-3486	251	2	studies	study	NOUN
dpc-3486	251	3	have	have	AUX
dpc-3486	251	4	suggested	suggest	VERB
dpc-3486	251	5	that	that	SCONJ
dpc-3486	251	6	some	some	DET
dpc-3486	251	7	manifestations	manifestation	NOUN
dpc-3486	251	8	such	such	ADJ
dpc-3486	251	9	as	as	ADP
dpc-3486	251	10	herpes	herpe	NOUN
dpc-3486	251	11	infections	infection	NOUN
dpc-3486	251	12	and	and	CCONJ
dpc-3486	251	13	angular	angular	ADJ
dpc-3486	251	14	cheilitis	cheilitis	NOUN
dpc-3486	251	15	are	be	AUX
dpc-3486	251	16	opportunistic	opportunistic	ADJ
dpc-3486	251	17	coinfection	coinfection	NOUN
dpc-3486	251	18	[	[	X
dpc-3486	251	19	26,27	26,27	NUM
dpc-3486	251	20	]	]	PUNCT
dpc-3486	251	21	.	.	PUNCT
dpc-3486	252	1	in	in	ADP
dpc-3486	252	2	the	the	DET
dpc-3486	252	3	present	present	ADJ
dpc-3486	252	4	study	study	NOUN
dpc-3486	252	5	,	,	PUNCT
dpc-3486	252	6	angular	angular	ADJ
dpc-3486	252	7	cheilitis	cheilitis	NOUN
dpc-3486	252	8	was	be	AUX
dpc-3486	252	9	more	more	ADV
dpc-3486	252	10	frequent	frequent	ADJ
dpc-3486	252	11	in	in	ADP
dpc-3486	252	12	patients	patient	NOUN
dpc-3486	252	13	with	with	ADP
dpc-3486	252	14	pneumonia	pneumonia	NOUN
dpc-3486	252	15	,	,	PUNCT
dpc-3486	252	16	suggesting	suggest	VERB
dpc-3486	252	17	opportunistic	opportunistic	ADJ
dpc-3486	252	18	coinfection	coinfection	NOUN
dpc-3486	252	19	.	.	PUNCT
dpc-3486	253	1	this	this	DET
dpc-3486	253	2	study	study	NOUN
dpc-3486	253	3	has	have	VERB
dpc-3486	253	4	some	some	DET
dpc-3486	253	5	limitations	limitation	NOUN
dpc-3486	253	6	.	.	PUNCT
dpc-3486	254	1	firstly	firstly	ADV
dpc-3486	254	2	,	,	PUNCT
dpc-3486	254	3	we	we	PRON
dpc-3486	254	4	only	only	ADV
dpc-3486	254	5	included	include	VERB
dpc-3486	254	6	symptomatic	symptomatic	ADJ
dpc-3486	254	7	patients	patient	NOUN
dpc-3486	254	8	with	with	ADP
dpc-3486	254	9	mild	mild	ADJ
dpc-3486	254	10	-	-	PUNCT
dpc-3486	254	11	to	to	ADP
dpc-3486	254	12	-	-	PUNCT
dpc-3486	254	13	moderate	moderate	ADJ
dpc-3486	254	14	disease	disease	NOUN
dpc-3486	254	15	in	in	ADP
dpc-3486	254	16	the	the	DET
dpc-3486	254	17	study	study	NOUN
dpc-3486	254	18	.	.	PUNCT
dpc-3486	255	1	thus	thus	ADV
dpc-3486	255	2	,	,	PUNCT
dpc-3486	255	3	our	our	PRON
dpc-3486	255	4	data	datum	NOUN
dpc-3486	255	5	can	can	AUX
dpc-3486	255	6	not	not	PART
dpc-3486	255	7	support	support	VERB
dpc-3486	255	8	oral	oral	ADJ
dpc-3486	255	9	lesions	lesion	NOUN
dpc-3486	255	10	in	in	ADP
dpc-3486	255	11	asymptomatic	asymptomatic	ADJ
dpc-3486	255	12	patients	patient	NOUN
dpc-3486	255	13	or	or	CCONJ
dpc-3486	255	14	with	with	ADP
dpc-3486	255	15	severe	severe	ADJ
dpc-3486	255	16	covid-19	covid-19	PROPN
dpc-3486	255	17	.	.	PUNCT
dpc-3486	256	1	secondly	secondly	ADV
dpc-3486	256	2	,	,	PUNCT
dpc-3486	256	3	as	as	SCONJ
dpc-3486	256	4	all	all	DET
dpc-3486	256	5	patients	patient	NOUN
dpc-3486	256	6	were	be	AUX
dpc-3486	256	7	adults	adult	NOUN
dpc-3486	256	8	,	,	PUNCT
dpc-3486	256	9	the	the	DET
dpc-3486	256	10	study	study	NOUN
dpc-3486	256	11	does	do	AUX
dpc-3486	256	12	not	not	PART
dpc-3486	256	13	provide	provide	VERB
dpc-3486	256	14	information	information	NOUN
dpc-3486	256	15	on	on	ADP
dpc-3486	256	16	the	the	DET
dpc-3486	256	17	relationship	relationship	NOUN
dpc-3486	256	18	between	between	ADP
dpc-3486	256	19	oral	oral	ADJ
dpc-3486	256	20	findings	finding	NOUN
dpc-3486	256	21	and	and	CCONJ
dpc-3486	256	22	pcr	pcr	ADJ
dpc-3486	256	23	positivity	positivity	NOUN
dpc-3486	256	24	in	in	ADP
dpc-3486	256	25	children	child	NOUN
dpc-3486	256	26	.	.	PUNCT
dpc-3486	257	1	oral	oral	ADJ
dpc-3486	257	2	aphthae	aphthae	NOUN
dpc-3486	257	3	and	and	CCONJ
dpc-3486	257	4	herpes	herpe	NOUN
dpc-3486	257	5	lesions	lesion	NOUN
dpc-3486	257	6	on	on	ADP
dpc-3486	257	7	the	the	DET
dpc-3486	257	8	entire	entire	ADJ
dpc-3486	257	9	oral	oral	ADJ
dpc-3486	257	10	mucosa	mucosa	NOUN
dpc-3486	257	11	were	be	AUX
dpc-3486	257	12	evaluated	evaluate	VERB
dpc-3486	257	13	.	.	PUNCT
dpc-3486	258	1	thus	thus	ADV
dpc-3486	258	2	,	,	PUNCT
dpc-3486	258	3	direct	direct	ADJ
dpc-3486	258	4	virus	virus	NOUN
dpc-3486	258	5	infection	infection	NOUN
dpc-3486	258	6	on	on	ADP
dpc-3486	258	7	the	the	DET
dpc-3486	258	8	tonsillar	tonsillar	ADJ
dpc-3486	258	9	pharynx	pharynx	NOUN
dpc-3486	258	10	could	could	AUX
dpc-3486	258	11	not	not	PART
dpc-3486	258	12	be	be	AUX
dpc-3486	258	13	differentiated	differentiate	VERB
dpc-3486	258	14	.	.	PUNCT
dpc-3486	259	1	another	another	DET
dpc-3486	259	2	limitation	limitation	NOUN
dpc-3486	259	3	was	be	AUX
dpc-3486	259	4	that	that	DET
dpc-3486	259	5	oral	oral	ADJ
dpc-3486	259	6	examination	examination	NOUN
dpc-3486	259	7	of	of	ADP
dpc-3486	259	8	patients	patient	NOUN
dpc-3486	259	9	and	and	CCONJ
dpc-3486	259	10	clinical	clinical	ADJ
dpc-3486	259	11	imaging	imaging	NOUN
dpc-3486	259	12	of	of	ADP
dpc-3486	259	13	lesions	lesion	NOUN
dpc-3486	259	14	were	be	AUX
dpc-3486	259	15	difficult	difficult	ADJ
dpc-3486	259	16	due	due	ADP
dpc-3486	259	17	to	to	ADP
dpc-3486	259	18	the	the	DET
dpc-3486	259	19	high	high	ADJ
dpc-3486	259	20	risk	risk	NOUN
dpc-3486	259	21	of	of	ADP
dpc-3486	259	22	contamination	contamination	NOUN
dpc-3486	259	23	at	at	ADP
dpc-3486	259	24	the	the	DET
dpc-3486	259	25	beginning	beginning	NOUN
dpc-3486	259	26	of	of	ADP
dpc-3486	259	27	the	the	DET
dpc-3486	259	28	pandemic	pandemic	NOUN
dpc-3486	259	29	.	.	PUNCT
dpc-3486	260	1	nonetheless	nonetheless	ADV
dpc-3486	260	2	,	,	PUNCT
dpc-3486	260	3	we	we	PRON
dpc-3486	260	4	made	make	VERB
dpc-3486	260	5	an	an	DET
dpc-3486	260	6	effort	effort	NOUN
dpc-3486	260	7	to	to	PART
dpc-3486	260	8	evaluate	evaluate	VERB
dpc-3486	260	9	patients	patient	NOUN
dpc-3486	260	10	correctly	correctly	ADV
dpc-3486	260	11	and	and	CCONJ
dpc-3486	260	12	our	our	PRON
dpc-3486	260	13	study	study	NOUN
dpc-3486	260	14	provides	provide	VERB
dpc-3486	260	15	valuable	valuable	ADJ
dpc-3486	260	16	observations	observation	NOUN
dpc-3486	260	17	of	of	ADP
dpc-3486	260	18	a	a	DET
dpc-3486	260	19	large	large	ADJ
dpc-3486	260	20	number	number	NOUN
dpc-3486	260	21	of	of	ADP
dpc-3486	260	22	cases	case	NOUN
dpc-3486	260	23	.	.	PUNCT
dpc-3486	261	1	our	our	PRON
dpc-3486	261	2	study	study	NOUN
dpc-3486	261	3	showed	show	VERB
dpc-3486	261	4	that	that	SCONJ
dpc-3486	261	5	especially	especially	ADV
dpc-3486	261	6	microvesicles	microvesicle	NOUN
dpc-3486	261	7	,	,	PUNCT
dpc-3486	261	8	petechiae	petechiae	NOUN
dpc-3486	261	9	,	,	PUNCT
dpc-3486	261	10	erythema	erythema	ADV
dpc-3486	261	11	on	on	ADP
dpc-3486	261	12	the	the	DET
dpc-3486	261	13	tonsils	tonsil	NOUN
dpc-3486	261	14	or	or	CCONJ
dpc-3486	261	15	pharynx	pharynx	NOUN
dpc-3486	261	16	,	,	PUNCT
dpc-3486	261	17	and	and	CCONJ
dpc-3486	261	18	some	some	DET
dpc-3486	261	19	other	other	ADJ
dpc-3486	261	20	oral	oral	ADJ
dpc-3486	261	21	lesions	lesion	NOUN
dpc-3486	261	22	such	such	ADJ
dpc-3486	261	23	as	as	ADP
dpc-3486	261	24	dry	dry	ADJ
dpc-3486	261	25	mouth	mouth	NOUN
dpc-3486	261	26	,	,	PUNCT
dpc-3486	261	27	oral	oral	ADJ
dpc-3486	261	28	aphthae	aphthae	NOUN
dpc-3486	261	29	,	,	PUNCT
dpc-3486	261	30	and	and	CCONJ
dpc-3486	261	31	primary/	primary/	NUM
dpc-3486	261	32	secondary	secondary	ADJ
dpc-3486	261	33	herpes	herpe	NOUN
dpc-3486	261	34	infection	infection	NOUN
dpc-3486	261	35	are	be	AUX
dpc-3486	261	36	associated	associate	VERB
dpc-3486	261	37	with	with	ADP
dpc-3486	261	38	pcr	pcr	NOUN
dpc-3486	261	39	positivity	positivity	NOUN
dpc-3486	261	40	and	and	CCONJ
dpc-3486	261	41	can	can	AUX
dpc-3486	261	42	guide	guide	VERB
dpc-3486	261	43	us	we	PRON
dpc-3486	261	44	in	in	ADP
dpc-3486	261	45	terms	term	NOUN
dpc-3486	261	46	of	of	ADP
dpc-3486	261	47	definite	definite	ADJ
dpc-3486	261	48	disease	disease	NOUN
dpc-3486	261	49	.	.	PUNCT
dpc-3486	262	1	however	however	ADV
dpc-3486	262	2	,	,	PUNCT
dpc-3486	262	3	the	the	DET
dpc-3486	262	4	pathophysiological	pathophysiological	ADJ
dpc-3486	262	5	mechanism	mechanism	NOUN
dpc-3486	262	6	and	and	CCONJ
dpc-3486	262	7	relationship	relationship	NOUN
dpc-3486	262	8	of	of	ADP
dpc-3486	262	9	these	these	DET
dpc-3486	262	10	oral	oral	ADJ
dpc-3486	262	11	manifestations	manifestation	NOUN
dpc-3486	262	12	in	in	ADP
dpc-3486	262	13	covid-19	covid-19	PROPN
dpc-3486	262	14	should	should	AUX
dpc-3486	262	15	be	be	AUX
dpc-3486	262	16	further	far	ADV
dpc-3486	262	17	investigated	investigate	VERB
dpc-3486	262	18	.	.	PUNCT
dpc-3486	263	1	references	reference	NOUN
dpc-3486	263	2	1	1	NUM
dpc-3486	263	3	.	.	PUNCT
dpc-3486	264	1	guo	guo	PROPN
dpc-3486	264	2	yr	yr	PROPN
dpc-3486	264	3	,	,	PUNCT
dpc-3486	264	4	cao	cao	PROPN
dpc-3486	264	5	qd	qd	PROPN
dpc-3486	264	6	,	,	PUNCT
dpc-3486	264	7	hong	hong	PROPN
dpc-3486	264	8	zs	zs	PROPN
dpc-3486	264	9	,	,	PUNCT
dpc-3486	264	10	tan	tan	PROPN
dpc-3486	264	11	yy	yy	PROPN
dpc-3486	264	12	,	,	PUNCT
dpc-3486	264	13	et	et	PROPN
dpc-3486	264	14	al	al	PROPN
dpc-3486	264	15	.	.	PUNCT
dpc-3486	265	1	the	the	DET
dpc-3486	265	2	origin	origin	NOUN
dpc-3486	265	3	,	,	PUNCT
dpc-3486	265	4	transmission	transmission	NOUN
dpc-3486	265	5	and	and	CCONJ
dpc-3486	265	6	clinical	clinical	ADJ
dpc-3486	265	7	therapies	therapy	NOUN
dpc-3486	265	8	on	on	ADP
dpc-3486	265	9	coronavirus	coronavirus	NOUN
dpc-3486	265	10	disease	disease	NOUN
dpc-3486	265	11	2019	2019	NUM
dpc-3486	265	12	(	(	PUNCT
dpc-3486	265	13	covid-19	covid-19	PROPN
dpc-3486	265	14	)	)	PUNCT
dpc-3486	265	15	outbreak	outbreak	NOUN
dpc-3486	265	16	an	an	DET
dpc-3486	265	17	update	update	NOUN
dpc-3486	265	18	on	on	ADP
dpc-3486	265	19	the	the	DET
dpc-3486	265	20	status	status	NOUN
dpc-3486	265	21	.	.	PUNCT
dpc-3486	266	1	mil	mil	PROPN
dpc-3486	266	2	med	med	PROPN
dpc-3486	266	3	res	re	NOUN
dpc-3486	266	4	.	.	PUNCT
dpc-3486	267	1	2020;7(1):11	2020;7(1):11	X
dpc-3486	267	2	.	.	PUNCT
dpc-3486	267	3	doi	doi	NOUN
dpc-3486	267	4	:	:	PUNCT
dpc-3486	267	5	10.1186	10.1186	NUM
dpc-3486	267	6	/	/	SYM
dpc-3486	267	7	s40779	s40779	PROPN
dpc-3486	267	8	-	-	PUNCT
dpc-3486	267	9	020	020	NUM
dpc-3486	267	10	-	-	PUNCT
dpc-3486	267	11	00240	00240	NUM
dpc-3486	267	12	-	-	PUNCT
dpc-3486	267	13	0	0	NUM
dpc-3486	267	14	.	.	PUNCT
dpc-3486	268	1	pmid	pmid	NOUN
dpc-3486	268	2	:	:	PUNCT
dpc-3486	268	3	32169119	32169119	NUM
dpc-3486	268	4	.	.	PUNCT
dpc-3486	269	1	pmcid	pmcid	ADJ
dpc-3486	269	2	:	:	PUNCT
dpc-3486	269	3	pmc7068984	pmc7068984	NOUN
dpc-3486	269	4	.	.	PUNCT
dpc-3486	270	1	2	2	X
dpc-3486	270	2	.	.	X
dpc-3486	270	3	guan	guan	PROPN
dpc-3486	270	4	wj	wj	PROPN
dpc-3486	270	5	,	,	PUNCT
dpc-3486	270	6	ni	ni	PROPN
dpc-3486	270	7	zy	zy	PROPN
dpc-3486	270	8	,	,	PUNCT
dpc-3486	270	9	hu	hu	PROPN
dpc-3486	270	10	y	y	PROPN
dpc-3486	270	11	,	,	PUNCT
dpc-3486	270	12	et	et	PROPN
dpc-3486	270	13	al	al	PROPN
dpc-3486	270	14	.	.	PROPN
dpc-3486	271	1	clinical	clinical	ADJ
dpc-3486	271	2	characteristics	characteristic	NOUN
dpc-3486	271	3	of	of	ADP
dpc-3486	271	4	coronavirus	coronavirus	NOUN
dpc-3486	271	5	disease	disease	NOUN
dpc-3486	271	6	2019	2019	NUM
dpc-3486	271	7	in	in	ADP
dpc-3486	271	8	china	china	PROPN
dpc-3486	271	9	.	.	PUNCT
dpc-3486	272	1	n	n	PROPN
dpc-3486	272	2	engl	engl	PROPN
dpc-3486	272	3	j	j	PROPN
dpc-3486	272	4	med	med	PROPN
dpc-3486	272	5	.	.	PUNCT
dpc-3486	273	1	2020;382(18):17081720	2020;382(18):17081720	X
dpc-3486	273	2	.	.	PUNCT
dpc-3486	274	1	doi	doi	NOUN
dpc-3486	274	2	:	:	PUNCT
dpc-3486	274	3	10.1056	10.1056	NUM
dpc-3486	274	4	/	/	SYM
dpc-3486	274	5	nejmoa2002032	nejmoa2002032	PROPN
dpc-3486	274	6	.	.	PUNCT
dpc-3486	275	1	pmid	pmid	NOUN
dpc-3486	275	2	:	:	PUNCT
dpc-3486	275	3	32109013	32109013	NUM
dpc-3486	275	4	.	.	PUNCT
dpc-3486	276	1	pmcid	pmcid	NOUN
dpc-3486	276	2	:	:	PUNCT
dpc-3486	276	3	pmc7092819	pmc7092819	ADJ
dpc-3486	276	4	.	.	PUNCT
dpc-3486	277	1	3	3	X
dpc-3486	277	2	.	.	X
dpc-3486	277	3	cireli	cireli	PROPN
dpc-3486	277	4	e	e	PROPN
dpc-3486	277	5	,	,	PUNCT
dpc-3486	277	6	mertoğlu	mertoğlu	VERB
dpc-3486	277	7	a	a	PRON
dpc-3486	277	8	,	,	PUNCT
dpc-3486	277	9	balcı	balcı	NOUN
dpc-3486	277	10	g	g	PROPN
dpc-3486	277	11	,	,	PUNCT
dpc-3486	277	12	bayram	bayram	PROPN
dpc-3486	277	13	a	a	PROPN
dpc-3486	277	14	,	,	PUNCT
dpc-3486	277	15	kuranoğlu	kuranoğlu	PROPN
dpc-3486	277	16	n	n	CCONJ
dpc-3486	277	17	,	,	PUNCT
dpc-3486	277	18	çırak	çırak	PROPN
dpc-3486	277	19	ak	ak	PROPN
dpc-3486	277	20	.	.	PROPN
dpc-3486	277	21	is	be	AUX
dpc-3486	277	22	polymerase	polymerase	NOUN
dpc-3486	277	23	chain	chain	NOUN
dpc-3486	277	24	reaction	reaction	NOUN
dpc-3486	277	25	positivity	positivity	NOUN
dpc-3486	277	26	more	more	ADV
dpc-3486	277	27	common	common	ADJ
dpc-3486	277	28	in	in	ADP
dpc-3486	277	29	patients	patient	NOUN
dpc-3486	277	30	with	with	ADP
dpc-3486	277	31	covid-19	covid-19	PROPN
dpc-3486	277	32	pneumonia	pneumonia	NOUN
dpc-3486	277	33	with	with	ADP
dpc-3486	277	34	fever	fever	NOUN
dpc-3486	277	35	?	?	PUNCT
dpc-3486	278	1	dubai	dubai	PROPN
dpc-3486	278	2	medical	medical	ADJ
dpc-3486	278	3	journal	journal	PROPN
dpc-3486	278	4	.	.	PUNCT
dpc-3486	279	1	2022:1–7	2022:1–7	X
dpc-3486	279	2	.	.	PUNCT
dpc-3486	279	3	doi	doi	NOUN
dpc-3486	279	4	:	:	PUNCT
dpc-3486	279	5	10.1159/000524218	10.1159/000524218	NUM
dpc-3486	279	6	.	.	PUNCT
dpc-3486	280	1	pmcid	pmcid	NOUN
dpc-3486	280	2	:	:	PUNCT
dpc-3486	280	3	pmc9148887	pmc9148887	ADJ
dpc-3486	280	4	.	.	PUNCT
dpc-3486	281	1	4	4	X
dpc-3486	281	2	.	.	X
dpc-3486	281	3	xu	xu	PROPN
dpc-3486	282	1	h	h	PROPN
dpc-3486	282	2	,	,	PUNCT
dpc-3486	282	3	zhong	zhong	PROPN
dpc-3486	282	4	l	l	PROPN
dpc-3486	282	5	,	,	PUNCT
dpc-3486	282	6	deng	deng	PROPN
dpc-3486	282	7	j	j	PROPN
dpc-3486	282	8	,	,	PUNCT
dpc-3486	282	9	peng	peng	PROPN
dpc-3486	282	10	j	j	PROPN
dpc-3486	282	11	,	,	PUNCT
dpc-3486	282	12	dan	dan	PROPN
dpc-3486	282	13	h	h	PROPN
dpc-3486	282	14	,	,	PUNCT
dpc-3486	282	15	zeng	zeng	PROPN
dpc-3486	282	16	x	x	PROPN
dpc-3486	282	17	,	,	PUNCT
dpc-3486	282	18	li	li	PROPN
dpc-3486	282	19	t	t	PROPN
dpc-3486	282	20	,	,	PUNCT
dpc-3486	282	21	chen	chen	PROPN
dpc-3486	282	22	q.	q.	PROPN
dpc-3486	282	23	high	high	ADJ
dpc-3486	282	24	expression	expression	NOUN
dpc-3486	282	25	of	of	ADP
dpc-3486	282	26	ace2	ace2	NOUN
dpc-3486	282	27	receptor	receptor	NOUN
dpc-3486	282	28	of	of	ADP
dpc-3486	282	29	2019	2019	NUM
dpc-3486	282	30	-	-	PUNCT
dpc-3486	282	31	ncov	ncov	ADV
dpc-3486	282	32	on	on	ADP
dpc-3486	282	33	the	the	DET
dpc-3486	282	34	epithelial	epithelial	ADJ
dpc-3486	282	35	cells	cell	NOUN
dpc-3486	282	36	of	of	ADP
dpc-3486	282	37	oral	oral	ADJ
dpc-3486	282	38	mucosa	mucosa	NOUN
dpc-3486	282	39	.	.	PUNCT
dpc-3486	283	1	int	int	PROPN
dpc-3486	283	2	j	j	PROPN
dpc-3486	283	3	oral	oral	PROPN
dpc-3486	283	4	sci	sci	PROPN
dpc-3486	283	5	.	.	PUNCT
dpc-3486	284	1	2020;12(1):8	2020;12(1):8	NUM
dpc-3486	284	2	.	.	PUNCT
dpc-3486	285	1	doi	doi	NOUN
dpc-3486	285	2	:	:	PUNCT
dpc-3486	285	3	10.1038	10.1038	NUM
dpc-3486	285	4	/s41368	/s41368	NOUN
dpc-3486	285	5	-	-	PUNCT
dpc-3486	285	6	020	020	NUM
dpc-3486	285	7	-	-	PUNCT
dpc-3486	285	8	0074	0074	NUM
dpc-3486	285	9	-	-	PUNCT
dpc-3486	285	10	x.	x.	NOUN
dpc-3486	285	11	pmid	pmid	PROPN
dpc-3486	285	12	:	:	PUNCT
dpc-3486	285	13	32094336	32094336	NUM
dpc-3486	285	14	.	.	PUNCT
dpc-3486	286	1	pmcid	pmcid	NOUN
dpc-3486	286	2	:	:	PUNCT
dpc-3486	286	3	pmc7039956	pmc7039956	NOUN
dpc-3486	286	4	.	.	PUNCT
dpc-3486	287	1	8	8	NUM
dpc-3486	287	2	original	original	ADJ
dpc-3486	287	3	article	article	NOUN
dpc-3486	287	4	|	|	ADV
dpc-3486	287	5	dermatol	dermatol	ADJ
dpc-3486	287	6	pract	pract	NOUN
dpc-3486	287	7	concept	concept	NOUN
dpc-3486	287	8	.	.	PUNCT
dpc-3486	288	1	2024;14(1):e2024045	2024;14(1):e2024045	NUM
dpc-3486	288	2	br	br	SYM
dpc-3486	288	3	 	 	SPACE
dpc-3486	288	4	j	j	PROPN
dpc-3486	288	5	dermatol	dermatol	NOUN
dpc-3486	288	6	.	.	PUNCT
dpc-3486	289	1	2021;184(1):e6	2021;184(1):e6	NUM
dpc-3486	289	2	.	.	PUNCT
dpc-3486	290	1	doi	doi	NOUN
dpc-3486	290	2	:	:	PUNCT
dpc-3486	290	3	10.1111	10.1111	NUM
dpc-3486	290	4	/	/	SYM
dpc-3486	290	5	bjd.19569	bjd.19569	NOUN
dpc-3486	290	6	.	.	PUNCT
dpc-3486	291	1	pmid	pmid	NOUN
dpc-3486	291	2	:	:	PUNCT
dpc-3486	291	3	33140407	33140407	NUM
dpc-3486	291	4	.	.	PUNCT
dpc-3486	292	1	pmcid	pmcid	NOUN
dpc-3486	292	2	:	:	PUNCT
dpc-3486	292	3	pmc9214009	pmc9214009	NOUN
dpc-3486	292	4	.	.	PUNCT
dpc-3486	293	1	24	24	NUM
dpc-3486	293	2	.	.	PUNCT
dpc-3486	293	3	brandini	brandini	PROPN
dpc-3486	293	4	da	da	PROPN
dpc-3486	293	5	,	,	PUNCT
dpc-3486	293	6	takamiya	takamiya	INTJ
dpc-3486	293	7	as	as	ADP
dpc-3486	293	8	,	,	PUNCT
dpc-3486	293	9	thakkar	thakkar	NOUN
dpc-3486	293	10	p	p	NOUN
dpc-3486	293	11	,	,	PUNCT
dpc-3486	293	12	schaller	schaller	NOUN
dpc-3486	293	13	s	s	PROPN
dpc-3486	293	14	,	,	PUNCT
dpc-3486	293	15	rahat	rahat	PROPN
dpc-3486	293	16	r	r	PROPN
dpc-3486	293	17	,	,	PUNCT
dpc-3486	293	18	naqvi	naqvi	PROPN
dpc-3486	293	19	ar	ar	PROPN
dpc-3486	293	20	.	.	PROPN
dpc-3486	294	1	covid-19	covid-19	PROPN
dpc-3486	294	2	and	and	CCONJ
dpc-3486	294	3	oral	oral	ADJ
dpc-3486	294	4	diseases	disease	NOUN
dpc-3486	294	5	:	:	PUNCT
dpc-3486	294	6	crosstalk	crosstalk	NOUN
dpc-3486	294	7	,	,	PUNCT
dpc-3486	294	8	synergy	synergy	NOUN
dpc-3486	294	9	or	or	CCONJ
dpc-3486	294	10	association	association	NOUN
dpc-3486	294	11	?	?	PUNCT
dpc-3486	295	1	rev	rev	PROPN
dpc-3486	295	2	med	med	PROPN
dpc-3486	295	3	virol	virol	NOUN
dpc-3486	295	4	.	.	PUNCT
dpc-3486	296	1	2021;31(6):e2226	2021;31(6):e2226	X
dpc-3486	296	2	.	.	PUNCT
dpc-3486	296	3	doi	doi	NOUN
dpc-3486	296	4	:	:	PUNCT
dpc-3486	296	5	10.1002	10.1002	NUM
dpc-3486	296	6	/rmv.2226	/rmv.2226	NOUN
dpc-3486	296	7	.	.	PUNCT
dpc-3486	297	1	pmid	pmid	NOUN
dpc-3486	297	2	:	:	PUNCT
dpc-3486	297	3	33646645	33646645	NUM
dpc-3486	297	4	.	.	PUNCT
dpc-3486	298	1	pmcid	pmcid	NOUN
dpc-3486	298	2	:	:	PUNCT
dpc-3486	298	3	pmc8014590.25	pmc8014590.25	ADJ
dpc-3486	298	4	.	.	PUNCT
dpc-3486	299	1	patel	patel	PROPN
dpc-3486	299	2	j	j	PROPN
dpc-3486	299	3	,	,	PUNCT
dpc-3486	299	4	woolley	woolley	PROPN
dpc-3486	299	5	j.	j.	PROPN
dpc-3486	299	6	necrotizing	necrotizing	PROPN
dpc-3486	299	7	periodontal	periodontal	ADJ
dpc-3486	299	8	disease	disease	NOUN
dpc-3486	299	9	:	:	PUNCT
dpc-3486	299	10	oral	oral	ADJ
dpc-3486	299	11	manifestation	manifestation	NOUN
dpc-3486	299	12	of	of	ADP
dpc-3486	299	13	covid-19	covid-19	PROPN
dpc-3486	299	14	.	.	PUNCT
dpc-3486	300	1	oral	oral	ADJ
dpc-3486	300	2	dis	dis	PROPN
dpc-3486	300	3	.	.	PUNCT
dpc-3486	301	1	2021;27	2021;27	NUM
dpc-3486	301	2	suppl	suppl	PROPN
dpc-3486	301	3	3(suppl	3(suppl	PROPN
dpc-3486	301	4	3	3	NUM
dpc-3486	301	5	):	):	PUNCT
dpc-3486	301	6	768	768	NUM
dpc-3486	301	7	-	-	SYM
dpc-3486	301	8	769	769	NUM
dpc-3486	301	9	.	.	PUNCT
dpc-3486	302	1	doi	doi	NOUN
dpc-3486	302	2	:	:	PUNCT
dpc-3486	302	3	10.1111	10.1111	NUM
dpc-3486	302	4	/	/	SYM
dpc-3486	302	5	odi.13462	odi.13462	NOUN
dpc-3486	302	6	.	.	PUNCT
dpc-3486	303	1	pmid	pmid	NOUN
dpc-3486	303	2	:	:	PUNCT
dpc-3486	303	3	32506662	32506662	NUM
dpc-3486	303	4	.	.	PUNCT
dpc-3486	304	1	pmcid	pmcid	NOUN
dpc-3486	304	2	:	:	PUNCT
dpc-3486	304	3	pmc7301037	pmc7301037	NOUN
dpc-3486	304	4	.	.	PUNCT
dpc-3486	305	1	25	25	NUM
dpc-3486	305	2	.	.	PUNCT
dpc-3486	306	1	riad	riad	PROPN
dpc-3486	306	2	a	a	PROPN
dpc-3486	306	3	,	,	PUNCT
dpc-3486	306	4	kassem	kassem	PROPN
dpc-3486	306	5	i	i	PROPN
dpc-3486	306	6	,	,	PUNCT
dpc-3486	306	7	issa	issa	PROPN
dpc-3486	306	8	j	j	PROPN
dpc-3486	306	9	,	,	PUNCT
dpc-3486	306	10	badrah	badrah	PROPN
dpc-3486	306	11	m	m	PROPN
dpc-3486	306	12	,	,	PUNCT
dpc-3486	306	13	klugar	klugar	PROPN
dpc-3486	306	14	m.	m.	NOUN
dpc-3486	306	15	angular	angular	ADJ
dpc-3486	306	16	cheilitis	cheilitis	NOUN
dpc-3486	306	17	of	of	ADP
dpc-3486	306	18	covid-19	covid-19	PROPN
dpc-3486	306	19	patients	patient	NOUN
dpc-3486	306	20	:	:	PUNCT
dpc-3486	306	21	a	a	DET
dpc-3486	306	22	case	case	NOUN
dpc-3486	306	23	-	-	PUNCT
dpc-3486	306	24	series	series	NOUN
dpc-3486	306	25	and	and	CCONJ
dpc-3486	306	26	literature	literature	PROPN
dpc-3486	306	27	review	review	PROPN
dpc-3486	306	28	.	.	PUNCT
dpc-3486	307	1	oral	oral	ADJ
dpc-3486	307	2	dis	dis	PROPN
dpc-3486	307	3	.	.	PUNCT
dpc-3486	308	1	2022;28	2022;28	NUM
dpc-3486	308	2	suppl	suppl	ADJ
dpc-3486	308	3	1(suppl	1(suppl	PRON
dpc-3486	308	4	1):999	1):999	NUM
dpc-3486	308	5	-	-	SYM
dpc-3486	308	6	1000	1000	NUM
dpc-3486	308	7	.	.	PUNCT
dpc-3486	309	1	doi	doi	NOUN
dpc-3486	309	2	:	:	PUNCT
dpc-3486	309	3	10.1111	10.1111	NUM
dpc-3486	309	4	/odi.13675	/odi.13675	NOUN
dpc-3486	309	5	.	.	PUNCT
dpc-3486	310	1	pmid	pmid	NOUN
dpc-3486	310	2	:	:	PUNCT
dpc-3486	310	3	33043573	33043573	NUM
dpc-3486	310	4	.	.	PUNCT
dpc-3486	311	1	pmcid	pmcid	NOUN
dpc-3486	311	2	:	:	PUNCT
dpc-3486	311	3	pmc7675282	pmc7675282	PROPN
dpc-3486	311	4	.	.	PUNCT
dpc-3486	312	1	26	26	NUM
dpc-3486	312	2	.	.	PUNCT
dpc-3486	313	1	kämmerer	kämmerer	PROPN
dpc-3486	313	2	t	t	PROPN
dpc-3486	313	3	,	,	PUNCT
dpc-3486	313	4	walch	walch	VERB
dpc-3486	313	5	j	j	PROPN
dpc-3486	313	6	,	,	PUNCT
dpc-3486	313	7	flaig	flaig	PROPN
dpc-3486	313	8	m	m	PROPN
dpc-3486	313	9	,	,	PUNCT
dpc-3486	313	10	french	french	ADJ
dpc-3486	313	11	le	le	X
dpc-3486	313	12	.	.	PUNCT
dpc-3486	314	1	covid-19	covid-19	PROPN
dpc-3486	314	2	associated	associate	VERB
dpc-3486	314	3	herpetic	herpetic	ADJ
dpc-3486	314	4	gingivostomatitis	gingivostomatitis	NOUN
dpc-3486	314	5	.	.	PUNCT
dpc-3486	315	1	clin	clin	PROPN
dpc-3486	315	2	exp	exp	NOUN
dpc-3486	315	3	dermatol	dermatol	NOUN
dpc-3486	315	4	.	.	PUNCT
dpc-3486	315	5	2021	2021	NUM
dpc-3486	315	6	;	;	PUNCT
dpc-3486	315	7	46(1):174	46(1):174	NOUN
dpc-3486	315	8	-	-	PUNCT
dpc-3486	315	9	176	176	NUM
dpc-3486	315	10	.	.	PUNCT
dpc-3486	316	1	doi	doi	NOUN
dpc-3486	316	2	:	:	PUNCT
dpc-3486	316	3	10.1111	10.1111	NUM
dpc-3486	316	4	/	/	SYM
dpc-3486	316	5	ced.14402	ced.14402	NOUN
dpc-3486	316	6	.	.	PUNCT
dpc-3486	317	1	pmid	pmid	NOUN
dpc-3486	317	2	:	:	PUNCT
dpc-3486	317	3	33405295	33405295	NUM
dpc-3486	317	4	.	.	PUNCT
dpc-3486	318	1	pmcid	pmcid	NOUN
dpc-3486	318	2	:	:	PUNCT
dpc-3486	318	3	pmc9213960	pmc9213960	PROPN
dpc-3486	318	4	.	.	PUNCT
dpc-3486	319	1	2020;24(17):9151	2020;24(17):9151	NUM
dpc-3486	319	2	-	-	SYM
dpc-3486	319	3	9153	9153	NUM
dpc-3486	319	4	.	.	PUNCT
dpc-3486	320	1	doi	doi	NOUN
dpc-3486	320	2	:	:	PUNCT
dpc-3486	320	3	10.26355	10.26355	NUM
dpc-3486	320	4	/	/	SYM
dpc-3486	320	5	eurrev_202009_22863	eurrev_202009_22863	PROPN
dpc-3486	320	6	.	.	PUNCT
dpc-3486	321	1	pmid	pmid	NOUN
dpc-3486	321	2	:	:	PUNCT
dpc-3486	321	3	32965008	32965008	NUM
dpc-3486	321	4	.	.	PUNCT
dpc-3486	322	1	20	20	NUM
dpc-3486	322	2	.	.	PUNCT
dpc-3486	323	1	jimenez	jimenez	PROPN
dpc-3486	323	2	-	-	PUNCT
dpc-3486	323	3	cauhe	cauhe	PROPN
dpc-3486	323	4	j	j	PROPN
dpc-3486	323	5	,	,	PUNCT
dpc-3486	323	6	ortega	ortega	PROPN
dpc-3486	323	7	-	-	PUNCT
dpc-3486	323	8	quijano	quijano	PROPN
dpc-3486	323	9	d	d	PROPN
dpc-3486	323	10	,	,	PUNCT
dpc-3486	323	11	de	de	X
dpc-3486	323	12	perosanz	perosanz	NOUN
dpc-3486	323	13	-	-	PUNCT
dpc-3486	323	14	lobo	lobo	NOUN
dpc-3486	323	15	d	d	PROPN
dpc-3486	323	16	,	,	PUNCT
dpc-3486	323	17	et	et	PROPN
dpc-3486	323	18	al	al	PROPN
dpc-3486	323	19	.	.	PROPN
dpc-3486	323	20	enanthem	enanthem	PROPN
dpc-3486	323	21	in	in	ADP
dpc-3486	323	22	patients	patient	NOUN
dpc-3486	323	23	with	with	ADP
dpc-3486	323	24	covid-19	covid-19	PROPN
dpc-3486	323	25	and	and	CCONJ
dpc-3486	323	26	skin	skin	NOUN
dpc-3486	323	27	rash	rash	NOUN
dpc-3486	323	28	.	.	PUNCT
dpc-3486	324	1	jama	jama	PROPN
dpc-3486	324	2	dermatol	dermatol	NOUN
dpc-3486	324	3	.	.	PUNCT
dpc-3486	325	1	2020;156(10):1134	2020;156(10):1134	NUM
dpc-3486	325	2	-	-	SYM
dpc-3486	325	3	1136	1136	NUM
dpc-3486	325	4	.	.	PUNCT
dpc-3486	326	1	doi	doi	NOUN
dpc-3486	326	2	:	:	PUNCT
dpc-3486	326	3	10.1001	10.1001	NUM
dpc-3486	326	4	/	/	SYM
dpc-3486	326	5	jamadermatol	jamadermatol	NOUN
dpc-3486	326	6	.2020.2550	.2020.2550	PUNCT
dpc-3486	326	7	.	.	PUNCT
dpc-3486	327	1	pmid	pmid	NOUN
dpc-3486	327	2	:	:	PUNCT
dpc-3486	327	3	32667631	32667631	NUM
dpc-3486	327	4	.	.	PUNCT
dpc-3486	328	1	pmcid	pmcid	NOUN
dpc-3486	328	2	:	:	PUNCT
dpc-3486	328	3	pmc7364334	pmc7364334	NOUN
dpc-3486	328	4	.	.	PUNCT
dpc-3486	329	1	21	21	NUM
dpc-3486	329	2	.	.	X
dpc-3486	329	3	martín	martín	PROPN
dpc-3486	329	4	carreras	carreras	PROPN
dpc-3486	329	5	-	-	PUNCT
dpc-3486	329	6	presas	presas	PROPN
dpc-3486	329	7	c	c	NOUN
dpc-3486	329	8	,	,	PUNCT
dpc-3486	329	9	amaro	amaro	PROPN
dpc-3486	329	10	sánchez	sánchez	PROPN
dpc-3486	329	11	j	j	PROPN
dpc-3486	329	12	,	,	PUNCT
dpc-3486	329	13	lópez	lópez	PROPN
dpc-3486	329	14	-	-	PUNCT
dpc-3486	329	15	sánchez	sánchez	PROPN
dpc-3486	329	16	af	af	PROPN
dpc-3486	329	17	,	,	PUNCT
dpc-3486	329	18	jané	jané	PROPN
dpc-3486	329	19	-	-	PUNCT
dpc-3486	329	20	salas	salas	PROPN
dpc-3486	329	21	e	e	PROPN
dpc-3486	329	22	,	,	PUNCT
dpc-3486	329	23	somacarrera	somacarrera	NOUN
dpc-3486	329	24	pérez	pérez	NOUN
dpc-3486	329	25	ml	ml	PROPN
dpc-3486	329	26	.	.	PUNCT
dpc-3486	330	1	oral	oral	ADJ
dpc-3486	330	2	vesiculobullous	vesiculobullous	ADJ
dpc-3486	330	3	lesions	lesion	NOUN
dpc-3486	330	4	associated	associate	VERB
dpc-3486	330	5	with	with	ADP
dpc-3486	330	6	sars	sar	NOUN
dpc-3486	330	7	-	-	PUNCT
dpc-3486	330	8	cov-2	cov-2	PART
dpc-3486	330	9	infection	infection	NOUN
dpc-3486	330	10	.	.	PUNCT
dpc-3486	331	1	oral	oral	ADJ
dpc-3486	331	2	dis	dis	PROPN
dpc-3486	331	3	.	.	PUNCT
dpc-3486	332	1	2021;27	2021;27	NUM
dpc-3486	332	2	suppl	suppl	NOUN
dpc-3486	332	3	3(suppl	3(suppl	PROPN
dpc-3486	332	4	3):710	3):710	NUM
dpc-3486	332	5	-	-	SYM
dpc-3486	332	6	712	712	NUM
dpc-3486	332	7	.	.	PUNCT
dpc-3486	333	1	doi	doi	NOUN
dpc-3486	333	2	:	:	PUNCT
dpc-3486	333	3	10.1111	10.1111	NUM
dpc-3486	333	4	/	/	SYM
dpc-3486	333	5	odi.13382	odi.13382	PROPN
dpc-3486	333	6	.	.	PUNCT
dpc-3486	334	1	pmid	pmid	NOUN
dpc-3486	334	2	:	:	PUNCT
dpc-3486	334	3	32369674	32369674	NUM
dpc-3486	334	4	.	.	PUNCT
dpc-3486	335	1	pmcid	pmcid	NOUN
dpc-3486	335	2	:	:	PUNCT
dpc-3486	335	3	pmc7267423	pmc7267423	NOUN
dpc-3486	335	4	.	.	PUNCT
dpc-3486	336	1	22	22	NUM
dpc-3486	336	2	.	.	PUNCT
dpc-3486	337	1	iranmanesh	iranmanesh	PROPN
dpc-3486	337	2	b	b	PROPN
dpc-3486	337	3	,	,	PUNCT
dpc-3486	337	4	khalili	khalili	PROPN
dpc-3486	337	5	m	m	PROPN
dpc-3486	337	6	,	,	PUNCT
dpc-3486	337	7	amiri	amiri	PROPN
dpc-3486	337	8	r	r	PROPN
dpc-3486	337	9	,	,	PUNCT
dpc-3486	337	10	zartab	zartab	NOUN
dpc-3486	337	11	h	h	NOUN
dpc-3486	337	12	,	,	PUNCT
dpc-3486	337	13	aflatoonian	aflatoonian	NOUN
dpc-3486	337	14	m.	m.	NOUN
dpc-3486	337	15	oral	oral	ADJ
dpc-3486	337	16	manifestations	manifestation	NOUN
dpc-3486	337	17	of	of	ADP
dpc-3486	337	18	covid-19	covid-19	PROPN
dpc-3486	337	19	disease	disease	NOUN
dpc-3486	337	20	:	:	PUNCT
dpc-3486	337	21	a	a	DET
dpc-3486	337	22	review	review	NOUN
dpc-3486	337	23	article	article	NOUN
dpc-3486	337	24	.	.	PUNCT
dpc-3486	338	1	dermatol	dermatol	NOUN
dpc-3486	338	2	ther	ther	ADV
dpc-3486	338	3	.	.	PUNCT
dpc-3486	339	1	2021;34(1):e14578	2021;34(1):e14578	X
dpc-3486	339	2	.	.	PUNCT
dpc-3486	340	1	doi	doi	NOUN
dpc-3486	340	2	:	:	PUNCT
dpc-3486	340	3	10.1111	10.1111	NUM
dpc-3486	340	4	/	/	SYM
dpc-3486	340	5	dth.14578	dth.14578	PROPN
dpc-3486	340	6	.	.	PUNCT
dpc-3486	341	1	pmid	pmid	NOUN
dpc-3486	341	2	:	:	PUNCT
dpc-3486	341	3	33236823	33236823	NUM
dpc-3486	341	4	.	.	PUNCT
dpc-3486	342	1	pmcid	pmcid	NOUN
dpc-3486	342	2	:	:	PUNCT
dpc-3486	342	3	pmc7744903	pmc7744903	VERB
dpc-3486	342	4	.	.	PUNCT
dpc-3486	343	1	23	23	NUM
dpc-3486	343	2	.	.	PUNCT
dpc-3486	344	1	soares	soares	PROPN
dpc-3486	344	2	cd	cd	PROPN
dpc-3486	344	3	,	,	PUNCT
dpc-3486	344	4	mosqueda	mosqueda	PROPN
dpc-3486	344	5	-	-	PUNCT
dpc-3486	344	6	taylor	taylor	PROPN
dpc-3486	344	7	a	a	PRON
dpc-3486	344	8	,	,	PUNCT
dpc-3486	344	9	de	de	PROPN
dpc-3486	344	10	carvalho	carvalho	PROPN
dpc-3486	344	11	mgf	mgf	PROPN
dpc-3486	344	12	,	,	PUNCT
dpc-3486	344	13	de	de	PROPN
dpc-3486	344	14	almeida	almeida	PROPN
dpc-3486	344	15	op	op	NOUN
dpc-3486	344	16	.	.	PUNCT
dpc-3486	345	1	oral	oral	ADJ
dpc-3486	345	2	vesiculobullous	vesiculobullous	ADJ
dpc-3486	345	3	lesions	lesion	NOUN
dpc-3486	345	4	as	as	ADP
dpc-3486	345	5	an	an	DET
dpc-3486	345	6	early	early	ADJ
dpc-3486	345	7	sign	sign	NOUN
dpc-3486	345	8	of	of	ADP
dpc-3486	345	9	covid-19	covid-19	PROPN
dpc-3486	345	10	:	:	PUNCT
dpc-3486	345	11	immunohistochemical	immunohistochemical	ADJ
dpc-3486	345	12	detection	detection	NOUN
dpc-3486	345	13	of	of	ADP
dpc-3486	345	14	sars	sar	NOUN
dpc-3486	345	15	-	-	PUNCT
dpc-3486	345	16	cov-2	cov-2	NOUN
dpc-3486	345	17	spike	spike	ADJ
dpc-3486	345	18	protein	protein	NOUN
dpc-3486	345	19	.	.	PUNCT